conference Program - CANO-ACIO

Transcription

FINAL
PROGRAM
1
At Sanofi Oncology, the patient is our inspiration. We are dedicated
to translating science into effective therapeutics that address unmet
medical needs for cancer and organ transplant patients.
Through our global organization of talented and passionate
employees, we are building a renewed and diversified portfolio,
driven by the principles of innovation, personalization and patient
access to medicines.
We believe that delivering innovative treatment solutions requires
collaboration with external experts, which is why we partner our
own internal expertise with the best experts in scientific discovery
and clinical research around the world.
La source d’inspiration chez Sanofi Oncologie est le patient. Nous
avons pour mission de traduire les avancées scientifiques en solutions
thérapeutiques efficaces pour répondre aux besoins non satisfaits
des patients cancéreux et transplantés.
S’appuyant sur une organisation mondiale de collaborateurs
talentueux et passionnés, nous avons constitué un portefeuille
renouvelé et diversifié dont les principaux leviers sont l’innovation,
la personnalisation et l’accès au médicament.
Nous croyons aux partenariats avec des experts de tout premier plan
et c’est pour cette raison que nous établissons des partenariats avec les
meilleurs spécialistes mondiaux de la recherche scientifique et clinique.
RECOGNIZING
CANO/ACIO STARS
WE ARE PLEASED TO
ANNOUNCE THAT FOR THE
FIRST TIME CANO/ACIO WILL
PROVIDE A LIVE WEBCAST OF
OUR AWARDS CEREMONY!
The CANO/ACIO Awards Ceremony is scheduled for TUESDAY, OCTOBER 22, 2013
FROM 9:30 AM TO 10:00 AM PACIFIC / 12:30 TO 1:00 PM EASTERN
in the GRAND BALLROOM OF THE SHERATON WALL CENTRE, VANCOUVER.
The awards ceremony will be webcast here:
HTTP://NEW.LIVESTREAM.COM/MEDIACO/CANOAWARDS2013.
At the ceremony we will recognize the extraordinary contributions of our members to their profession,
their patients and their community.
THE FOLLOWING AWARDS WILL BE PRESENTED:
BOEHRINGER INGLEHEIM NURSE OF THE YEAR AWARD
ROCHE BREAST CANCER CARE AWARD
PFIZER AWARD FOR EXCELLENCE IN NURSING RESEARCH
PFIZER AWARD FOR EXCELLENCE IN NURSING EDUCATION
PFIZER AWARD FOR EXCELLENCE IN NURSING LEADERSHIP
PFIZER AWARD FOR EXCELLENCE IN NURSING CLINICAL PRACTICE
KIDNEY CANCER CANADA AWARD
As well, we will present the education scholarships and travel grants.
OUR TWO AWARD LECTURES ARE SCHEDULED FOR:
SUNDAY, OCTOBER 20, 2013 FROM 11:15 AM TO 12:15 PM
TUESDAY, OCTOBER 22, 2013 FROM 2 PM TO 3 PM
Helene Hudson Lecture and Award presentation, sponsored by Amgen. Merck Lectureship and Award Presentation.
THE FOLLOWING ABSTRACT AWARDS WILL BE PRESENTED AT THE CLOSING CEREMONY
BRAIN TUMOUR ABSTRACT AWARD
MANITOBA CHAPTER POSTER AWARD
OVARIAN CANCER CANADA AWARD
THE CLOSING CEREMONY IS WEDNESDAY, OCTOBER 23, 2013 AT 3:30 PM IN THE GRAND BALLROOM
We wish to thank members for the leadership shown in nominating one of their colleagues for an award. And, we wish to thank the sponsors of the awards!
CONGRATULATIONS TO THE NOMINEES OF
THE 2013 NURSE OF THE YEAR AWARD!
Colleen Sherriff
SURREY BC
Cynthia McLennan
ARNPRIOR ON
Donna Van Allen
MILLBANK ON
Fiona Barham
LONDON ON
Geneviève Lepage
QUEBEC QC
Jodi Hyman
WINNIPEG MB
Kathleen Fitzgerald
ST JOHN’S NL
Komal Patel
BRAMPTON ON
Kristy MacLeod
WHITEHORSE YT
Leslie Fedorak
EDMONTON AB
Lollita Rahaman
BRAMPTON ON
Pamela Savage
TORONTO ON
The 2013 Nurse of the Year Award will be live webcast
on October 22nd, 9:30 - 10:00 am PDT /12:30 - 1 PM EDT at
http://new.livestream.com/mediaco/CanoAwards2013
Congratulations and best wishes to all nominees.
CANO/ACIO gratefully acknowledges the generous support of
Boehringer Ingelheim (Canada) for this award.
Driven by passion. Committed to life.
As the largest pharmaceutical company in Japan and a leader in the global
industry, Takeda’s mission is focused on people, to strive toward better health for
patients worldwide through leading innovation in medicine.
We have always been driven by passion; the passion to build a healthier society.
For over 230 years, our core principles have guided us through a world of
constant changes ensuring that we always act with integrity, always putting
people first.
We are dedicated to pharmaceutical innovation, tackling diseases for which there
is currently no cure and expanding into new fields of treatment and therapy. Our
commitment is to improve the quality of the most precious thing we know: life.
With a head office in Oakville, Ontario, Takeda employs more than 275 people
across the country with a combined goal of bringing important medicines to
Canadians who need them in the areas of metabolic diseases, gastroenterology,
oncology, cardiovascular health, CNS diseases, inflammatory and immune
disorders, respiratory diseases and pain management. Our passion combined
with our global business philosophy prescribes that all of our corporate activities
are based on the highest levels of integrity, fairness, honesty and perseverance.
Sponsor & Exhibitor Listing
Liste des commanditaires et exposants
The 25th CANO/ACIO Annual Conference is made possible by the generous support of the following organizations:
La 25ème conférence annuelle de l’ACIO/CANO est rendue possible grâce au généreux soutien des organisations suivantes:
Platinum|Platine
Gold|Or
Silver|Argent
Bronze|Bronze
Internet Centre|Centre Internet
Symposia|Symposium
Amgen • Astellas • Boehringer Ingelheim • Janssen • Lundbeck Oncology • Novartis
Focus Group|Panel de discussion
Bayer • Lundbeck Oncology • Roche
Award Sponsors|Sponsors des récompenses
Amgen • Boehringer Ingelheim • Merck • Pfizer • Roche
Exhibitors|Autres commmanditaires de la conférence
3M • Abbott Nutrition • AbbVie • Amgen • Astellas • Bayer • BD • Beutlich Pharmaceuticals • Bio-Oil • Boehringer
Ingelheim • Calmoseptine • The Canadian Cancer Society • Cancer and Careers • Cardinal Health Canada •
CANO/ACIO • Canadian Nurses Association • Celgene • Cold Comfort Canada • De Souza • Eisai • Fertile Future
• Fisher Health Care Inc. • Fresenius Kabi Canada • GlaxoSmithKline • ICU Medical Inc • International Society
of Nurses in Cancer Care • Janssen Inc. • Kidney Cancer Canada • Leukemia and Lymphoma Society of Canada
• Look Good Feel Better and FacingCancer.ca • Lundbeck • Lymphoma Canada • Merck • Novartis • Oncology
Nursing Society • On the Tip of the Toes Foundation • Paladin Labs Inc. • Pendopharm • Pfizer Canada Inc. • Rethink
Breast Cancer • Roche Canada • Sanofi • Shoppers Drugmart Specialty Health Network • Takeda Canada Inc.
10
CANO/ACIO 2013 Conference Sheraton Vancouver Wall Center, British Columbia
Table of Contents/
Table des matières
Welcome Notes Mots de bienvenue.................................................................................................... 16
Greetings from Vancouver! Bonjour de Vancouver!............................................................................ 18
General Conference Information Informations sur la conférence....................................................... 20
Committee Listing Liste des membres des comités............................................................................ 21
About Vancouver Au sujet de Vancouver. ............................................................................................ 22
Vancouver Map Carte de Vancouver................................................................................................... 24
Conference Centre Floor Plan Plan du centre de conférences........................................................... 25
Exhibitor Floor Plan and Listing Plan et liste des exposants............................................................... 26
Conference Program at-a-glance Programme de la conference d’un coup d’oeil............................... 28
Meeting Schedule Horaire des reunions............................................................................................. 30
Day One Jour Un. ................................................................................................................................ 31
Day Two Jour deux. ............................................................................................................................. 38
Day Three Jour Trois........................................................................................................................... 44
Day Four Jour Quatre.......................................................................................................................... 49
Abstract Listing Liste des abrégés pour presentation orale................................................................ 54
Poster Presentations Séance d’affichage........................................................................................ 104
Conference Exhibitor Listings Liste des exposants.......................................................................... 119
Sunday, October 20 to Wednesday, October 23, 2013 CANO/ACIO Conference 2013
11
I am pleased to extend my warmest greetings to everyone attending the 25th annual Conference of the Canadian Association of Nurses in Oncology (CANO) taking place in Vancouver. Founded in 1984, CANO fosters excellence in oncology nursing practice and actively promotes education, research, and leadership amongst its members. This yearʹs convention, “Inspiration, Innovation, Transformation,” offers an ideal forum in which to share experiences with colleagues from across the country while learning about the latest research. I am sure that delegates will come away from this gathering with increased knowledge and new ideas to improve cancer patient care. I would like to commend everyone associated with CANO for their commitment to excellence and compassion. Your efforts make a critical difference in the lives of many Canadians coping with cancer and are deeply appreciated. Please accept my best wishes for an enjoyable and productive meeting. OTTAWA 2013 The Rt. Hon. Stephen Harper, P.C., M.P. Je suis heureux de présenter mes salutations les plus chaleureuses à tous ceux et celles qui participent à la 25e Conférence annuelle de l’Association canadienne des infirmières en oncologie (ACIO), qui se déroule à Vancouver. Fondée en 1984, l’ACIO favorise l’excellence en matière de pratique des soins infirmiers en oncologie et fait la promotion active de l’éducation, de la recherche et du rôle prépondérant de l’Association auprès de ses membres. La conférence de cette année, qui a pour thème « Inspiration, Innovation et Transformation », offre un cadre idéal pour faire part de ses expériences à des collègues venus des quatre coins du pays, tout en permettant dʹen apprendre davantage sur les recherches les plus récentes. Je n’ai aucun doute qu’à la fin de cette conférence, les participants auront amélioré leurs connaissances et acquis de nouvelles idées afin de prodiguer des soins encore meilleurs aux patients atteints d’un cancer. Je tiens à féliciter toutes les personnes associées à l’ACIO de leur engagement envers l’excellence et de leur compassion. Les efforts que vous déployez revêtent une importance considérable dans la vie de nombreux Canadiens qui combattent le cancer et nous vous en sommes tous profondément reconnaissants. Je vous souhaite une conférence agréable et productive. OTTAWA 2013
Le très honorable Stephen Harper, c.p., député Letter from the President
Dear Colleagues,
On behalf of the CANO/ACIO Board of Directors I am
Finally, I’d like to thank the Scientific Programming
excited to welcome you to the 25 Annual Conference
Committee chaired by Jennifer Stephens and Tracy
of the Canadian Association of Nurses in Oncology
Truant. Their attention to our diverse membership has
taking place in Vancouver, BC. We hope you will join
ensured a conference program that will interest and
us for another year of learning, networking and growing
provide further resources for a wide cross-section of
both as individuals and as oncology nurses.
nurses. I encourage you to take advantage of the many
th
educational sessions offered and to attend the abstract
The theme of this year’s conference: Inspiration –
presentations, focus groups and workshops taking
Innovation – Transformation, truly reflects the landscape
place over the course of the four days.
we work in as oncology nurses. Rapid scientific and
technological advances along with constantly shifting
Throughout the conference there will be a number of
and growing patient populations require us to embrace
opportunities to come together and get involved in our
the challenges that come along with providing the best
association. We encourage you to attend the committee
care possible; something that is only achievable with a
meetings and get involved in a special interest group,
great deal of passion. We hope that this year’s program
connect with other nurses in your area at the Council
provides ample opportunity for nurses to come together
of Chapters meeting and attend the Annual General
and inspire one another to remain energized and grow
Meeting to find out more about our association.
with the constant development in our field.
I wish to thank all of our members, old and new, for their
This conference would not be possible without the hard
support and participation in our association. We hope
work and dedication of our various planning committees.
this conference will support your educational goals and
The Conference Planning Steering Committee, chaired
leave you feeling inspired and supported.
by Karyn Perry and Jeanne Robertson, has spent a
great deal of time managing the planning and creation
Sincerely,
of a wonderful conference for our members.
The Local Planning Committee, led by Brenda Ross,
has worked tirelessly to provide our delegates with an
authentic Vancouver experience and fully incorporate
the conference theme into every aspect of the program.
Brenda Sabo, RN, MA, PhD
Don’t miss the exciting social event they have put
together for us!
President
Canadian Association of Nurses in Oncology
16
Lettre de la Présidente
Chers collègues,
Enfin, j’aimerais remercier le comité de planification
C’est au nom du conseil d’administration de l’ACIO/
Comme elles ont porté grande attention aux besoins
CANO que j’ai le vif plaisir de vous inviter à assister à la
variés de nos membres, le programme de la conférence
25e conférence annuelle de l’Association canadienne des
saura intéresser un large éventail d’infirmières et leur
infirmières en oncologie qui se tiendra à Vancouver,
fournir de nouvelles ressources. Je vous encourage à
C.-B. Nous espérons que vous vous joindrez à nous
vous prévaloir des nombreuses séances pédagogiques
pour la nouvelle édition de cet événement favorisant
offertes et à assister aux présentations d’abrégés,
l’apprentissage, le réseautage et la croissance des
groupes de discussion et ateliers qui se tiendront au
infirmières en oncologie, sur les plans à la fois personnel
cours des quatre journées.
et professionnel.
scientifique dirigé par Jennifer Stephen et Tracy Truant.
La conférence vous fournira également diverses
Le thème retenu pour la conférence de cette année
opportunités de vous réunir entre collègues et de vous
Inspiration – Innovation – Transformation reflète
impliquer dans la vie de votre association. Nous vous
fidèlement l’environnement dans lequel œuvrent
encourageons à assister aux réunions de comités et à
les infirmières en oncologie. Les rapides avancées
vous joindre à un groupe d’intérêts spéciaux, à prendre
technologiques et scientifiques ainsi que l’évolution
contact avec d’autres infirmières de votre région dans le
et la croissance constantes des groupes de patients
cadre de la réunion du conseil des sections et à assister
exigent que nous relevions les défis auxquels nous
à l’assemblée générale annuelle pour en savoir plus sur
sommes confrontés tout en dispensant les meilleurs
votre association.
soins; il arrive quelquefois qu’il nous faille beaucoup
de passion pour y parvenir. Nous espérons que le
programme de cette année saura inciter les infirmières
à se rassembler et à s’inspirer les unes les autres
afin de conserver leur vitalité et de suivre les progrès
Je voudrais remercier tous les membres, anciens et
nouveaux, de leur appui et de leur participation aux
activités de notre association. Nous espérons que vous
serez des nôtres à Vancouver en octobre prochain
constants caractérisant notre spécialité.
afin de participer à un événement conçu pour inspirer,
Cette conférence ne pourrait pas avoir lieu sans le travail
peu partout au Canada.
et le dévouement sans faille de nos divers comités de
planification. Le comité directeur de la conférence,
dirigé par Karyn Perry et Jeanne Robertson, a consacré
beaucoup de temps à la planification et à la mise sur
soutenir et instruire les infirmières en oncologie d’un
Je vous prie d’agréer mes salutations professionnelles.
Bien à vous,
pied d’une merveilleuse conférence pour le bénéfice
des membres.
Le comité de planification local, dirigé par Brenda Ross,
a travaillé sans relâche pour fournir aux délégués une
expérience authentique de la ville de Vancouver et
pour intégrer pleinement le thème de la conférence
à chacun des aspects du programme. Ne manquez
surtout pas la passionnante soirée sociale que nous
Brenda Sabo, inf., MA, PhD
Présidente
Association canadienne des infirmières en oncologie
avons préparée à votre intention!
17
greetings from vancouver!
On behalf of the BC Oncology Nurses Group (BCONG),
For a CANO/ACIO favourite event, we encourage
we welcome you to the 25 th Annual CANO/ACIO
you to join us for a social evening of celebration in
conference in beautiful Vancouver, British Columbia!
the heart of Vancouver. The Great Hall of the Law
We believe you will be inspired by our glorious
Courts building is an amazing atmosphere settled in
natural west coast setting while being professionally
the shadows of city-scape vistas, and there we will
and personally transformed through learning about
dine, dance to a live ABBA tribute band (70’s attire
innovations and acquiring new knowledge as you
encouraged!), and sample the first-ever CANO/ACIO
engage with others throughout the conference.
cocktail. All social night attendees will receive a
complimentary photographic souvenir, sure to impress
The
conference
theme,
Inspiration,
Innovation,
family and friends!
Transformation, comes to life through our keynote
speakers. Mr. Daniel Stolfi, actor, comedian, cancer
Our hope is that you will return to your practice setting
survivor
and
inspired, ready to inspire others and to embrace fresh
transform us through his original performance of
innovations as you integrate them into your nursing
“Cancer Can’t Dance Like This”. Dr. Barbara Pesut,
practice. More than anything else, prepare to be
Canada Chair in Health, Ethics and Diversity, will
personally and professionally transformed in a way
explore spirituality in oncology nursing. Her inspiring
that will transform others through your enthusiasm and
message will offer reflections on how ethically good
new knowledge.
and
patient
advocate
will
inspire
care in a spiritually diverse society is an essential, and
sometimes transformative component of nursing care.
Welcome to the 2013 Annual CANO/ACIO conference
Ms. Janie Brown, founder of the Callanish Society and
in Vancouver!
an oncology nurse with innovative vision, will inspire
through stories of transformation of people and families
affected by cancer. Janie’s work nourishes both heart
and soul, and her stories will touch you forever.
The conference’s scientific program of workshops,
oral, and poster presentations is rich and diverse,
with something for everyone. Novice to expert, across
practice, education, research and leadership roles, and
covering the cancer control spectrum from prevention
to end-of-life care, the program offers opportunities to
Brenda Ross
transform your practice. An additional highlight this
Chair, Local Planning Committee
year is an innovative symposium on health disparities in
CANO/ACIO Conference 2013
cancer care. Experts will discuss Canadian, American
Vancouver, BC
and international challenges and overarching issues
regarding the many health disparities influencing the
care of people at risk for and/or experiencing cancer.
This inspiring, interactive symposium will feature
strategies that oncology nurses may use to transform
lives through influencing marginalizing conditions and
working toward addressing these disparities.
18
Bonjour de Vancouver!
Au nom du BC Oncology Nurses Group (BCONG),
bienvenue à la 25e édition de la Conférence annuelle
de l’ACIO/CANO, et bienvenue à la magnifique
ville de Vancouver, en Colombie-Britannique! Nous
sommes persuadées que nos magnifiques paysages
de la côte Ouest vous inspireront et que vous sortirez
transformées sur les plans personnel et professionnel
par les innovations et les connaissances que vous
découvrirez et les personnes que vous rencontrerez
tout au long de cet événement.
Le thème de la conférence, Inspiration, Innovation,
Transformation, prendra vie à travers nos conférenciers.
M. Daniel Stolfi, acteur, comédien, survivant du cancer
et défenseur de la cause des patients, nous inspirera
et nous transformera par le biais de son interprétation
originale de “Cancer Can’t Dance Like This”. La Dre
Barbara Pesut, détentrice de la Chaire de recherche du
Canada sur la santé, l’éthique et la diversité, explorera
la question de la spiritualité dans les soins infirmiers
en oncologie. Son message inspirant examinera la
façon dont les soins basés sur l’éthique dans une
société spirituellement diversifiée constituent un
élément essentiel et parfois transformateur des soins
infirmiers. Mme Janie Brown, fondatrice de la Callanish
Society et infirmière en oncologie, présentera sa vision
novatrice et nous inspirera par le biais d’histoires sur
la transformation de personnes et de familles touchées
par le cancer. Le travail de Mme Brown nourrit à la fois
le cœur et l’esprit, et ses histoires vous marqueront
pour toujours.
Le programme scientifique de la conférence
comprendra des ateliers, des présentations orales
et des présentations d’affiches. Sa richesse et sa
diversité permettront à tous d’en retirer quelque
chose. L’événement attirera des infirmières de tous les
niveaux d’expérience – de novice à expert – engagées
dans des rôles de pratique, d’éducation, de recherche
et de leadership. Le programme couvrira tout l’éventail
de la lutte contre le cancer, des soins préventifs aux
soins de fin de vie, et vous offrira de nombreuses
occasions de transformer votre pratique. Cette année,
la conférence comprendra en outre un symposium
novateur sur les disparités en matière de santé parmi
les personnes atteintes d’un cancer. Les spécialistes
aborderont les défis auxquels font face les infirmières
au Canada, aux États-Unis et dans d’autres pays,
ainsi que les grands enjeux afférant aux nombreuses
disparités en santé qui influencent les soins dispensés
aux personnes à risque de développer un cancer ou
qui en sont déjà atteintes. Ce symposium inspirant et
interactif illustrera des stratégies que les infirmières en
oncologie peuvent utiliser pour transformer des vies,
des stratégies axées sur le changement de conditions
de marginalisation et sur la réduction des disparités en
matière de santé.
La conférence est l’un des principaux événements
de l’ACIO/CANO, et nous vous encourageons à vous
joindre à nous pour une soirée sociale de célébrations
en plein cœur de Vancouver. Le grand hall de l’édifice
des Law Courts offrira une ambiance envoûtante
nichée à l’ombre de paysages urbains. Nous dînerons
et danserons au rythme d’un groupe rendant hommage
à ABBA (une belle occasion de sortir vos vêtements
des années 70!) et aurons droit au tout premier
cocktail de l’ACIO/CANO. Tous les participants à la
soirée sociale recevront une photo souvenir gratuite
qui impressionnera sûrement votre famille et vos amis!
Nous espérons que vous retournerez à votre pratique
sur une vague d’inspiration, prêtes à inspirer autrui
et à intégrer avec entrain des innovations dans
votre pratique. Et surtout, préparez-vous à vivre une
transformation personnelle et professionnelle; votre
enthousiasme et vos nouvelles connaissances auront
à leur tour un effet transformateur sur votre entourage.
Bienvenue à la Conférence 2013 de l’ACIO/CANO à
Vancouver!
Brenda Ross
Présidente, Comité de
planification local Conférence
2013 de l’ACIO/CANO
Vancouver, C.-B.
19
General Conference Information
Informations sur la conférence
Registration/Inscription and
Speaker Services/Services aux
conférencières et conférenciers
To register for the conference, go to the CANO/ACIO website
at www.cano-acio.ca and either complete your registration
online (pay by credit card online & receive a $25 discount)
or download and submit by fax or mail a registration form
(cheque payment only). Once your registration has been
processed, a receipt will be emailed to you.
On-site registration will be available. Cheque and credit
card payment will be accepted.
The registration desk is located in the Gulf Islands Lobby.
Social Evening/Soirée Sociale
On October 22nd party in the heart of Vancouver! Our
social night is at the Great Hall of the Law Courts where
there is plenty of room for dancing and conga lines! We
will be entertained by a local ABBA tribute band, ABRA
Cadabra, who are guaranteed to get us up and shake that
thang*. A photographic souvenir, a signature CANO/ACIO
cocktail, gaiety and frivolity with friends, wine, music, and
good food are all included in the price of admission. We’ll
have amazing prizes for the best ABBA attitude (i.e. 70’s
outfits) so make sure to get to the costume shop early.
Get your social ticket at the registration desk!
*pre-tested by the Local Planning Committee
The Speaker Services Center, located in Gulf Islands A,
is equipped with PC laptops for speakers to review their
presentations before their session.
Simultaneous Translation/
Interprétation simultanée
Speaker Services and Registration hours are as follows:
Keynote lectures, the Helene Hudson Memorial Lecture
and Merck-CANO/ACIO Lecture may be presented in
English, with simultaneous translation into French or
vice versa. We strongly recommend that you reserve
a simultaneous translation headset. Please reserve a
simultaneous translation headset when you register.
Saturday, October 19 | 2:00 pm - 8:00 pm
Sunday, October 20 | 6:30 am - 7:00 pm
Monday, October 21 | 6:30 am - 7:00 pm
Tuesday, October 22 | 6:30 am - 7:00 pm
Wednesday, October 23 | 8:00 am - 4:00 pm
Accommodation/Logement
For the convenience of conference attendees, a limited
number of rooms have been reserved at the Sheraton
Wall Centre at a special rate.
Please call the hotel directly at 1-888-627-7058 to
make reservations and identify yourself as being with
“Canadian Association of Nurses in Oncology” to obtain
Scents/Odeurs
Please note that the CANO/ACIO 2013 Conference is a
scent free environment. Please refrain from the use of
perfumes or other strong scents during the conference.
Yoga
You can also book online by following the link on the
We are pleased to offer yoga at this conference. An
exploration of yoga to support the journey to vibrant health;
synchronize breath with movement, experience the depths
of presence while cultivating strength and flexibility. All
levels welcome, please wear comfortable clothing. Please
annual conference page at www.cano-acio.ca.
see the conference program at-a-glance for the schedule.
the conference rate.
Information
For further information contact the Conference Secretariat:
CANO/ACIO Management Office 375 West 5th Avenue, Suite 201 Vancouver, BC V6Y 1J6
Tel: 604.874.4322 Fax: 604.874.4378 Email: cano@malachite-mgmt.com
Web: www.cano-acio.ca
20
Committee Listing
Liste des membres des comités
Local Planning Committee/
Comité de planification local
Scientific Program Committe/
Comité du programme scientifique
Brenda Ross, RN, BScN, CON(C)
Jennifer Stephens, RN, BSN, MA, OCN
SPC Co-Chair
LPC Chair
Janet Bates, RN, BScN, CON(C)
Elizabeth Beddard-Huber, RN, MSN, CHPCN(C)
Mary McCullum, RN, MSN, CON(C)
Tracy Truant, RN, MSN
SPC Co-Chair
Virginia Lee, BA, MScN, PhD
Gail Macartney, RN(EC), MSc(A), CON(C), PhD
Sally Thorne, RN, PhD, FCAHS
Lindsay Schwartz, MScA
SPC Co-Chair
CANO Board of Directors/
Conseil d’administration de l’ACIO
SPC Co-Chair
Brenda Sabo, RN, MA, PhD
President
Conference Planning Steering
Committee/Comité d’organisation
de la conférence
Barbara Fitzgerald, RN, MScN
Vice-President
Karyn Perry, RN, BSN, CON(C), MBA
Corsita Garraway, RN(EC),MScN, CON(C)
Director-at-Large, Membership
CPSC co-chair
Jeanne Robertson, RN, BSc, BA, MBA
CPSC co-chair
Genevieve Lepage, MScN
2014 Co-Chair
Brenda Ross, RN, BScN, CON(C)
LPC Chair
SPC Co-Chair
Karyn Perry, RN, BSN, CON(C), MBA
Director-at-Large, Education
Heather Porter, RN, BScN, PhD
Canadian Oncology Nursing Journal Editor-in-Chief
Laura Rashleigh, RN, BScN, MScN, CON(C)
Director-at-Large, Professional Practice
Lorna Roe, RN, MScN, BSc
Director-at-Large, Communications
Sally Thorne, RN, PhD, FCAHS
Director-at-Large, Research
Lucie Tardif, MScN
2014 Co-Chair
SPC Co-Chair
Jeanne Robertson, RN, BSc, BA, MBA
Treasurer
Christine Zywine, RN(EC), MScN
Director-at-Large, External Relations
Margaret Fitch, RN, PhD
Canadian Oncology Nursing Journal Editor-in-Chief
Vice-President Elect
21
About vancouver
VANCOUVER, British Columbia, is two cities rolled into one with interests for one and all. For an outdoor lover, this
western Canadian city is a nature paradise, with miles of scenic hiking and bike trails that sweep along the Strait
of Georgia, the tree-lined waterway that connects Vancouver with the Pacific Ocean. For urbanites, Vancouver
is a sophisticated destination, with thriving immigrant enclaves, an ever-expanding restaurant scene, quirky
neighborhoods, distinctive shops and lively bars that party all night. Part of the fun is weaving your way through
Vancouver’s two sides, and realizing that’s why the city ranks as one of the world’s most livable places.
Come by the Tourism Vancouver booth in the exhibit hall to learn more about our beautiful city!
www.tourismvancouver.com
22
Au sujet de Vancouver
La ville de Vancouver, en Colombie-Britannique, a en fait une identité double qui lui permet de répondre aux besoins
de tout un chacun. Pour les amoureux de plein air, cette ville de l’Ouest canadien est un paradis naturel qui offre
de vastes réseaux de sentiers pédestres et pistes cyclables panoramiques le long du détroit de Georgie, le bras
de mer au littoral boisé qui relie Vancouver à l’océan Pacifique. Et pour les citadins, Vancouver est une destination
sophistiquée qui compte des quartiers d’immigrants prospères, une culture de la restauration en perpétuelle
expansion, des quartiers uniques en leur genre, des boutiques originales et des bars animés ouverts toute la nuit.
Amusez-vous à découvrir les deux visages de Vancouver, et vous comprendrez pourquoi la ville se classe parmi les
meilleurs endroits au monde où il fait bon vivre.
Rendez-vous au kiosque de Tourism Vancouver dans la salle des exposants afin d’en savoir plus sur notre magnifique ville!
www.tourismvancouver.com/travel-trade/international-sites/french/
23
vancouver map
Carte de Vancouver
Sheraton Vancouver Wall Centre
24
Vancouver Law Courts
088 Burrard Street Vancouver, British Columbia V6Z 2R9 Canada
Phone (604) 33-000
n
n
conference centre floor plan
Plan du centre de conférences
PORT Vancouver Wall Centre
Sheraton
ELEVATOR
LOBBY
HARDY
088 Burrard Street Vancouver, British Columbia V6Z 2R9 Canada
Phone (604) 33-000
n
PORT
MCNEILL
n
PORT
ALBERNI
fourth floor
FOURTHnorth
FLOOR
tower hotel
NORTH TOWER HOTEL
Third floor north and south hotel
B
UPPER
PASSAGE

C
9
GRAND BALLROOM
A
LOWER
PASSAGE
GRAND
BALLROOM
FOYER
D
GRAND
COAT CHECK
grand ballroom level
north tower hotel
GRAND BALLROOM LEVEL
NORTH TOWER HOTEL
26
exhibitor floor plan
Plan et liste des exposants
Third floor
north TOWER
Third floor
south TOWER
ES
C
HO ALA
TE TO
LL RT
OB O
BY
47
1
45
39 40
2
44
JUNIOR B
JUNIOR A
3
5
23 24 25 26
SERVICE
4
30 29 28 27
KITCHEN
INTERNET
CAFE
32 33 34
SERVICE
FOOD &
BEVERAGE
31
FOOD &
BEVERAGE
38 37 36 35
JUNIOR C
JUNIOR
FOYER
7
8
41
22
21
20
19
15
16
17
18
14
13
COMPANY NAME
12
11
JUNIOR D
FOOD &
BEVERAGE
43 42
10
9
BOOTH
COMPANY NAME
BOOTH
COMPANY NAME
BOOTH
7
Cold Comfor t Canada
24
Lymphoma Canada
13
Abbott Nutrition
5
de Souza
12
Merck
38
AbbVie
33
Eisai
8
Novar tis
Amgen
27
Fer tile Future
16
Oncology Nursing Society
Astellas
3
Fisher Health Care Inc.
46
On the Tip of the Toes Foundation
17
Bayer
22
Fresenius Kabi Canada
20
Paladin Labs Inc.
25
BD
21
GlaxoSmithKline
2
Pendopharm
28
Beutlich Pharmaceuticals
19
ICU Medical Inc
4
Pfizer Canada Inc.
41
Bio-Oil
32
Rethink Breast Cancer
9
Boehringer Ingelheim
30
Calmoseptine
23
Janssen Inc.
The Canadian Cancer Society
44
Canadian Nurses Association
18
Cancer and Careers
26
CANO/ACIO
47
Cardinal Health Canada (CHC)
Celgene
3M
International Society of Nurses in
Cancer Care
42
Roche Canada
36
10 & 11
39 & 40
31
Sanofi
35
Kidney Cancer Canada
14
29
Leukemia and Lymphoma
Society of Canada
Shoppers Drugmar t Specialty Health
Network
45
Takeda Canada Inc.
37
43
Look Good Feel Better and
FacingCancer.ca
15
1
Lundbeck
34
27
Conference Program at-a-Glance
Programme de la conférence d’un coup d’oeil
Pre-Conference Day/ Journée pré-conférence: Saturday, October 20, 2013 / samedi, 20 octobre 2013
2:00 pm – 8:00 pm
Registration Gulf Islands Lobby
5:00 pm – 6:30 pm
CANO/ACIO SIO Joint Public Lecture St. Andrews Wesley Church
Day ONe / Jour UN: Sunday, October 20, 2013 / dimanche, 20 octobre 2013
Breakfast on Own
6:30 am – 7:00 pm
8:00 am – 9:15 am
Opening Ceremony Grand Ballroom
9:15 am – 9:45 am
Health Break sponsored by Janssen Junior Ballroom Foyer
9:45 am – 11:15 am
Concurrent Session
I-01 Parksville
11:15 am – 12:15 pm
Helene Hudson Lectureship - sponsored by Amgen Grand Ballroom
12:15 pm – 1:45 pm
Lundbeck Lunch Symposium Grand Ballroom
2:00 pm – 5:00 pm
Workshop
II-01 Parksville
3:00 pm – 3:15 pm
Health Break sponsored by Roche Junior Ballroom Foyer
5:00 pm – 6:00 pm
Advanced Practice
Nursing SIG
Junior Ballroom A-B
6:00 pm – 7:00 pm
Bayer Focus Group Junior Ballroom C
7:00 pm – 8:30 pm
Keynote Presentation I — Daniel Stolfi - sponsored by Lundbeck Grand Ballroom
8:30 pm – onward
Welcome Reception Pavillion Ballroom
Concurrent Session
I-02 Junior Ballroom D
Concurrent Session
II-02 Junior Ballroom D
Complementary
Medicine SIG
Parksville
Concurrent Session Concurrent Session
Concurrent Session
I-03 Junior Ballroom C I-04 Junior Ballroom A-B I-05 Port Alberni
Concurrent Session Concurrent Session
Workshop
II-03 Junior Ballroom C II-04Junior Ballroom A-B II-05 Port Alberni
Gynecologic
Oncology SIG
Junior Ballroom D
Northern Nurses
SIG
Finback
Radiation
SIG
Port McNeil
Concurrent Session
I-06 Port McNeil
Concurrent Session
II-06 Port McNeil
Surgical Oncology
SIG
Blue Whale
Lundbeck Oncology Focus Group Port Alberni
Dinner on Own
Day two / Jour deux: Monday, October 21, 2013 / lundi, 21 octobre 2013
6:30 am – 7:00 pm
7:30 am - 8:45 am
Boehringer Ingleheim Breakfast Symposium Grand Ballroom
9:00 am - 10:15 am
Keynote Presentation II — Barbara Pesut - sponsored by Sanofi Grand Ballroom
10:15 am – 10:45 am
Health Break in Exhibit Hall with Poster Group 1 Presentations sponsored by Astellas Pavillion Ballroom
10:15 am – 10:45 am
Yoga Finback
10:45 am – 12:15 pm
CANO/ACIO - ONS Symposium: Health Disparities in Cancer Care Grand Ballroom
12:15 pm – 1:45 pm
Novartis Lunch Symposium Grand Ballroom
2:00 pm – 3:30 pm
Concurrent Session
III-01 Parksville
3:30 pm – 4:00 pm
Health Break in Exhibit Hall with Poster Group 2 Presentations sponsored by Lundbeck Pavillion Ballroom
3:30 pm – 4:00 pm
Yoga Finback
4:00 pm – 5:30 pm
Workshop
IV-01 Parksville
5:30 pm – 6:30 pm
Council of Chapters Meeting Grand Ballroom
6:30 pm
CANO/ACIO Website Presentation Junior Ballroom A-B
6:30 pm – 8:00 pm
Roche Canada Focus Groups Junior Ballroom C-D
Concurrent Session
Concurrent Session
Concurrent Session
Concurrent Session
III-02 Junior Ballroom D III-03 Junior Ballroom C III-04 Junior Ballroom A-B III-05 Port Alberni
Concurrent Session
Concurrent Session
Concurrent Session
Concurrent Session
IV-02 Junior Ballroom D IV-03 Junior Ballroom C IV-04 Junior Ballroom A-B IV-05 Port Alberni
Dinner on Own
28
Concurrent Session
III-06 Port McNeil
Concurrent Session
IV-06 Port McNeil
Day three / Jour Trois: Tuesday, October 22, 2013 / mardi, 22 octobre 2013
6:30 am – 7:00 pm
6:30 am – 7:45 am
Amgen Breakfast Symposium Grand Ballroom
8:00 am – 9:15 am
CANO/ACIO Annual General Meeting Grand Ballroom
9:30 am – 10:00 am
CANO/ACIO Awards of Excellence Ceremony Grand Ballroom
10:00 am – 10:30 am
Health Break in Exhibit Hall with Poster Group 3 Presentations sponsored by Takeda Pavillion Ballroom
10:00 am – 10:30 am
Yoga Finback
10:30 am – 12:00 pm
Workshop
V-01 Parksville
12:15 pm – 1:45 pm
Astellas Lunch Symposium Grand Ballroom
2:00 pm – 3:00 pm
Merck Lectureship and Award Presentation Grand Ballroom
3:00 pm – 3:30 pm
Health Break in Exhibit Hall with Poster Group 4 Presentations sponsored by Sanofi Pavillion Ballroom
3:00 pm – 3:30 pm
Yoga Finback
3:30 pm – 5:00 pm
Workshop
VI-01 Parksville
5:15 pm – 6:15 pm
Education Committee
Junior Ballroom C
7:00 pm – onwards
Social Event Vancouver Law Courts
Concurrent Session
V-02 Junior Ballroom D
Concurrent Session
V-03 Junior Ballroom C
Concurrent Session
Concurrent Session
V-04 Junior Ballroom A-B V-05 Port Alberni
Concurrent Session
Concurrent Session
Concurrent Session
Workshop
VI-02 Junior Ballroom D VI-03 Junior Ballroom C VI-04 Junior Ballroom A-B VI-05 Port Alberni
Leadership SIG
Junior Ballroom D
Concurrent Session
V-06 Port McNeil
Concurrent Session
VI-06 Port McNeil
Palliative Care SIG
Parksville
Day four / Jour quatre: Wednesday, October 23, 2013 / mercredi, 23 octobre 2013
Breakfast on Own
8:00 am – 4:00 pm
9:00 am – 10:00 am
Keynote Presentation III — Janie Brown - sponsored by Celgene Grand Ballroom
10:00 am – 10:30 am
Health Break in Exhibit Hall sponsored by Celgene Pavillion Ballroom
10:00 am – 10:30 am
Yoga Finback
10:30 am – 12:00 pm
Concurrent Session
VII-01 Parksville
12:15 pm – 1:45 pm
Janssen Lunch Symposium Grand Ballroom
2:00 pm – 3:30 pm
Concurrent Session
VIII-01 Parksville
3:30 pm – 4:00 pm
Closing Ceremonies and Abstract Award Presentation Grand Ballroom
Concurrent Session
Concurrent Session
Concurrent Session
Concurrent Session
VII-02 Junior Ballroom D VII-03 Junior Ballroom C VII-04 Junior Ballroom A-B VII-05 Port Alberni
Concurrent Session
Concurrent Session
Concurrent Session
Concurrent Session
VIII-02 Junior Ballroom D VIII-03 Junior Ballroom C VIII-04 Junior Ballroom A-B VIII-05 Port Alberni
Concurrent Session
VII-06 Port McNeil
Concurrent Session
VIII-06 Port McNeil
29
Meeting Schedule
Horaire des reunions
Sunday, October 20, 2013 5:00 pm – 6:00 pm
Advanced Practice Nursing Special Interest Group (Junior Ballroom A–B)
Complementary Medicine Special Interest Group (Parksville)
Gynecologic Oncology Special Interest Group (Junior Ballroom D)
Radiation Special Interest Group (Port McNeil)
Surgical Oncology Special Interest Group (Blue Whale)
Northern Nurses Special Interest Group (Finback)
Monday, October 21, 2013 5:30 pm – 6:30 pm
Council of Chapters Meeting (Grand Ballroom)
Monday, October 21, 2013 6:30 pm – 8:00 pm
CANO/ACIO Website Presentation (Junior Ballroom A–B)
Tuesday, October 22, 2013 8:00 am – 9:15 am
CANO/ACIO Annual General Meeting (Grand Ballroom)
Tuesday, October 22, 2013 9:30 am – 10:00 am
CANO/ACIO Awards of Excellence Ceremony (Grand Ballroom)
Tuesday, October 22, 2013 5:15 pm – 6:15 pm
Education Committee (Junior Ballroom C)
Leadership Special Interest Group (Junior Ballroom D)
Palliative Care Special Interest Group (Parksville)
Wednesday, October 23, 2013 3:30 pm – 4:00 pm
Closing Ceremonies and Abstract Award Presentation (Grand Ballroom)
30 30 CANO/ACIO
CANO/ACIO
20132013
Conference
Conference
Sheraton
Sheraton
Vancouver
Vancouver
WallWall
Center,
Center,
British
British
Columbia
Columbia
Day One/Jour Un
Saturday, October 19, 2013/
samedi, 19 Octobre 2013
Opening Ceremony
Canadian Association of Nurses
in Oncology joint lecture with the
Society for Integrative Oncology
Health Break
sponsored by Janssen
Coming Home to Yourself: Finding Calm,
Clarity and Compassion in the Storm of
Cancer and Caregiving
Concurrent Session I-01
Arrivez à la maison pour vous-même: Trouver
le calme, la clarté et la Compassion dans la
tempête du cancer et des soins
Concurrent Session I-01-A
5:00 pm - 6:30 pm |
St. Andrew’s-Wesley Church
Susan Bauer-Wu, RN, PhD, FAAN. University of Virginia,
School of Nursing, Charlottesville, VA, United States.
Join us at St. Andrew’s-Wesley Church
(1012 Nelson Street) for a free public lecture.
In this presentation, co-sponsored by the Canadian
Association of Nurses in Oncology and the Society for
Integrative Oncology, Dr. Susan Bauer-Wu will explore
the use of contemplative practices, like mindfulness
and compassion meditation, to foster well-being and
stress resilience for cancer patients, family caregivers,
oncology nurses, and other health care professionals,
and will offer the audience an opportunity to participate
in a guided meditation.
Dans cette présentation gratuite, co-parrainée par
l’Association canadienne des infirmières en oncologie et la
Société d’oncologie intégrative, le Dr Susan Bauer-Wu va
explorer l’utilisation de pratiques contemplatives, comme
l’attention et la méditation de la compassion, de favoriser
le bien-être et le stress la résilience des patients atteints de
Day One/Jour Un
Pre-Conference
Day/Journée
pré-conférence
Sunday, October 20, 2013 /
Dimanche, 20 Octobre 2013
8:00 AM – 9:15 AM | Grand Ballroom
9:15 AM – 9:45 AM |
Junior Ballroom Foyer
9:45 AM – 11:15 AM | Parksville
Supportive Care Needs of Individuals with
Cancer from Rural or Remote Communities:
Impact of a Manitoba Project
Patricia Benjaminson, RN1, Joanne Loughery, RN,
BN2, Dr Roberta Woodgate PhD3, 1CancerCare Manitoba,
Winnipeg, MB, Canada, 2Red River College, Winnipeg, MB,
Canada, 3University of Manitoba Winnipeg, Manitoba,
Canada.
Concurrent Session I-01-B
A Collaborative Approach Across Three
Health Authorities to Standardize the
Management of Refractory Malignant Ascites
for Palliative Patients.
Elizabeth Beddard-Huber, RN, MSN1, Nicole Wikjord,
RN, MSN2, Ruth Topolnicky, RN, MSN3, Sarah Cobb,
RN, BSN4, Ingrid See, RN, MSN5. 1BCCA, Vancouver, BC,
Canada, 2Vancouver General Hospital, Vancouver, BC,
Canada, 3Fraser Health Authority, Vancouver, BC, Canada,
4Providence Health, Vancouver, BC, Canada, 5Vancouver
Coastal Health Community, Vancouver, BC, Canada.
cancer, des aidants naturels, des infirmières en oncologie
et d’autres professionnels de la santé, et offrira au public
l’occasion de participer à une méditation guide.
31
Day One/Jour Un
9:45 AM - 11:15 AM | Junior Ballroom D
Transitioning Cancer Centre Patients back
to their Primary Care Providers: Reviewing a
Model of Care, Project Implementation, and
Evaluation Data
Amy B. Boucher, RN, Liane Kandler, MA, Doctoral
Student. Thunder Bay Regional Health Sciences Centre,
Thunder Bay, ON, Canada.
Navigation: A Key Component to Enhance
Comprehensive Cancer Care in Rural Manitoba
Zenith Poole, RN, Megan McLeod, MSW.
CancerCare Manitoba, Winnipeg, MB, Canada.
Concurrent Session I-02-C
Transforming Lung Cancer Patient Care:
Empowering Patients through Innovations in
System Navigation
Jennifer Smylie, RN, BScN, MHSM, Lynn Kachuik, RN,
BA, MS, CON(C), CHPCN(C). The Ottawa Hospital,
Ottawa, ON, Canada.
Lynne Jolicoeur RN, MScN, CON(C); Wendy HicksBoucher RN, BScN, CON(C); Ann Schibli RN, BScN;
Catherine Adamson RN, BScN; Elizabeth Contestible
RN, BScN, NCMP; Kristen Dupuis RN, BScN;; Barbara
D’Entremont RN, BScN; Wylam Faught MD; Laura
Hopkins MD; Robert Weber RN; Joanne Weberpals,
Tien Le, MD, Michael Fung Kee Fung, MD. The Ottawa
Hospital, Ottawa, ON, Canada.
“I Saw It On The Web”: Influence of Internet
Information in Cancer Care
Jennifer M. L. Stephens, BSN, MA, RN, OCN 1,2,
Sally Thorne, PhD, RN, FA AN, FCAHS2, Kim Taylor, MA2.
1Vancouver Coastal Health, Vancouver, BC, Canada,
2University of British Columbia, Vancouver, BC, Canada.
9:45 AM - 11:15 AM | Junior Ballroom A-B
Oncology and Palliative Care Partnership:
Whole Person Care Inspiring an Innovative
Treatment Approach and a Transformation in
Clinical Practice
Carmel M. Collins, RN, BN, NP-PHC, CHPCN(C),
Kathy Fitzgerald, RN, BN, CON(C), Jonathan Greenland,
MD, FRCPC, Susan M. MacDonald, BScN, MD, CCFP, FCFP.
Innovative Use of Morbidity and Mortality
Rounds: Palliative Care Leads the Way to
Inspire and Transform Oncology Nursing
Practice
9:45 AM - 11:15 AM | Junior Ballroom C
Web-marketing of Prostate Cancer Support
Groups
John L. Oliffe, PhD, MEd, RN1, Christina Han,
MA1, Joan Bottorff, PhD, RN2, Michael McKenzie, MD3,
Estephanie Sta. Maria, BA1. 1University of British
Columbia, Vancouver, BC, Canada, 2University of British
Columbia - Okanagan, Kelowna, BC, Canada, 3British
Columbia Cancer Agency, Vancouver, BC, Canada.
I Had Major Surgery and Was in Hospital for
24 Hours!: Robotic Assisted Hysterectomy
(ENGLISH)
32
Wendy L. Petrie, RN, BScN, MScN, CON(C),
CHPCN(C), Sylvie C. Bruyere, RN, BScN, CON(C),
CHPCN(C). The Ottawa Hospital, Ottawa, ON, Canada.
Bringing Academic and Practice Together
to Transform Nursing Care for People at the
End of Life
Kelli Stajduhar, PhD1, Carolyn Tayler, RN, BN, MSA.
1University of Victoria, Victoria, BC, Canada, 2Fraser
Health Authority, Surrey, BC, Canada.
Innovation in After Cancer Care: Investigating
the Relationship Between Health Literacy and
Patient Satisfaction Among Cancer Survivors
9:45 AM - 11:15 AM | Port Alberni
Invisible Practices: Nursing in a
Nurse-Run Clinic
Lorelei Newton, RN, PhD, Sally Kimpson, PhD(C),
Mary Ellen Purkis, PhD, Maxine Alford, PhD. University of
Victoria, Victoria, BC, Canada
Effective Use of Advanced Practice Nurses
(APNs) in Cancer Control
Denise Bryant-Lukosius, RN, PhD1, Roxanne Cosby,
na1, Debra Bakker, na2, Vanessa Burkoski, na3, Craig
Earle, na4, Barbara Fitzgerald, na5, Esther Green, na6,
Saadia Israr, na1. 1McMaster University, Hamilton, ON,
Canada, 2Laurentian University, Sudbury, ON, Canada,
3McGill University, Montreal, QC, Canada, 4Ontario
Institute for Cancer Research, Toronto, ON, Canada,
5Princess Margaret Hospital, Toronto, ON, Canada,
6Cancer Care Ontario, Toronto, ON, Canada.
Redefining Value - How Much is a
Nurse Worth?
Cynthia A. McLennan, RN, BScN, MBA, CON(C).
Shoppers Drug Mart Specialty Health Network,
Misissauga, ON, Canada.
9:45 AM - 11:15 AM | Port McNeil
Utilizing Survivorship Care Plans: Understanding
the Barriers in a Canadian Environment
Margaret I. Fitch, RN, PhD1, Holly Bradley, MA2,
Geoff Eaton, BBA3, Janine Giese-Davis, BS, MA, PhD4,
Jeff Sisler, MD, MCISc, FCFP5, Jill Taylor-Brown, MSW,
RSW5. 1Odette Cancer Centre, Sunnybrook Health Sciences
Centre, Toronto, ON, Canada, 2Wellspring, Toronto, ON,
Canada, 3Young Adult Cancer Canada, St. John’s, NL,
Canada, 4Alberta Health Services, Calgary, AB, Canada,
5CancerCare Manitoba, Winnipeg, MB, Canada.
Shari L. Moura, RN, MN, CON(C)1,3, Joyce Nyhof-Young,
PhD2, Edwin Cheung, RA3, Hilda Ulloa, RA3, Malcolm J. Moore,
MD, FRCPC1, Barbara Fitzgerald, RN, MScN1, Carol Townsley,
MD, MSc, CCFP3, Gillian Hawker, MD, MSc, FRCPC3. 1Princess
Margaret Hospital -University Health Network, Toronto, ON,
Canada, 2University Health Network, Toronto, ON, Canada,
3Women’s College Hospital, Toronto, ON, Canada.
Helene Hudson Lectureship and
Award Presentation
sponsored by Amgen
11:15 AM – 12:15 PM
Grand Ballroom
Taking an “Upstream” Approach in the Care
of Dying Cancer Patients: The Case for a
Palliative Approach
Carolyn M. Tayler, RN, BN, MSA1, Kelli Stajduhar,
RN, PhD2. 1Fraser Health Authority, Surrey, BC, Canada,
2University of Victoria, Victoria, BC, Canada.
Advances in technology and drug therapy have
resulted in many cancer patients living longer with
malignant disease. It is still the case, however, that
most of these patients will face the end of life much
sooner than the general population. Adopting a
“palliative approach” earlier in the illness trajectory
is one innovation that has the potential to promote
anticipatory planning in order to enhance care at the
end of life. This presentation will provide an overview
of iPANEL (The Initiative for a Palliative Approach
in Nursing: Evidence and Leadership), a Michael
Smith Foundation for Health Research (MSFHR)
funded program. This research initiative explores the
integration of a palliative approach into the care of
people with advancing illness. We will highlight core
elements of a palliative approach, briefly discuss our
research program, share preliminary findings, and
discuss the important role that oncology nurses can
play in transforming the ways in which cancer patients
are cared for within our health care system.
33
Day One/Jour Un
Day One/Jour Un
Conférence et présentation du Prix
à la mémoire de Helene Hudson
Description:
11 h 15 – 12 h 15 | Grand Ballroom
This interactive case-based program will provide attendees
with useful tips and advice on how to manage CLL and iNHL
patients across various histology and therapy.
L’adoption d’une approche « en amont » dans
les soins aux patients mourant du cancer : les
mérites d’une approche palliative
The program will examine how to circumvent potential
hurdles a healthcare professional and patient may
experience on the way to therapeutic goals in CLL and iNHL.
Carolyn M. Tayler, inf., M.Sc.inf.1, Kelli Stajduhar,
inf., Ph.D.2. 1Fraser Health Authority, Surrey, C.-B.,
Canada, 2University of Victoria, Victoria, B.-C., Canada.
The attendees will also have an opportunity to share
and discuss difficult questions related to treatment and
Les progrès aux niveaux de la technologie et de la pharmacothérapie ont permis de prolonger la vie de nombreux patients
atteints d’un cancer malin. Cependant, le fait demeure que la
plupart de ces patients verront leur vie se terminer bien plus tôt
que les membres de la population générale. L’adoption d’une
« approche palliative » plus tôt dans la trajectoire de la maladie
est une innovation qui pourrait promouvoir la planification de
meilleurs soins en fin de vie. Cette présentation offrira un aperçu d’iPANEL (Initiative for a Palliative Approach in Nursing: Evidence and Leadership – Initiative de soins palliatifs infirmiers
: données probantes et leadership), un programme financé
par la Michael Smith Foundation for Health Research (MSFHR)
[Fondation Michael Smith pour la recherche en santé]. Ce projet de recherche explore l’intégration d’une approche palliative
dans les soins aux personnes souffrant d’un cancer en évolution. Nous illustrerons les éléments centraux d’une approche
palliative, présenterons brièvement notre programme de recherche, partagerons des résultats préliminaires et aborderons
le rôle important que les infirmières en oncologie peuvent jouer
dans la transformation du traitement que reçoivent les patients
atteints de cancer dans notre système de santé.
Learning Objectives:
management of CLL and iNHL in their own practice.
• Contrast new treatment options versus previous standard
of care for the management of CLL/iNHL patients
• Determine optimal supportive medications, administration
and dosage adjustments of new therapies
• Compare potential adverse events of new treatment
options to that of previous treatment strategies
• Develop an action plan to manage potential adverse
events and optimize patient outcomes
Workshop II-01
2:00 PM – 5:00 PM | Parksville
Transforming Lymphedema Management
Martina A. Reddick, RN. Dr. H. Bliss Murphy Cancer
Centre, St. John’s, NL, Canada.
Concurrent Session II-02
2:00 PM – 5:00 PM | Junior Ballroom D
Lundbeck Lunch Symposium
12:15 PM – 1:45 PM | Grand Ballroom
Adapting to a New Standard of Care for Chronic
Lymphocytic Leukemia (CLL) and Indolent NonHodgkin Lymphoma (iNHL) in Daily Practice –
Practical Tips and Recommendations
Speakers:
Tina Crosbie, BSc Pharm, ACPR Clinical Pharmacist –
Hematology, Ottawa Hospital - General Campus, Ottawa, ON
Judith Koolwine, RN, BScN, MHA, CRM Hematology
Clinical Trials Manager, Ottawa Hospital - General
Campus, Ottawa, ON
34
Concurrent Session II-02-A
Nurse-Led Newsletter in Surgical Oncology:
Promoting Interprofessional Communication
and Relationships
Tracyann Machado, RN, Rosemarie Rivera, RN, BScN, MN.
Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Concurrent Session II-02-B
CANO/ACIO’s National Strategy for
Chemotherapy Administration: Evaluation
Results Driving Action
Concurrent Session II-02-C
Chemotherapy Appointment Reservation
Manager (CHARM): Innovative Technology to
Advance Scheduling and Communication
Kirsty Albright, RN, BScN, MScN, Sherri Rotenberg,
RN, BScN, CON(C), Angela Boudreau, RN, BScN,
MN, CON(C), Kathy Beattie, RN, CON(C), Philomena
Sousa, HB.S.B.A., B.E.D., B.S.N.S. Odette Cancer Centre,
Concurrent Session II-02-D
Transforming Nursing Assessment and
Documentation in the Care of People
Receiving Chemotherapy
Karen Janes, RN, MSN1, Caroline Ehmann, BSc, MA2,
Michelle Moore, RN, BSc, BSN1, Judy Oliver, RN, BSN,
MEd3. 1BC Cancer Agency, Vancouver, BC, Canada, 2BC
Cancer Agency - Vancouver Island Centre, Victoria, BC,
Canada, 3BC Cancer Agency, Victoria, BC, Canada.
Concurrent Session II-02-E
Translating Practice(s): Promises and Perils
of Adopting Best Practice Guidelines
Sally Kimpson, RN, PhD(C)1, Lorelei Newton, RN,
PhD1, Maxine Alford, RN, PhD2, Mary Ellen Purkis,
RN, PhD1. 1University of Victoria, Victoria, BC, Canada,
2BCCA, Victoria, BC, Canada.
Concurrent Session II-02-F
New CVAA Guidelines 2013 - Occlusion
Management for Central Vascular Access
Devices (CVADs)
Jocelyn A. Grecia Hill, MN, RN, OCN®, CVAA(c), VA-BC™,
Providence Health Care - St. Paul’s Hospital, Vancouver, BC,
Canada. President – CVAA National (2013-2014)
2:00 PM – 5:00 PM | Junior Ballroom C
Eliminating “I Never Knew that was
Available!”: Development of My Survivorship
Map Initiative
Ai Tanimizu, RN, BScN1, Maurene McQuestion, RN, BA,
BScN, MSc, CON(C) 1,2, Aronela Benea, RN, MScN, BScN1,
Scott Secord, RSW, MSW1,2,Carolyn Plummer, RN, BScN,
MHSc3. 1Princess Margaret Cancer Centre – University
Health Network, Toronto, ON, Canada, 2University of
Toronto, Toronto, ON, Canada, 3University Health Network,
Toronto, ON, Canada.
Addressing Fear of Cancer Recurrence
Among Women with Cancer: A Pilot Study
of a 6-Week Group Cognitive-Existential
Intervention
Christine Maheu, PhD1, Sophie Lebel, PhD2, Monique
Lefebvre, PhD3, Scott Secord, MSc.4, Christine Courbasson,
PhD5, Mina Singh, PhD6, Lynne Jolicoeur, MScN3, Aronela
Benea, MScN7, Pamela Catton, M.D.7, 1McGill University,
Montreal, QC, Canada, 2University of Ottawa, Ottawa,
ON, Canada, 3The Ottawa Hospital, Ottawa, ON, Canada,
4Canadian Partnership Against Cancer, Toronto, ON,
Canada, 5Cognitive Behavioural Therapy Centre, Toronto,
ON, Canada, 6York University, Toronto, ON, Canada,
7Princess Margaret Hospital, Toronto, ON, Canada.
Perspectives from ‘The Desk’ and ‘The Corporate
Office’ on the Return to Work Experience
Tracy L. Powell, BScN, RN, MN, Lori Buchart, CD, CHRP
Mount Royal University, Calgary, AB, Canada.
The Survivorship Conversation with South
Asian Breast Cancer Patients - A Nursing
Perspective
Colleen S. Sherriff, RN, Dr. Savitri Singh-Carlson, Dr.
Frances Wong, BC Cancer Agency - Fraser Valley Centre,
Surrey, BC, Canada.
35
Day One/Jour Un
Renée Hartzell, RN, BScN, CON (C)1, Laura Rashleigh,
RN, MScN, CON(C)2, Tracy Truant, RN, MSN3, Sally
Thorne, RN, PhD, FAAN, FCAHS3. 1Centre de santé et de
services sociaux de Chicoutimi, Chicoutimi, QC, Canada, 2de
Souza Institute, Toronto, ON, Canada, 3University of British
Columbia School of Nursing, Vancouver, BC, Canada.
Day One/Jour Un
Successful Implementation of the Multidisciplinary Collaboration in the Development
of a Chinese-Speaking Cancer Patient
Survivorship Program
Transforming Silos of Care into an Integrated
Regional Hospice Palliative Care Program: A
Two Year Long Journey
Sandy Kwong, MSW, RSW, Esther Chow, RN, MSN,
CON(C). BC Cancer Agency, Vancouver, BC, Canada.
Return to Work Following Cancer:
Perspectives of Survivors, Employers, and
Insurance Agencies
Margaret I. Fitch, RN, PhD. Odette Cancer Centre,
2:00 PM – 5:00 PM | Junior Ballroom A-B
Lynn Kachuik, RN, BA, MS, CON(C), CHPCN(C).
The Ottawa Hospital, Ottawa, ON, Canada.
An Innovative Approach to Clinical Trials
Nursing: Transforming Care to Inspire Change.
Valerie Bowering, RN, CON(C), Marcia Flynn-Post, RN, B.A.
CON(C). Princess Margaret Cancer Center, Toronto, ON, Canada.
Supporting Advance Care Planning for Patients
through Oncology Professional Education
Elizabeth Beddard-Huber, MSN, Angela Bedard, MS.
BCCA, Vancouver, BC, Canada.
Using the Transitional Care Model to Inform
Practice Innovation in Well Breast Follow Up
Colleen P. Campbell, NP-PHC, MN. Simcoe Muskoka
Regional Cancer Program, Barrie, ON, Canada.
Inspired by Patient Delirium: Management
Transformed through an Interdisciplinary
Approach
Janice Dirksen, BSN, Arlyn Heywood, BScN, Elizabeth
Beddard - Huber, MSN, Karen Janes, BSN, MSN. British
Workshop II-05
2:00 PM – 5:00 PM | Port Alberni
Building on the Basics: Practical Tips in Oncology
Nursing Systemic Cancer Therapy Practice
Kim Chapman, MScN1, Caroline Devereux, MHST2, Eleanor
Getson RN, BN, CON(C), CHPCN(C), ONDEC 20083,
1Horizon Health Network, Area 3, Fredericton, NB, Canada,
2Horizon Health Network, Area 1, Moncton, NB, Canada, 3Saint
John Regional Hospital, Saint John NB, Canada.
2:00 PM – 5:00 PM | Port McNeil
Innovative Implementation of Standards in a
Resource Challenged Country
Tailoring the Disease Self-Management Model
for Cancer: A Mixed-Methods Evaluation
Zahra Lalani, RN, BSN. BC Cancer Agency, Vancouver,
BC, Canada.
Doris Howell, PhD, RN, Amy Kossert, PhD candidate,
Jennifer Jones, PhD, Audrey Friedman, MSW, Samantha
Mayo, PhD candidate, Shan Mohammed, PhD candidate,
Joan Bottoroff, PhD. University Health Network, Toronto,
ON, Canada.
36
Factors Influencing the Information and
Decision Making Preferences of Prostate
Cancer Patients on Active Surveillance
B. Joyce Davison, PhD. University of Saskatchewan,
Saskatoon, SK, Canada.
Person-Centred Virtual Navigation in Cancer
Care: Pathways to Patient Empowerment?
Health Break
sponsored by Roche
3:00 PM – 3:15 PM |
Junior Ballroom Foyer
Committee and Special Interest
Groups Meetings
5:00 PM – 6:00 PM
[See page 30 for more info]
Focus Groups
Carmen G. Loiselle, N., Ph.D. McGill University,
Jewish General Hospital
6:00 PM – 7:00 PM Concurrent Session II-06-D
Junior Ballroom C
Bayer Focus Group
Developing Comprehensive Supportive Care
Resources to Address the Information and
Support Needs of Patients Attending a Rapid
Diagnostic Centre for Breast Abnormalities
Bayer HealthCare will be hosting a peer-facilitated focus
Aronela Benea, BScN, MScN1, Christine Maheu,
PhD2, Bridgette Lord, MN, NP1, Scott Secord, MSW3, Janet
Papapdakos, MEd1, Pamela Catton, MD, MHPEd, FRCPC1,
Nazek Abdelmutti, MSc1. 1Princess Margaret Cancer
Centre, Toronto, ON, Canada, 2Ingram School of Nursing,
McGill University, Montreal, QC, Canada, 3Canadian
Partnership Against Cancer, Toronto, ON, Canada.
persistence and adherence and preventing and managing
Creating and Implementing a Team-Based
Approach to Breast Cancer Care
Day One/Jour Un
group on the role of the nurse in managing cancer patients
on oral cancer therapies. Nurses are key in educating
patients with regards to the value of a patient’s prescribed
therapy, simplifying the regimen for the patient, encouraging
side effects. When delivered, these interventions have been
shown to have positive clinical and economic impact. How
are these interventions different when the prescribed therapy
is oral rather than infusional? Are there institutional changes
that could be adopted to assure these vital interventions
take place? What is happening now in your hospital? Let’s
discuss and share best practices
Lundbeck Oncology Focus Group
Port Alberni
Leslie M. Cameron, RN, CON(C), Neda A. Soltani, RN.
Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.
Arsenic trioxide in the management of APL
“I Can Do it Myself”; Transforming Patient
Centred Bone Health Care.
Objectives:
Colleen Graham, RN, BNSc, CON(C), Donna
Van Allen, RN, BHScN, CON(C), Patricia Bieronski,
BScN, CON(C), Anna Grani, Pharmacist and, Theresa
Underwood, Pharmacy Technician. Grand River Regional
Cancer Centre, Kitchener, ON, Canada.
toxicities of arsenic trioxide for the treatment of APL
1. Understand warning and precautions, side effects and
2. Review nurse considerations (administration, side effects
and toxicities of ATO)
3. Evaluating the learning needs around administration and monitoring & patient education for APL patients treated with ATO
This session is intended for nurses working with leukemia
patients either in an out-patient or in-patient setting.
37
Keynote Presentation I: Cancer
Can’t Dance Like This
sponsored by Lundbeck
partout au Canada. À l’automne 2012, Cancer Can’t
partager son histoire avec tous ceux et celles qui font
Dance Like This fera ses débuts près de Broadway,
à New York, dans le cadre du festival United Solo.
Avec une bonne dose d’humour, M. Stolfi continue de
face à un ou plusieurs des défis et obstacles que la vie
place sur le chemin de chacun.
www.cancercantdancelikethis.com
Daniel Stolfi, Actor,
Comedian and Cancer
Patient Advocate
Day Two/Jour Deux
A member of the Playwrights
Welcome Reception
8:30 PM Onward | Pavillion Ballroom
Guild of Canada, Daniel Stolfi
is an established actor, comedian, and cancer patient
advocate. In March of 2008 Daniel was diagnosed with
Acute Non-Hodgkin’s T-Lymphoblastic Lymphoma, an
aggressive form of cancer requiring equally aggressive
chemotherapy and radiation treatments over the next two
years of his life.
Day Two/Jour Deux
Monday, October 21, 2013 /
Lundi, 21 Octobre 2013
Through his ongoing battle with the disease, Daniel
created his simultaneously heart warming and hysterical,
Canadian Comedy Award winning one-person show,
“Cancer Can’t Dance Like This”. To date, the show has
helped raise over $75,000.00 for health related charities
and organisations across Canada. In the fall of 2012
“Cancer Can’t Dance Like This” made its Off-Broadway
Breakfast Symposium
Sponsored by Boehringer Ingleheim
7:30 AM – 8:45 AM | Grand Ballroom debut at the United Solo Festival in New York City. With
humour at its core, Daniel continues to share his story
with all of those who have faced any of the challenges
and adversity that life throws your way.
www.cancercantdancelikethis.com
Daniel Stolfi est membre de la Playwrights Guild
of Canada. Humoriste et acteur bien connu, il est
également porte-parole des personnes vivant avec
un cancer. En mars 2008, M. Stolfi a été diagnostiqué
d’un lymphome lymphoblastique non hodgkinien, une
Making the Most of First-line Treatment for
Advanced NSCLC: The Role of EGFR TKIs
Optimizing Treatment of NSCLC According to
Mutation Status
Dr. Janessa Laskin, Medical Oncologist, Senior Scientist,
Clinical Assistant Professor, BC Cancer Agency.
forme agressive de cancer qui l’a amené pendant
les deux années suivantes à subir des traitements de
chimiothérapie et de radiothérapie tout aussi agressifs.
C’est au cours de son combat contre la maladie que M.
Stolfi a créé son spectacle solo à la fois réconfortant
et hilarant, Cancer Can’t Dance Like This. À ce jour,
Side Effects, Quality of Life and Adherence:
A Nursing Perspective
Esther Dajczman, Clinical Nurse Specialist - Pulmonary
Diseases, Jewish General Hospital / McGill University.
ce spectacle primé a permis de recueillir plus de 75
000 $ pour des organismes de bienfaisance et d’autres
organisations qui œuvrent dans le domaine de la santé
38
Keynote Presentation II: BOTH/AND:
Transforming the Fractured Soul of
Spiritual Care in a Diverse World
Barbara Pesut
sponsored by Sanofi
Barbara Pesut, inf., Ph.D.
Barbara Pesut est professeure agrégée à l’École de sciences
infirmières de l’Université de la Colombie-Britannique (UBC)
et détentrice d’une chaire de recherche du Canada sur la
santé, l’éthique et la diversité. Au cours de sa carrière de
trente ans en soins infirmiers, Mme Pesut a assumé des rôles
en pratique clinique, en enseignement infirmier, en recherche
infirmière et en leadership en matière de formation infirmière.
Son programme de recherche vise à améliorer les soins
pour les personnes en fin de vie touchées par les disparités
Barbara Pesut is an Associate
Professor in the School of Nursing
at the University of British Columbia and holds a Canada
Research Chair in Health, Ethics and Diversity. Dr. Pesut’s
thirty year career in nursing has included roles in clinical
practice, nursing education, nursing research and nursing
education leadership. Her program of research seeks to
improve care for individuals at end-of-life who are at risk
for health disparities with a particular emphasis on rural
populations and those from diverse spiritual backgrounds.
Dr. Pesut’s interest in spirituality in nursing began when working
in pediatric oncology as a new graduate. The challenges of
providing ethically good care in a spiritually diverse society and
of fostering nurses’ own well-being and meaning while they care
for those who are suffering has spawned a decade of inquiry.
Dr. Pesut completed the first philosophic dissertation at the
UBC School of Nursing in which she analyzed the development
of spirituality in nursing literature. She went on to lead an
International team of nurse scholars in studying emerging
issues of religious and spiritual diversity in healthcare. This
team recently published a book on Religious Ethics in Nursing.
Barbara has published widely and spoken to international
audiences in the area of spirituality and philosophy in nursing
and serves on the Editorial Boards of Nursing Philosophy and
the Journal for the Study of Spirituality.
Barbara has received the College of Registered Nurses Award
for Excellence in Nursing Research and Teaching Awards from
the University of British Columbia and Trinity Western University.
en santé, notamment dans les régions rurales et parmi les
groupes appartenant à différents horizons spirituels.
Mme Pesut a commencé à s’intéresser à la spiritualité
dans les soins infirmiers alors qu’elle venait d’obtenir son
diplôme universitaire et qu’elle travaillait en oncologie
pédiatrique. Les infirmières qui s’occupent de personnes
souffrantes font face à des défis qui ont fait l’objet d’une
décennie de réflexion : comment offrir, au sein d’une société
spirituellement diversifiée, des soins de qualité sur le plan
éthique d’une façon qui favorise le sentiment de bien-être et
d’utilité des infirmières. Mme Pesut a terminé une première
dissertation philosophique à l’École de sciences infirmières
de UBC, dans laquelle elle analysait le développement de la
spiritualité dans la documentation infirmière. Elle a ensuite
dirigé une équipe internationale de recherche infirmière
qui s’intéressait aux enjeux émergents de la diversité
religieuse et spirituelle dans les soins de santé. Cette
équipe a récemment publié un livre sur l’éthique religieuse
dans les soins infirmiers. Mme Pesut a beaucoup publié et
a fait de nombreuses présentations devant des auditoires
internationaux dans le domaine de la spiritualité et de la
philosophie et ce, dans le contexte infirmier. De plus, elle
siège aux comités de rédaction de Nursing Philosophy et du
Journal for the Study of Spirituality.
Mme Pesut s’est vu décerner – par UBC et par l’Université Trinity
Western – les Prix d’excellence en recherche infirmière et en
enseignement du College of Registered Nurses.
Health Break in Exhibit Hall with
Poster Group 1 Presentations
sponsored by Astellas
10:15 AM – 10:45 AM
Pavillion Ballroom
39
Day Two/Jour Deux
Barbara Pesut, RN,
PhD, Canada Research
Chair in Health, Ethics
and Diversity
CANO/ACIO - ONS Symposium:
Health Disparities in Cancer Care:
Exploring Canadian, American and
International Perspectives
10:45 AM – 12:15 PM | Grand Ballroom
Greta Cummings, RN, PhD, FCAHS. Professor,
University of Alberta. Edmonton, Canada. President,
International Society of Nurses in Cancer Care (ISNCC)
Margaret Fitch, MScN, PhD. Head, Oncology Nursing,
Odette Cancer Centre. Toronto, Canada. Expert Lead,
Patient Reported Outcomes and Survivorship, Canadian
Partnership Against Cancer (CPAC).
Day Two/Jour Deux
Mary Gullatte, RN, PhD, ANP-BC, AOCN®, FAAN.
Vice President of Patient Services & Chief Nursing, Emory
University Hospital-Midtown. Atlanta, United States.
President, Oncology Nursing Society
Christina Sinding, PhD. Associate Professor, McMaster
University. Hamilton, Canada.
Colleen Varcoe, RN, BSN, MEd, MSN, PhD. Professor,
University of British Columbia. Vancouver, Canada.
Despite recent advances in the detection and treatment
This symposium will explore the common challenges,
issues and gaps in cancer care from Canadian, American,
and International perspectives, which may promote health
disparities. Strategies for oncology nurses to influence
marginalizing conditions and work toward addressing
health disparities in cancer care will be discussed.
Objectives:
• Become familiar with terminology such as health equity,
health disparities, inequities, and social determinants
of health.
• Appreciate how marginalizing conditions within society
may influence social determinants of health and other
intersecting factors, and their effect on cancer morbidity
and mortality outcomes.
• Describe similarities and differences among Canadian,
American, and international perspectives regarding
health disparities in cancer care.
• Describe opportunities for oncology nurses (and
organizations, e.g. CANO/ACIO) to influence
marginalizing conditions within society to promote equity
and quality of cancer care for all.
of cancer, increasing disparities in cancer care have been
identified. Age, race, gender, location, socioeconomic
status, immigration status, and other social determinants of
health may intersect to limit access to and quality of health
and cancer care for some individuals and/or groups. As a
Novartis Lunch Symposium
result, these individuals may experience increased cancer
risk, diagnosis of more advanced disease, poorer quality
of life, increased treatment-related morbidity and overall
increased mortality.
Disparities in cancer care are evident not only within wellresourced countries such as Canada, the United States
(US) and Europe but in low and middle-resourced countries
Challenges in the Management of Patients on
Oral Targeted Agents
Description: Panel Symposium
such as Africa and India. Even with well-developed health
Educational objectives:
and cancer care systems, health disparities continue to
• Discuss optimal process depending on setting
negatively affect cancer morbidity and mortality outcomes.
(community, hospital, external) to insure proper
It is imperative that oncology nurses understand the
management of side effects with targeted agents.
impact of health disparities on the health of people and
their families at risk for and/or experiencing cancer.
Nurses have a moral imperative to influence marginalizing
conditions (e.g. racialization, poverty, disability) within
society to reduce health disparities, and to ensure that
peoples’ needs, rather than their social privileges, guide the
• Familiarize oncology nurses with the management of
AfiniTOR and JAKAVI side effects through detailed
and interactive case studies.
• Learn about the AfiniTOR patient support program
and the JAKAVI Alliance program.
distribution of opportunities for well–being.
40
Concurrent Session III-01
Concurrent Session III-01-A
Male Cancer Survivors; Barriers Towards
Participation in Cancer Rehabilitation - A
Qualitative Study
Breast Cancer 101: Understanding Pathology
and Treatment, the Basics
Charlotte Handberg, PhD student, MPH, RN1, Kirsten
Lomborg, Professor, PhD, MSN, RN1, Claus Vinther Nielsen,
Professor, PhD, MD,1, Julie Midtgaard, PhD, Psychologist,
Associate Professor2. 1Aarhus University, Aarhus, Denmark,
2University of Copenhagen, Copenhagen, Denmark.
Concurrent Session III-01-B
The Canadian port (Psychosocial Oncology
Research Training) Program Reaches to
International Partners
Carmen G. Loiselle, N., PhD. McGill University, Jewish
General Hospital
Concurrent Session III-01-C
A Nursing Approach to Prevention and Early
Detection of Secondary Malignancies in
Patients with CLL
Erin Streu, RN, MN, CON(C)1, Jayne Kopala, RN, BN1,
Donna Hewitt, RN2. 1CancerCare Manitoba, Winnipeg, MB,
Canada, 2University of Manitoba, Winnipeg, MB, Canada.
Krista Rawson, RN, BScN, MN. Alberta Heatlh
Services, Cancer Care, Red Deer, AB, Canada.
Innovative, Prospective Roles for Canadian
Oncology Nurses in Breast Cancer Rapid
Diagnostic Clinics
Lorena Baku, BScN-RN1, Margareth Zanchetta, PhD-RN2,
Christine Maheu, PhD-RN3, Patrice Nembhard, BScN-RN4,
Manon Lemonde, PhD-RN5. 1Ryerson University, Toronto, ON,
Canada, 2Ryerson University & Community of Practice-Nursing
Research (CCO), Toronto, ON, Canada, 3McGill University &
Community of Practice-Nursing Research (CCO), Montreal,
ON, Canada, 4St.Joseph Healthcare, Hamilton, ON, Canada,
5University of Ontario Institute of Technology & Community of
Practice-Nursing Research (CCO), Oshawa, ON, Canada.
An Introduction to Oncology Nursing for
Bachelor of Science in Nursing (BSN)
Programme Students
Dignity Conserving Care: The Heart of
Oncology Nursing
Shellie Steidle, MSN, Sarah Johanson, BSc. University
of the Fraser Valley, Chilliwack, BC, Canada
Susan E. McClement, RN, PhD1,2. 1CancerCare
Manitoba, Winnipeg, MB, Canada, 2Faculty of Nursing,
University of Manitoba, Winnipeg, MB, Canada.
A Hospice Ethnography of Delirium
David Wright, PhD, RN, CHPCN(C)1, Susan Brajtman,
PhD, RN2, Mary Ellen Macdonald, PhD3, Betty Cragg, PhD,
RN2. 1Jewish General Hospital, Montreal, QC, Canada,
2University of Ottawa, Ottawa, ON, Canada, 3McGill
University, Montreal, QC, Canada.
Enhancing Oncology Nursing Education
Through Innovation and Technology
Komal Patel, RN, BScN, CON(C), CHPCN(C), Jiahui
Wong, PhD, Tracy Soong, BSc(C), Shanna Brisebois, BA,
Mary Jane Esplen, PhD, RN. de Souza Institute, Toronto,
ON, Canada.
41
Day Two/Jour Deux
Telephone Support Training for Oncology
Nurses in Canada: An Environmental Scan
Day Two/Jour Deux
Dawn Stacey, RN, PhD CON(C)1, Myriam Skrutkowski,
RN, M.Sc., CONC(C)4,Meg Carley, BSc2, Jagbir Kohli,
RN, MN3, Astride Bazile, BScN, MEd, CON(C), NPDE4,
Arlene Court, RN, BScN, CON(C)5, Denise Budz, RN,
BSN, MN6, Jonathan Avery, PhD student1, For the PanCanadian Oncology Symptom Triage and Remote Support
(COSTaRS), Team1. 1University of Ottawa, Ottawa, ON,
Canada, 2Ottawa Hospital Research Institute, Ottawa,
ON, Canada, 3BC Cancer Agency, Vancouver, BC, Canada,
4McGillUniversity Health Centre, Montreal, QC, Canada,
5Sunnybrook Odette Cancer Centre, Toronto, ON, Canada,
6Saskatchewan Cancer Agency, Saskatoon, SK, Canada.
Contextualizing Complementary and
Alternative Medicine (CAM) Education for
Oncology Professionals: Lessons Learned
from a Provincial Pilot
Brenda Ross, RN, BScN1, Lynda Balneaves, RN, PhD2,
Tracy Truant, RN, MSN2, Marja Verhoef, PhD3, Antony
Porcino, PhD2. 1BC Cancer Agency, Vancouver, BC,
Canada, 2UBC School of Nursing, Vancouver, BC, Canada,
3University of Calgary, Calgary, AB, Canada.
Ligne Info-Onco : ligne téléphonique d’urgence
pour des conseils spécialisés en cancérologie
Cécile Bergeron, infirmière clinicienne1, Sonia
Joannette2. 1CSSS Champlain Charles-Lemoyne,
Greenfield Park, QC, Canada, 2Ministère de la santé et des
services sociaux, QC, Canada
I am a Nurse in a Radiotherapy Department
Maryse Carignan, MSc., CON(C), Isabelle Tremblay,
BSc., Michèle Daigneault, BSc. CSSS de Laval, Laval,
QC, Canada.
Le leadership infirmier: un levier vers de
meilleures pratiques contemporaines en
oncologie
Decision Support for Making Complex
Complementary Medicine (CAM) Decisions:
An Innovative Nurse-led Intervention
Tracy L. Truant, RN, MSN1, Lynda G. Balneaves, RN,
PhD1, Brenda C. Ross, RN, BSN2, Margurite E. Wong, RN,
MSN3, Carla Hilario, RN, MSN1, Marja Verhoef, PhD4,
Antony Porcino, PhD1. 1UBC School of Nursing, Vancouver,
BC, Canada, 2BC Cancer Agency, Vancouver, BC, Canada,
4Department of Community Health Services, University of
Calgary, Vancouver, BC, Canada.
Healing Places And Spaces: Dying In Context
Vasiliki Bitzas, N, PhD(C), CHPCN(C). S.M.B.D.
Jewish General Hospital, Montreal, QC, Canada.
sponsored by Lundbeck
3:30 PM – 4:00 PM | Pavillion Ballroom
Louise Compagna, BSc, Caroline Provencher, MSc,
Francine Grondin, BSc, Odette Roy, PhD, MSc, MAP.
Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
42
Workshop IV-01
Concurrent Session IV-03
Research Workshop: Speed Dating with the
Experts: Networking and Consulting Toward
Research Development
Concurrent Session IV-03-A
Sally Thorne, RN, PhD1, Carmen Loiselle, BScN, MScN,
PhD2, Greta Cummings, RN, PhD3, Kelli Stadjuhar, RN,
PhD4, John Oliffe, RN, PhD1, Denise Bryant-Lukosius, RN,
PhD5, Margaret Fitch, MScN, PhD6, Doris Howell, RN,
PhD7, Roberta Woodgate, RN, PhD8, 1University of British
Columbia, Vancouver, BC, Canada, 2McGill University,
Jewish General Hospital, Montreal, QE, Canada, 3University
of Alberta, Edmonton, AB, Canada. 4University of Victoria,
Victoria, BC, Canada, 5McMaster University, Hamilton,
ON, Canada, 6Odette Cancer Centre. Toronto, Canada,
7University Health Network, Toronto, ON, Canada,
8University of Manitoba, Winnipeg, MB, Canada.
Improving Assessment and Care for People
Receiving Chemotherapy: There has to
be a Better Way…Inspiration, Innovation,
Transformation and Perspiration!
Brenda J. LaPrairie, RN, BSN, CON(C)1, Michelle
Moore, RN, BSN, CON(C)2, Karen Janes, RN, MA2,
Caroline Ehmann, OT, MA1. 1BC Cancer Agency, Victoria,
BC, Canada, 2BC Cancer Agency, Vancouver, BC, Canada.
Concurrent Session IV-02-B
Meeting the Standard: Striving for Excellence
in Chemotherapy Education
Bernadine O’Leary, RN, MN, CON(C). Dr. H. Bliss
Murphy Cancer Centre, St. John’s, NL, Canada.
Concurrent Session IV-02-C
Raising the Bar: An Innovative Oral
Chemotherapy Program Designed to Promote
Patient Safety, Education and Adherence
Terry MacKenzie, RN. Northeast Cancer Centre,
Sudbury, ON, Canada.
Assessing the Need in Alberta for a Virtual
Breast Cancer Survivorship Clinic
Cindy Railton, RN, MN, NP1, Carmen Loiselle, BScN,
MScN, PhD2, Greta Cummings, RN, PhD3, Kelli Stadjuhar,
RN, PhD4, John Oliffe, RN, PhD1, Denise Bryant-Lukosius,
RN, PhD5, Margaret Fitch, MScN, PhD6, Doris Howell, RN,
PhD7, Roberta Woodgate, RN, PhD8, 1University of British
Columbia, Vancouver, BC, Canada, 2McGill University,
Jewish General Hospital, Montreal, QE, Canada, 3University
of Alberta, Edmonton, AB, Canada. 4University of Victoria,
Victoria, BC, Canada, 5McMaster University, Hamilton,
ON, Canada, 6Odette Cancer Centre. Toronto, Canada,
7University Health Network, Toronto, ON, Canada,
Adjuvant Endocrine Therapy in Breast
Cancer: Personal, Social and Structural
Factors Influencing Adherence
Leah K. Lambert, RN, PhD Candidate, Lynda G.
Balneaves, RN, PhD, Sabrina T. Wong, RN(C), PhD. The
University of British Columbia, Vancouver, BC, Canada.
Shaking Up the System - A Patient Centred
Approach to Transformational Change
Infection Prevention & Control Project for
Surgical Oncology Patients - A Best Practice
Champion Initiation
Philiz Goh, RN, BScN, CON(C), Anita Long, RN, MSN/
ED, CON(C), Mary Glavassevich, RN, BA, MN. Sunnybrook
Odette Cancer Centre, Toronto, ON, Canada.
43
Day Two/Jour Deux
Implementing the Safe Handling of
Hazardous and Cytotoxic Drugs
Lollita Rahaman, RN, MScN, CON(C), CHPCN(C),
Valerie Hursefield, RN, BA, MHA, CHPCN(C).
Willliam Osler Health System, Brampton, ON, Canada.
Transition Care Clinic for Patients with
Colorectal Cancer and Lymphoma: An
Innovative Approach
Day Two/Jour Deux
Improving Patient Safety and Adherence
Through a Nurse-led Oral Chemotherapy Clinic.
Debbie Miller, RN, BScN, CETN (C), Angela
Boudreau, RN, BScN, MN, CON (C), Dr. Matthew
Cheung, MD, FRCPC, SM; Dr. Lisa Del Giudice, MSc, CRCP
& Dr. Simron Singh, MD, MPH, FRCP (C)
Mary S. Gorr, RN , CON(C), CHPCN(C), Colleen
Campbell, NP MN CON(C). Simcoe Muskoka Regional
Cancer Centre, Barrie, ON, Canada.
Breast Cancer in Young Women in Canada:
A Needs Assessment
Alison Gordon, MA, Vice President, Rethink Breast
Cancer, MJ Decoteau Exective Director Rethink Breast Cancer.
Innovations in Quality Improvement: Daily
Management Rounds in Chemotherapy
“It made me feel like I still existed”: Awesome
Interventions to Inspire and be Inspired by
Young Adults in Transition with Cancer
Nancy Runzer, RN, MSN, Mary Flaherty, RN, MSc(A),
MA. BC Cancer Agency, Vancouver, BC, Canada.
Harnessing the Wisdom of New Nurse
Navigators: Learning from Experience to
Enhance Role Integration
Jennifer Anderson, RN, MN, CON(C)1, Robbi Allen, RN2,
Shannon Groff, BSc1, Andrea Williams, BA1, Linda Watson,
RN, PhD(C), CON(C)1. 1Community Oncology, AHS
Cancer Care, Calgary, AB, Canada, 2Community Oncology,
AHS Cancer Care, Bonnyville, AB, Canada.
Virginia Lee, N, PhD1, Scott Adams, MSc2, Jennifer
Finestone, MA, CCC3, Doreen Edward41McGill University
Health Centre, Montreal, QC, Canada, 2Hope & Cope
Wellness Centre, Montreal, QC, Canada, 3Cedars
CanSupport Royal Victoria Hospital, Montreal, QC,
Canada, 4VOBOC (Venturing Out Beyond Our Cancer).
Council of Chapters Meeting
CANO/ACIO Website Presentation
6:30 PM | Junior Ballroom A-B
Clinical Practice Change: Transforming
Response to Conditions or Phenomena,
Sustaining the Change and Improving Patient
Outcomes
Angela D. Boudreau, RN, BScN., MN, CON(C), Elaine
Walker, RN, CON(C), CVAA (C), Kirsty Albright, RN,
BScN, MScN. Odette Cancer Centre, Sunnybrook Health
Sciences Centre, Toronto, ON, Canada.
44
Roche Canada Focus Groups
• Evaluate the available treatment options to manage
Junior Ballroom C
• Describe the interdisciplinary approach to bone health
6:30 PM – 8:00 PM
bone health in patients with advanced cancer
management for patients with advanced cancer at the
Best Practice Sharing for
Nurses Managing Central Venous Access
devices (CVADs) (including PICCs and Ports)
Summary
Objectives:
SREs are a serious and often debilitating consequence of
• Share best practices to enhance patient care
advanced cancer. With increasing survival times among
• Discuss current clinical challenges and explore possible solutions
patients with advanced cancers, the likelihood of a patient
Junior Ballroom D
Metastatic Breast Cancer: What Does a Nurse
Need to Know?
Objectives:
Grand River Regional Cancer Centre (GRRCC)
developing an SRE is also increasing. This symposium
will describe the impact of SREs on patient outcomes and
quality of life, and their management with bone-modifying
agents. The speakers will also discuss the development of
an interdisciplinary approach to bone health and patient
outcomes at a clinic currently in operation at the GRRCC.
• Discuss novel developments and new treatments for HER2+
metastatic breast cancer
effect management with novel agents
Day Three/
Jour Trois
Tuesday, October 22, 2013 /
Mardi, 22 Octobre 2013
Amgen Breakfast Symposium
6:30 AM – 7:45 AM
Grand Ballroom
Evolution of Bone Health
Management in Advanced Cancer
Colleen Graham, RN BNSc CON(C), Nurse Manager.Patricia
Bieronski, BScN RN CON(C), Medical Oncology Clinic Nurse.
Grand River Regional Cancer Centre. Kitchener, Ontario
By participating in this symposium, health care providers
can expect to:
CANO/ACIO Annual General Meeting
8:00 AM - 9:15 AM | Grand Ballroom
CANO/ACIO Awards of Excellence
Ceremony
Day three/Jour trois
• What all Nurses need to know about treatment and side
sponsored by Takeda
10:00 AM – 10:30 AM
Pavillion Ballroom
Workshop V-01
10:30 AM – 12:00 PM | Parksville
Inspiring Innovative Care for the Transformation
of Psychosocial Nursing for Young Adults with
Cancer
Anne Katz, PhD, RN. CancerCare Manitoba, Winnipeg,
MB, Canada.
• Recognize the impact of skeletal-related events (SREs)
on outcomes in patients with advanced breast, lung, or
prostate cancer
45
Concurrent Session V-02
Concurrent Session V-02-A
Leading with Patients and Family Members:
Moving from the “Doing to” model to “Doing with”
Transforming the Patient Experience of
Malignant Pleural Effusions with Innovative
Healthcare
10:30 AM – 12:00 PM | Junior Ballroom D
Esther Green, BScN, MSc(T), Joanne MacPhail.
Cancer Care Ontario, Toronto, ON, Canada.
Concurrent Session V-02-B
Person-Centred Perspective and Canada’s
National Strategy for Cancer Control
Scott Secord, MSW, RSW, Andrea Reed, Larry Librach,
MD, Margaret I Fitch, RN, PhD, Irene Nichol. Canadian
Partnership Against Cancer (CPAC), Toronto, ON, Canada.
10:30 AM – 12:00 PM | Junior Ballroom C
Supporting the Foundation: Development
of an Innovative Orientation Program for
Oncology Nurses
Theressa Zapach, RN, BSN, CON(C)1, Ava Hatcher,
RN, BSN2, Lindsay Schwartz, RN, MSc(A)3, G. Anne
Hughes, RN, BSN, MN, CON(C)1, Jagbir Kohli, RN, MN4,
Esther Chow, RN, MN, CON(C)3, Andrea Knox, RN, BSN,
CON(C)5. 1British Columbia Cancer Agency, Victoria,
BC, Canada, 2British Columbia Cancer Agency, Prince
George, BC, Canada, 3British Columbia Cancer Agency,
Vancouver, BC, Canada, 4British Columbia Cancer
Agency, Surrey, BC, Canada, 5British Columbia Cancer
Agency, Kelowna, BC, Canada.
Quality Improvement: Using Data Can Lead
to Many Positive Outcomes
Vicki Lejambe, MN. Saint Elizabeth Health Care,
Barrie, ON, Canada.
46
10:30 AM – 12:00 PM | Junior Ballroom A-B
Shawne P. C. Gray, RN, BScN, CON(C), Larissa Day,
RN, BScN, MSc, CON(C), Harvey H. Wong, MD, FRCP(C).
PleurX catheter Can Help Improve Quality of
Life for Patients With End Stage Cancer
Margaret H. McGregor, RN, MCLin N, CON(C), Patti
Marchand, RN, MN CON(C). Lakeridge Health/Durham
Regional Cancer Centre, Oshawa, ON, Canada.
Concurrent Session V-04-C
Innovation in Cancer Survivorship Care:
Application of the Chronic Care Model to
Design Nursing Roles in New Models of Care
Denise Bryant-Lukosius, RN, PhD1, Ruth MartinMisener, RN, PhD2, Saadia Israr, MMI1, Alan Katz,
MBChB, MSc, CCFP3, Linda Watson, MN, PhD (C)4, Nancy
Carter, PhD1, Ruta Valaitis, PhD1. 1McMaster University,
Hamilton, ON, Canada, 2Dalhousie University, Halifax,
NS, Canada, 3University of Manitoba, Winnipeg, MB,
Canada, 4Alberta Health Services, Calgary, AB, Canada.
10:30 AM – 12:00 PM | Port Alberni
It Takes a Village: Adopting a Complementary
and Alternative Medicine Decision Support
Strategy in a Provincial Cancer Center
Kathleen Yue, RN, BSN, MN1, Brenda La Prairie,
RN, BSN, CON (C)1, Brenda Ross, RN, BScN2, Lynda
Balneaves, RN, PhD3. 1BC Cancer Agency, Victoria, BC,
Canada, 2BC Cancer Agency, Vancouver, BC, Canada,
3UBC School of Nursing, Vancouver, BC, Canada.
Bereaved Families’ Perceptions of Massage
Therapy Services for Paediatric Oncology
and Palliative Care
Andrea M. Laizner, Ph.D.. McGill University Health
Centre, Montreal, QC, Canada.
Astellas Lunch Symposium
12:15 PM – 1:45 PM
Grand Ballroom
The ABC’s of Managing Castrate Resistant
Prostate Cancer (CRPC)
Speaker:
Alan So, MD FRCS (C)
10:30 AM – 12:00 PM | Port McNeil
J’ai subi une importante intervention
chirurgicale et je ne suis restée que 24 heures
à l’hôpital! Hytérectomie assistée par robotique
Lynne Jolicoeur RN, MScN, CON(C); Wendy HicksBoucher RN, BScN, CON(C); Ann Schibli RN, BScN;
Catherine Adamson RN, BScN; Elizabeth Contestible
RN, BScN, NCMP; Kristen Dupuis RN, BScN;; Barbara
D’Entremont RN, BScN; Wylam Faught MD; Laura
Hopkins MD; Robert Weber RN; Joanne Weberpals,
Tien Le, MD, Michael Fung Kee Fung, MD. The Ottawa
Hospital, Ottawa, ON, Canada.
Patients at the Table - Engaging Patients
in the Design and Development of an
Orientation Program for Newly Diagnosed
Cancer Patients
Manon Allard, MBA, Rosana Faria, Psychology.
St.Mary’s Hospital, Montreal, QC, Canada.
Implementation of a New Model of Nursing
Practice in Radiation Oncology in a University
Hospital Center
Catherine Derval, RN, MScN, Centre hospitalier de
l’Université de Montréal, Montréal, QC, Canada.
Associate Professor, Department of Urologic Sciences,
University of British Columbia. Chair, Urology Surgical
Tumor Group, Research Scientist, Prostate Centre,
Vancouver General Hospital
At the conclusion of this meeting, participants should be able to:
1. Review the Advances in new hormonal therapies for CRPC.
2. Determine appropriate patient selection criteria that will
Benefit from the new hormonal therapies for CRPC.
3. Discuss current and future Clinical practices in CRPC.
Merck Lectureship and
Award Presentation
2:00 PM – 3:00 PM
Grand Ballroom
“I Can’t Sleep!” Evaluation of an Innovative
Intervention for Cancer Patients Experiencing
Insomnia
Nancy (Surya) A. Absolon, RN, BA, BSN1, Lynda G.
Balneaves, RN, BSc, PhD2, Tracy L. Truant, RN, MSN,
PhD Student2, Rosemary L. Cashman, RN, MA, MSc(A),
NP(A)1, Margurite E. Wong, RN, MSN3, Jeremy D. Hamm,
M.Sc. Statistics1, Manisha B. Witmans, MD, FRCPC, FAAP,
FASM4. 1Vancouver Centre, British Columbia Cancer
Agency, Vancouver, BC, Canada, 2School of Nursing,
University of British Columbia, Vancouver, BC, Canada,
3Pacific Spirit Community Health Unit, Vancouver Coastal
Health, Vancouver, BC, Canada, 4University of Alberta,
Edmonton, AB, Canada.
Sleep-wake disturbances, particularly insomnia, are
commonly experienced by 30-75% of oncology patients.
This symptom is rarely systematically addressed by health
professionals and few interventions have been found to be
effective in managing this issue in cancer populations.
47
The purpose of this pilot study was to evaluate feasibility
Les perturbations du cycle sommeil-éveil, en particulier
and effect of a novel intervention to facilitate sleep in
l’insomnie, sont courantes parmi 30 à 75 p. 100 des patients
the oncology population. The intervention, based on
en oncologie. Ce symptôme est rarement traité de façon
components within mindfulness-based stress reduction and
systématique par les professionnels de la santé, et peu
cognitive behavioral therapy, allows patients quickly to learn
d’interventions se sont révélées efficaces dans la gestion de
techniques of meditation, visualization and intonation within
cet enjeu parmi les personnes atteintes de cancer.
a clinical setting.
L’objectif de cette étude pilote était d’évaluer la faisabilité
A mixed methods approach was used to determine whether
et l’effet d’une intervention novatrice visant à favoriser le
the sleep intervention improved sleep quality and other
sommeil chez les patients en oncologie. L’intervention,
measures. Quantitative data [Pittsburgh Sleep Quality
fondée sur des éléments de la technique de réduction du
Index, State-Trait Anxiety Inventory, and demographic
stress par la pleine conscience et de la thérapie cognitive
variables] were collected pre- and post-intervention.
basée sur la pleine conscience, permet aux patients
Qualitative data, including field notes, sleep diary and focus
group interviews, were collected to assess feasibility of the
d’apprendre rapidement des techniques de méditation, de
visualisation et d’intonation dans un milieu clinique.
intervention, including ease with which it was learned and
Les chercheurs ont utilisé une méthodologie mixte pour
used by patients.
déterminer, entre autres mesures, si l’intervention améliorait la
Survey data were summarized using descriptive and inferential
statistics to describe sample and outcomes associated with
the intervention. Sleep diary, field notes, and focus group data
were subjected to thematic analysis, in which major concepts
and relationships among them were identified.
This presentation will provide an overview, including final
data analysis and implications for oncology nursing practice.
Participants attending will be taught the intervention.
Conférence et présentation du
Prix Merck
14 h – 15 h | Grand Ballroom
« Je n’arrive pas à dormir! » : Évaluation
d’une intervention novatrice pour les patients
atteints d’un cancer qui souffrent d’insomnie
Nancy (Surya) A. Absolon, B.A., inf., B.Sc.inf.1,
Lynda G., Balneaves, inf., B.Sc., Ph.D.2, Tracy L. Truant,
inf., M.Sc.inf., étudiante au doctorat2, Rosemary L.
Cashman, inf., M.A., M.Sc.(A), IP(A)1, Margurite E.
Wong, inf., M.Sc.inf.3, Jeremy D. Hamm, M.Sc. Statistics1,
Manisha B. Witmans, MD, FRCPC, FAAP, FASM4.
1Vancouver Centre, British Columbia Cancer Agency,
Vancouver, C.-B., Canada, 2School of Nursing, University
of British Columbia, Vancouver, C.-B., Canada, 3Pacific
Spirit Community Health Unit, Vancouver Coastal
Health, Vancouver, C.-B., Canada, 4University of Alberta,
48
qualité du sommeil. Ils ont recueilli des données quantitatives
[Indice de qualité du sommeil de Pittsburgh, Inventaire
d’anxiété situationnelle et variables démographiques] avant et
après l’intervention. Ils ont également recueilli des données
qualitatives, dont des notes de terrain, des journaux du
sommeil et des entrevues de groupe, en vue d’évaluer la
faisabilité de l’intervention, y compris la facilité avec laquelle
les patients l’apprenaient et l’utilisaient.
Les données tirées de l’enquête ont été résumées au moyen
de statistiques descriptives et inférentielles, afin de décrire
l’échantillon et les résultats de l’intervention. Les journaux
du sommeil, notes de terrain et données sur les entrevues
de groupe ont fait l’objet d’une analyse thématique qui a
permis de dégager d’importants concepts et relations.
Cette présentation fournira un aperçu de l’intervention, y
compris une analyse finale des données et les implications
pour la pratique infirmière en oncologie. Les participants
auront l’occasion d’apprendre l’intervention.
sponsored by Sanofi
3:00 PM – 3:30 PM | Pavillion Ballroom
Workshop VI-01
Concurrent Session VI-03
Nursing Interventions in Cardiovascular Risk
Reduction Among Adult Cancer Survivors
Concurrent Session VI-03-A
Edith Pituskin, PhD(C). University of Alberta,
Existential Challenges in Children with Cancer
Roberta L. Woodgate, PhD1, Christina West, PhD1,
Ketan Tailor, MEd2. 1University of Manitoba, Winnipeg,
MB, Canada.2Faculty of Nursing, University of Manitoba,
Winnipeg, MB, Canada.
Concurrent Session VI-03-B
Parental Restitution, Chaos, and Quest Narratives:
Their Value in Pediatric Oncology Nursing
Developing Interdisciplinary Research
Partnerships within the Clinical Setting
Savitri Singh-Carlson, PhD1, Frances Wong, MD2,
Kris Trevillion, RN3, Colleen Sherriff, RN4. 1California
State University Long Beach, Long Beach, CA, USA, 2Fraser
Valley Centre, British Columbia Cancer Agency, Surrey,
BC, Canada, 3Abbotsford Centre, British Columbia Cancer
Centre, Abbotsford, BC, Canada, 4Fraser Valley Centre,
British Columbia Cancer Agency, Surrey, NB, Canada.
Inspiring Change: Using Nursing Vignettes to
Highlight how Screening for Distress Impacts
Cancer Care Delivery
Sydney Farkas, RN, BN, CON(C)1, Shannon Groff,
BSc1, Brent Schaitel, RN2, Andrea Williams, BA1, Barry
Bultz, BA, MA, PhD, R. Psych3, Linda Watson, RN, PhD(C),
CON(C)1.1Community Oncology, AHS-Cancer Care,
Calgary, AB, Canada, 2Community Oncology, AHSCancer Care, Edmonton, AB, Canada, 3AHS-Cancer Care
and the University of Calgary, Calgary, AB, Canada.
Concurrent Session VI-02-C
A Chemotherapy Unit Transformation Journey
Kirsty Albright, RN, BScN, MScN, Angela D. Boudreau,
RN, BScN, MN, CON(C). Odette Cancer Centre,
Jill M. G. Bally, RN, PhD1, Lorraine F. Holtslander, RN, PhD1,
Wendy Duggleby, RN, PhD2. 1College of Nursing, University
of Saskatchewan, Saskatoon, SK, Canada, 2Faculty of
Nursing, University of Alberta, Edmonton, AB, Canada.
When You Think it’s Over, There is More: How
Nursing Care Can Create Hope in Cancer
Patients’ End of Life Treatment.
Émilie Gravel, R.N. Cert. Mental Health and
Community Health, Marie-Graitha Personna, R.N,
BScN, Tracy Regimbald, R.N. BSc.N., Antoinette Ehrler,
R.N. DESS, Dina Linardos, R.N. BSc.N. Jewish General
Hospital, Montreal, QC, Canada.
Mind the Gap: Creating an Environment for
Comprehensive Care in Pain and Symptom
Management; Palliative Care
Jagbir Kaur Kohli, MN1, Elizabeth Beddard-Huber,
MSN2, Megan Stowe, MSN2, Anne Hughes, MN3, Heather
Watson, BSN3, Ava Hatcher, BN4. 1BC Cancer Agency,
Surrey & Abbotsford, BC, Canada, 2BC Cancer Agency,
Vancouver, BC, Canada, 3BC Cancer Agency, Victoria, BC,
Canada, 4BC Cancer Agency, Prince George, BC, Canada.
49
Transforming the Ways in which Oncology
Nurses Support Family Caregiver Coping in
End-of-life Cancer Care.
Kelli I. Stajduhar, RN, PhD1, Wanda Martin, RN, MN,
PhD (C)1, Doris Barwich, MD2, Gillian Fyles, MD3, Kristine
Votova, PhD1. 1University of Victoria, Victoria, BC,
Canada, 2Fraser Health Authority, Surrey, BC, Canada,
3BC Cancer Agency, Kelowna, BC, Canada.
Committee and Special Interest
Groups Meetings
5:15 PM – 6:15 PM
See page 30 for more information
Social Event
7:00 PM Onward | Vancouver Law Courts
A CANO/ACIO favorite event, we encourage you to join us
Workshop VI-05
Inspiring Nurses to Share Innovations by
Writing in the Canadian Oncology Nursing
Journal (CONJ): Let Us Help You Get Started
Margaret I. Fitch, RN, PhD1, Jeanne Robertson, RN,
MBA2, Pat Sevean, RN, PhD3, Sharon Thomson, RN, MSc4,
Sally Thorne, RN, PhD5, Janice Chobanuk, RN6. 1Odette
Cancer Centre, Sunnybrook Health Sciences Centre, Toronto,
ON, Canada, 2Eastern Health, St. John’s, NL, Canada,
3Lakehead University, Thunder Bay, ON, Canada, 4BC
Cancer Agency, Vancouver, BC, Canada, 5University of
British Columbia, Vancouver, BC, Canada, 6Alberta Health
Services, Calgary, AB, Canada.
for a social evening of celebration in the heart of Vancouver.
The great hall of the law courts building is an amazing
atmosphere settled in the shadows of city-scape vistas,
and there we will dine, dance to a live ABBA tribute band
(70’s attire encouraged!), and sample the first-ever CANO/
ACIO cocktail. All social night attendees will receive a
complimentary photographic souvenir, sure to impress
family and friends! Tickets are available at registration!
Day Four/
Jour Quatre
Wednesday, October 23, 2013 /
Mercredi, 23 Octobre 2013
Perceptions of Illness and Self-efficacy for
Coping Behaviours in Advanced Stage Lung
Cancer Patients
Doris Howell, PhD, RN, Gerald Devins, PhD, Julie
Trudel, PhD, Andrea Bezjak, MD, Natasha Leighl, MD,
Samantha Mayo, PhD candidate. University Health
Network, Toronto, ON, Canada.
Day four/Jour quatre
A Narrative Practice Model: Attending to Loss
and Life Restoration in Cancer Care
Christina H. West, RN, PhD1, Janice M. Bell, RN, PhD2,
Roberta L. Woodgate, RN, PhD1. 1University of Manitoba,
Winnipeg, MB, Canada, 2University of Calgary, Calgary,
AB, Canada.
50
Keynote Presenation III: Awakening
to Life in the Midst of Cancer
Janie Brown
sponsored by Celgene
9:00 AM – 10:00 AM
Grand Ballroom
Janie Brown, RN, MSN,
MA (Psych.), Oncology
Nurse and Founder,
Callanish Society
Janie has worked with families with
cancer for over 25 years. As an
oncology nurse for many years, Janie always wanted to
do more. She saw how it was the physical disease and
treatment that defined much of the care provided. She
dreamed of a place where people with cancer, and their
were, finding ways to strengthen the heart and the spirit.
In 1995, along with a team of other professionals, Janie
founded the Callanish Society (www.callanish.org), a
non-profit organization that provides weeklong retreats
and support programs for families with cancer, and the
professionals who care for them.
Concurrent Session VII-01-B
A Recruitment and Retention Strategy to
Transform Nurses into Specialized Oncology
Nurses in Clinical Trials
Marcia Flynn-Post, R.N., B.A., CON(C). University
Health Network, Toronto, ON, Canada.
Seventy weeklong retreats later, Janie has an unshakeable faith
that cancer happens to a person, and the family, but it does not
Concurrent Session VII-01-C
have to define who they are, nor who they can become.
Formalising Cancer Care Coordination into
Nurses’ Daily Practice: A Pilot Study
Janie Brown, inf., M.Sc.inf., M.A. (Psych.)
Voilà plus de 25 ans que Mme Brown travaille auprès de
familles qui vivent avec un cancer. Infirmière en oncologie
pendant de nombreuses années, elle a toujours voulu en
faire plus. Elle constatait que c’était la maladie physique et
le traitement qui définissaient en grande partie la fourniture
des soins. Elle rêvait d’un endroit où les personnes atteintes
d’un cancer et leur famille pourraient reprendre contact
avec la vie et trouver des façons de se fortifier le cœur et
l’esprit, indépendamment de la progression de la maladie.
En 1995, avec une équipe de professionnels, Mme
Brown a fondé la Callanish Society (www.callanish.org),
un organisme sans but lucratif qui offre des retraites les
fins de semaine ainsi que des programmes de soutien
pour les familles vivant avec un cancer et pour les
professionnels leur prodiguant des soins. Soixante-dix
retraites plus tard, Mme Brown est plus convaincue que
jamais que le cancer est une expérience qui touche les
personnes et les familles, mais qui ne définit ni qui elles
sont, ni qui elles peuvent devenir.
Health Break in Exhibit Hall
sponsored by Celgene
10:00 AM – 10:30 AM
Pavillion Ballroom
Heather Watson, RN, BScN1, Catherine van Mossel,
MA, PhD (C)2, G. Anne Hughes, RN, BSN, MN, CON(C)1.
1British Columbia Cancer Agency, Victoria, BC, Canada,
Concurrent Session VII-02
Concurrent Session VII-02-A
Oncology Nursing - Where is it Heading?
Redesigning and Implementing a Nursing
Delivery Model to Improve Teamwork and
Patient Care
Neda A. Soltani, RN, Leslie Cameron, RN, CON(C).
Sunnybrook Hospital, Toronto, ON, Canada.
“Expert” Novices: Innovation, Inspiration
and Transformation of Mid-Career Radiation
Oncology Nurses
Corsita T. Garraway, RN(EC), MScN, CON(C),
CHPCN(C), Joanne Duggan, RN, CON(C), CHPCN(C),.
Stronach Regional Cancer Centre, Newmarket, ON, Canada.
Concurrent Session VII–01
Enhancing the Oncology Clinic-A Team Effort
Michelle D. Lowe, RN, CON(C), Colleen Cameron-Mosher,
RN, CON(C). South Shore Health, Bridgewater, NS, Canada.
51
families, could reconnect with life, no matter how ill they
Inspiration, Innovation and Transformation:
Support for Children When a Family Member
Has Cancer
The MUHC Ovarian Cancer Patient Guide: An
Innovative Approach to Patient Education
Jagbir Kaur Kohli, MN1, Karen Janes, MSN2. 1BC
Cancer Agency, Surrey, BC, Canada, 2BC Cancer Agency,
Vancouver, BC, Canada.
Joanne Power, RN, MScN, CON(C)1, Nancy Posel, N,
PhD2, Julia Thomas, RN, MSc(A)1, Enza Ambrosio, RN,
BScN, CON(C)1, Nadine Al-Hawari, RN, MSc(A)1, Virginia
Lee, N, PhD1. 1McGill University Health Centre, Montreal,
QC, Canada, 2McGill University, Montreal, QC, Canada.
The Development of an Interprofessional
Clinical Pathway for Gynecological Oncology
Patients Undergoing Abdominal Surgery
10:30 AM – 12:00 PM |Junior Ballroom A-B
Inspiring Person-Centred Care through the
Integration of Screening for Distress and
Navigator Roles into practice
Jennifer Anderson, RN, MN, CON(C)1, Sydney Farkas,
BN, RN, CON(C)1, Shannon Groff, BSc1, Brent Schaitel,
RN2, Andrea Williams, BA1, Barry Bultz, BA, MA, PhD,
R. Psych3, Linda Watson, RN, PhD(C), CON(C)1.
1Community Oncology, AHS-Cancer Care, Calgary, AB,
Canada, 2Community Oncology, AHS-Cancer Care,
Edmonton, AB, Canada, 3AHS-Cancer Care and the
University of Calgary, Calgary, AB, Canada.
Transforming the Ambulatory Oncology Clinic
Interdisciplinary Model of Care
Mary Flaherty, RN, MSc(A), MA, Jen Rosychuk,
RN, BSC, BSN, Nancy Runzer, RN, MSN. BC Cancer
Agency, Vancouver, BC, Canada.
Factors Perceived to Influence Nurses;
Use of Evidence-informed Protocols for
Remote Cancer Treatment-related Symptom
Management: A Qualitative Study
Dawn Stacey, RN, PhD, CON(C)1, Meg Carley, BSc2,
Myriam Skrutkowski RN, MSc, CONC(C)3, For the
Pan-Canadian Oncology Symptom Triage and Remote
Support (COSTaRS), Team1. 1University of Ottawa,
Ottawa, ON, Canada, 2Ottawa Hospital Research
Institute, Ottawa, ON,Canada,3McGill University Health
52
Mary Glavassevich, BA, MN, Elaine Avila, BScN, Ivy
Henry, BScN. Sunnybrook Health Sciences Centre, Toronto,
ON, Canada.
Qualitative Exploration of Families’
Experience Caring for Loved Ones with
Advanced Ovarian Cancer
Margaret I. Fitch, RN, PhD1, Tracey DasGupta, RN,
MN, CON(C)1, Alison McAndrew, BA, R AP1, Marilyn
Sapsford, BA, M.Div.2, Shari Moura, RN, MN, CON(C),
CHPCN(C)1, Kalli Stilos, RN, MScN, CHPCN(C)1, Kim
Barrow, MSW, RSW1, Lynn Faltl, RN1. 1Odette Cancer
Centre, Sunnybrook Health Sciences Centre, Toronto, ON,
Canada, 2Ovarian Cancer Canada, Toronto, ON, Canada.
Awakening from the Cocoon: Family
Members Transitioning Through 100 Days
Post Stem Cell Transplant
Daniel J. Gagné, MN1, Roberta Woodgate, Ph D2.
1Universite de Saint-Boniface, Winnipeg, MB, Canada,
Janssen Lunch Symposium
12:15 PM – 1:45 PM
Grand Ballroom
Optimizing Patient Care: Nursing
Considerations for Patients With Multiple
Myeloma
Speaker: Kathleen Colson
Clinical Research Nurse, RN, BSN, BS
Multiple Myeloma
Dana Farber Cancer Institute, Boston, MA
Concurrent Session VIII-01-B
“You Do What Needs to Be Done”: Transition
Experiences of Male Spouses of Female
Partners with Breast Cancer
Kelly Struthers Montford, M.A.1, Wendy D. Duggleby,
PhD1, Cheryl Nekolaichuk, PhD, RPsych2, Sunita Ghosh,
PhD, P.Stat2, Ceinwen Cumming, PhD2, Katia Tonkin, PhD2.
1Faculty of Nursing, University of Alberta, Edmonton, AB,
Canada, 2Department of Oncology, University of Alberta,
Concurrent Session VIII-01-C
• Describe symptoms and clinical presentation of
multiple myeloma
• Understanding etiology, incidence and risk factors of
multiple myeloma
• Current trends in MM treatment
• Practical nursing considerations for administration of
SQ Velcade
Inspiring Hope and Increasing Capacity to
Cope for Patients and Caregivers
Heather Sinardo, BScN, MN1, Sandra Krueckl, PhD2.
1Canadian Cancer Society, Toronto, ON, Canada,
2Canadian Cancer Society, Vancouver, BC, Canada.
Concurrent Session VIII-02
Fact or Fiction?Candid Prostate Cancer
Discussion with Alan So MD, FRCSC
Speaker: Alan So MD
MD, FRCSC
Associate Professor Faculty of Medicine, Department of
Urologic Sciences, The University of British Columbia
Concurrent Session VIII-02-A
A Systematic Follow-up of Patients
receiving Palliative Radiotherapy;
The Story of a Team Effort
Maryse Carignan, M.Sc. , CON(C), Stéphanie Nunès,
B.Sc.. CSSS de Laval, Laval, QC, Canada.
prostate cancer (mCRPC).
• Review the available treatment options for mCRPC.
• Discuss the safety, efficacy profile, dosing,
administration & QOL of Zytiga.
• Learn some interesting facts, in an interesting way
Innovative “All-Inclusive” Breast Cancer
Support: The Patient’s Perspective
Kris J. Trevillion, RN1, Savitri Singh-Carlson, PhD2,
Frances Wong, M.D.1. 1B.C. Cancer Agency- Abbotsford
Centre, Abbotsford, BC, Canada, 2California State
University, Longbeach, CA, USA.
Inspiring change in Interprofessional Care:
Defining Scope of Practice for Specialized
Oncology Nurses and Radiation Therapists in
Radiation Oncology; Focusing on Role clarity,
Enhanced Communication, and Improved
Collaboration
Arlene Court, RN, BScN, CON (C)1, Lisa Di Prospero,
MRT(T) BSc MSc2,3, Tracey Das Gupta, RN BScN MN
CON(C)4, Sheila Robson, MRT(T) BSc ACT12, Philiz Goh, RN,
BScN, CON(C)1, Alison McAndrew, BA RAP1. 1Sunnybrook
Odette Cancer Centre, Toronto, ON, Canada, 2Department
of Radiation Therapy, Odette Cancer Centre, Toronto, ON,
Canada, 3Department of Radiation Oncology, University
of Toronto, Toronto, ON, Canada, 4Department of Nursing,
53
• Define the burden of metastatic castration-resistant
Oncology Patient Classification System
The Experience of Well-being in the Midst of
Advanced Cancer
Janette S. Klaver, BScN CON(C), Yvonne Zettel, RN
CON(C). Grand River Hospital, Kitchener, ON, Canada.
Kathleen Yue, BSN, MN. BC Cancer Agency, Victoria,
BC, Canada.
When the Best They Can Do Is Live With It:
Exploring the Experience of Families Living
with Chronic Cancer
Linda Watson, RN, MN, PhD(C), CON(C)1, Shelley
Raffin Bouchal, RN, PhD2. 1Alberta Health Services
Cancer Care, Calgary, AB, Canada, 2Faculty of Nursing,
Living with a Primary Malignant Brain Tumor:
Recurrent Themes from a Psychosocial
Oncology Practice
Brenda Sabo, PhD Nursing. Dalhousie University,
Halifax, NS, Canada.
An Innovative Solution to Improving the
Delivery of Chemotherapy to Rural Cancer
Centres
Janice L. Chobanuk, RN, BScN, MN, CON(C),
HPCN(C), Wayne Enders, RN, Pam Barnaby, RN, BScN,
Pamela Sutton, Pharm Tech (C), Allison Cann, HIM Tech
II, Dave Whiteside, RN, BN, MBA(C), Shelley Cloutier, RN,
BScN, Sarah Champ, RN, BScN, MN(C), CON(C). AHS
Cancer Care, Community Oncology, AB, Canada.
Oral Chemotherapy & Biotherapy: Effective
Care and Support for Patients
Haley Back, BSN, BKIN, Tyrone Maguire, BSN.
Proactive or Reactive? Transforming the
practice of safer delivery of Toxic Chemicals.
Professional Grief: Lets be Proactive!
Anet Julius, BScN, RN, MN, CON(C). Princess
Margaret Cancer Center, Toronto, ON, Canada.
Compassion Fatigue: Increasing Awareness
and Encouraging Self-Care Strategies Among
Oncology Nurses
Laura Mitchell, RN, BA, MN, CON(C), CNS. Princess
Margaret Hospital, Toronto, ON, Canada.
54
Anne Schmidt, RN, CON(C), Donna Van Allen, RN,
BHScN, CON(C). Grand River Regional Cancer Centre,
Kitchener, ON, Canada.
From Patient to Participant: Enhancing the
Validity and Ethics of Cancer Research
through Participatory Research
Redesigning the Delivery of Nursing Care to
Cancer Patients
Margaret I. Fitch, RN, PhD, Sherrol Palmer-Wickham,
RN, BScN, CON(C). Odette Cancer Centre, Sunnybrook
Health Sciences Centre, Toronto, ON, Canada.
Closing Ceremonies and
Abstract Award Presentation
their home communities, it remains that many still
need to travel to Winnipeg for certain indications such
as treatment for acute leukemia, blood and marrow
transplantation, participation in clinical studies and
radiotherapy. There is a wealth of literature on the
impact of place of residence on the unmet needs
of cancer patients. Rural community residents tend
to have many disadvantages in the supportive care
domains based on geographic location. In this
presentation we will provide an overview of literature
that illustrates the challenges that are encountered
by our rural residents and provide grounding for
future research. As well, we will present a Manitoba
initiative, A Port in the Storm, which was established
to provide a safe, supportive, and affordable, homelike environment for rural and northern adults and their
families who are in Winnipeg for medical treatments.
We will present the milestones of this important
Manitoba project and testimonial data that supports
the impact that this initiative has had on lives of rural
Manitobans living with cancer.
abstract listing/
Liste des abrégés
pour presentation
orale
9:45 AM – 11:15 AM | Parksville
Supportive Care Needs of Individuals with
Cancer from Rural or Remote Communities:
Impact of a Manitoba project
Patricia Benjaminson, RN1, Joanne Loughery,
BN, RN2, Dr Roberta Woodgate PhD3. 1CancerCare
Manitoba, Winnipeg, MB, Canada, 2Red River College,
Winnipeg, MB, Canada, 3University of Manitoba
Winnipeg, Manitoba, Canada.
A cancer journey is a life changing experience that
affects all aspects of a person’s life. Individuals with
cancer face many challenges in a variety of domains
including physical, emotional, social, informational,
spiritual, psychological and practical. Although many
Manitoba patients have access to oncology care in
A Collaborative Approach Across Three
Health Authorities to Standardize the
Management of Refractory Malignant Ascites
for Palliative Patients.
Elizabeth Beddard-Huber, MSN1, Nicole Wikjord,
MSN2, Ruth Topolnicky, MSN3, Sarah Cobb, BSN4, Ingrid
See, MSN5. 1BCCA, Vancouver, BC, Canada, 2Vancouver
General Hospital, Vancouver, BC, Canada, 3Fraser Health
Authority, Vancouver, BC, Canada, 4Providence Health,
Vancouver, BC, Canada, 5Vancouver Coastal Health
Community, Vancouver, BC, Canada.
Palliative patients with refractory malignant ascites (MA) have
a reduced quality of life and experience a significant symptom
burden. Paracentesis has been shown to be effective in
reducing symptom burden for these patients. The need for an
indwelling catheter is a reality for patients requiring frequent
paracenteses to relieve symptom burden and who have
difficulty accessing out-patient services. Challenges with the
current materials, guidelines and systems of care have
been problematic for patients, families and care providers.
Overcoming these challenges became our inspiration.
Five nurse leaders from three health authorities
collaborated to transform the management of symptomatic
refractory malignant ascites in palliative patients across
settings. This presentation will highlight the hurdles and
successes of collaborating across health authorities, all
with individual requirements for guidelines, ethics and
internal approval processes, to develop and implement a
standardized approach to care.
55
abstract listing/liste des abrégés pour presentation orale
Margaret I. Fitch, RN, PhD1, Connie G. Chiu, MD2,
Terry L. Mitchell, PhD, C.Psych.3. 1Odette Cancer Centre,
Sunnybrook Health Sciences Centre, Toronto, ON, Canada,
2John Wayne Cancer Institute, Santa Monica, CA, USA,
3Wilfrid Laurier University, Waterloo, ON, Canada.
A Quality Improvement Project, intended to evaluate a
new tunneled intraperitoneal catheter (Asept™ Catheter)
for use in the management of malignant ascites has been
initiated. The evaluation will explore the effectiveness,
ease and comfort of use of the Asept™ Catheter from the
perspective of interventional radiology, nursing and patients
prior to recommending it for broader use across three
Health Authorities. Moving forward together, this innovative,
collaborative project aims to promote best clinical practices
in the management of malignant ascites through evidencebased enquiry, interdisciplinary team work and crossorganizational leadership.
9:45 AM - 11:15 AM | Junior Ballroom D
Transitioning Cancer Centre Patients back
to their Primary Care Providers: Reviewing a
Model of Care, Project Implementation, and
Evaluation Data.
Amy B. Boucher, RN, Liane Kandler, MA, Doctoral
Student Thunder Bay Regional Health Sciences Centre,
Thunder Bay, ON, Canada.
Regional Cancer Care Northwest (RCC-NW) implemented a
Transition Clinic (TC), wherein colorectal and breast cancer
patients are discharged to their primary care provider for
follow-up treatment. This presentation will focus on (1)
detailing benefits and challenges of the novel TC model, and
the process of implementation and management and (2)
presenting preliminary results from the ongoing TC evaluation.
The evaluation surveyed patient reactions to the Transition
Clinic at time of discharge (n = 83) and again approximately
4 months post (n = 50), focusing on patient understanding
of the TC, perceived benefits and drawbacks, relationship
with primary care provider, overall satisfaction with the model
and with being transitioned, distress, and satisfaction with life.
Descriptives and frequencies will be presented, as well as
correlational, t-test, and chi square analyses. Notable finding
include increased patient distress associated with decreased
understanding who is responsible for their care, decreased
perception of TC benefits, decreased perception that their
family doctor will be able to provide follow-up care, decreased
overall satisfaction with the TC, and a poorer reaction to
being transferred. Amount of time they have been seeing
their family doctor was unrelated to other variables, however
increased belief in family doctor’s ability to provide followup care significantly related with positive feedback across
variables. Findings will be discussed in the context of how
the TC model can be adapted to address common patient
concerns and feedback.
56
Navigation: A Key Component to Enhance
Comprehensive Cancer Care in Rural Manitoba
Zenith Poole, RN, Megan McLeod, MSW. CancerCare
Manitoba, Winnipeg, MB, Canada.
The Manitoba government is funding the Cancer Patient
Journey Initiative (CPJI) for 5 years, from 2011-2016.
This first-in-Canada cancer control strategy is designed
to streamline cancer services, dramatically reducing wait
times for rural Manitoba patients to 60 days or less from the
point of suspicion to the start of treatment. Envisioned as a
leader and key component in the CPJI, the role of Navigation
in transforming Community Cancer Programs into regional
‘Cancer Hubs’ will be described. The synergistic benefits of
implementing Screening for Distress, Psychosocial Oncology
Clinicians and Nurse Navigators together to enhance the
services provided by Oncology Nurses and Family Physicians
in Oncology will be demonstrated. Early implementation of
these roles in Phase One of the CPJI will be examined, from
the perspectives of the challenges as well as the strategies
leading to success. The development of regional cancer
control Hubs to provide quality, culturally safe, coordinated,
evidence-based cancer care and support throughout the
cancer patient journey includes the development of diagnostic
clinics, strengthened links with Primary Care, engagement of
virtual communities of practice, including surgical, diagnostic
and supportive care. This presentation will focus on the role of
Nurse Navigators and Primary Care in the development and
impact of diagnostic clinics to first, deliver reduced wait times
and second, improve patient outcomes throughout the entire
patient journey.
Transforming Lung Cancer Patient Care:
Empowering Patients through Innovations in
System Navigation
Jennifer Smylie, RN, BScN, MHSM, Lynn Kachuik, RN,
BA, MS, CON(C), CHPCN(C). The Ottawa Hospital,
Ottawa, ON, Canada.
Literature supports that lung cancer patients experience
many concerns and symptoms throughout their care
trajectory (Lehto, 2011). Informed patients, participating in
their care are empowered to identify concerns and potential
resources. (Scaramuzzo, 2007). The Ottawa Hospital (TOH)
Cancer Program implemented a Lung Cancer Improvement
Project (LCIP) including innovative strategies to improve
system navigation, empower patients, and enhance
communication amongst the inter-professional team.,
This presentation will describe the various innovations
implemented to achieve our goals of: centralized access to
integrated, co-ordinated, inter-professional care; improved
patient / family system navigation; enhanced team, patient
and family communication; empowered patients more
involved in their care; and individualized holistic lung
cancer care across the continuum. We will share the tools,
tactics and processes that have resulted in improved
care for our lung cancer patients and their families. These
include our patient passport, lung cancer patient information
guide, virtual advanced lung cancer clinic, LnEAP clinic and
our Lung Cancer Improvement Committee. We hope our
presentation will inspire other oncology nurses to take up the
challenge of improving care for this vulnerable population.
9:45 AM - 11:15 AM | Junior Ballroom C
Web-marketing of Prostate Cancer Support
Groups
John L. Oliffe, PhD, MEd, RN1, Christina Han,
MA1, Joan Bottorff, PhD, RN2, Michael McKenzie, MD3,
Estephanie Sta. Maria, BA1. 1University of British
Columbia, Vancouver, BC, Canada, 2University of British
Columbia - Okanagan, Kelowna, BC, Canada, 3British
Background: Prostate cancer (PCa) is the most diagnosed
male cancer in North America, characterized by its high
incidence and low mortality rates as the aging population
and men’s life expectancy increases. Premised on the
belief that prostate cancer support groups (PCGs) provide
psychosocial benefits and promote continuous health
communication in men who experience PCa and their
family, a research study was completed in Vancouver,
Canada to better understand the role of PCSGs in
health promotion. Subsequently, a website - www.
prostatecancerhelpyourself.ubc.ca - was developed to
disseminate study findings and improve PCSGs awareness.
Aim: The presentation aims to communicate the
processes and challenges experienced throughout website
development, as well as focus on data describing uptake
and overall site performance.
Methods: Web development is derived from the research
team’s experiences, including content development and
work with information technology professionals. Detailed
summary of Google AnalyticsTM and YouTube AnalyticsTM
data from October 2012, along with a content analysis of
website forum postings are provided.
Findings: The website attracts over 100 new visitors per
month, with popular site traffic on healthcare professionals’
videos. Although utility of web 2.0 content is supported,
modest forum participation has limited our ability to provide
a comprehensive evaluation of the site. Based on our
findings, recommendations for developing and sustaining
men’s health websites are shared to guide e-health efforts.
I Had Major Surgery and Was in Hospital for
24 Hours!: Robotic Assisted Hysterectomy.
(ENGLISH)
Lynne Jolicoeur RN, MScN, CON(C); Wendy HicksBoucher RN, BScN, CON(C); Ann Schibli RN, BScN; Catherine
Adamson RN, BScN; Elizabeth Contestible RN, BScN, NCMP;
Kristen Dupuis RN, BScN;; Barbara D’Entremont RN, BScN;
Wylam Faught MD; Laura Hopkins MD; Robert Weber RN;
Joanne Weberpals, Tien Le, MD, Michael Fung Kee Fung, MD.
Robotic assisted surgery has been demonstrated to
be a safe, effective and efficient surgical approach for
endometrial cancer. It reduces intraoperative blood
loss, surgical complications and reduces length of stay
without compromising surgical staging when compared to
laparotomy. With shorter length of stays, health care teams
are challenged in providing best supportive care, especially
support and education.
A year after robotic assisted surgery was implemented
we conducted a quality assurance survey. The purpose of
the survey was to obtain patient perspective regarding: 1)
recovery after surgery (time to return to normal activity),
2) post-operative side effects (wound infection, urinary
infection, pain, nausea), 3) quality of life post-surgery:
(overall, treatment inducted menopause), 4) satisfaction
with care and 5) area to improve.
Sixty-one women out of 110 responded to the survey.
Overall women were very satisfied with the surgery (rated
9.3; scale 0-10) and few women reported side effects.
Women appreciated the absence of large incisions and
the faster recovery. Thirteen (21%) women reported quite
a bit to very much pain and some commented on the early
discharge on the first day post-op.
57
In 2011-2012, TOH Thoracic Cancer Assessment Clinic
received 1371 new referrals (785 patients had malignant
disease and 548 were diagnosed with lung cancer) Patients
are often diagnosed at a late stage (< 5 year survival) and
less actively involved in their care.
During this presentation, the author will: 1) describe
the treatment trajectory of women undergoing robotic
assisted surgery for endometrial cancer; 2) present the
tools developed to guide care (clinical pathway, patient
education booklet and pre-printed orders and 3) summarise
the findings of the patient survey.
“I saw it on the web”: Influence of Internet
Information in Cancer Care
Jennifer M. L. Stephens, BSN, MA, RN, OCN1,2,
Sally Thorne, PhD, RN, FA AN, FCAHS2, Kim Taylor, MA2.
2University of British Columbia, Vancouver, BC, Canada.
The internet now plays a significant role in the patient
experience of information access. Much of the research
on patient internet use has focused on accuracy, web
environment, and contradictory messaging. In the context
of a longitudinal qualitative cohort study of cancer
patient experiences communicating with health care
professionals over the course of their illness trajectory,
numerous accounts detailed the complex role that internet
information plays in the communicative dynamics of the
clinical consultation. In this presentation, we describe
what patients believe they gain from internet sources, their
perception of how such sources inform them about their
disease and treatment options, the complications such
information poses for authority, expertise and decision
making in the context of their cancer care, and their capacity
to assess the quality of the care to which they have access.
That patients will have access to greater and more diverse
knowledge sources through their use of the web is a reality
of modern health care systems. The implications for the
communicative context of cancer care delivery can be richly
informed with the experiential perspective of patients across
the care spectrum. These findings not only highlight how the
internet is being utilized by cancer patients, but also provide
clinically-relevant strategies for managing complex patientprovider conversations interwoven with web references.
9:45 AM - 11:15 AM | Junior Ballroom A-B
Oncology and Palliative Care Partnership:
Whole Person Care Inspiring an Innovative
Treatment Approach and a Transformation in
Clinical Practice.
58
Carmel M. Collins, RN, BN, NP-PHC, CHPCN(C),
Kathy Fitzgerald, RN, BN, CON(C), Jonathan Greenland,
MD, FRCPC, Susan M. MacDonald, BScN, MD, CCFP,
FCFP. Eastern Health, St. John’s, NL, Canada.
Metastatic lung cancer is non-curative and many patients
are suffering with symptoms related to the disease from
the time of their initial diagnosis. Although the goals of the
cancer treatments for these patients are to improve quality
and length of life, referral to palliative care clinicians for
symptom management may not be offered until much later
in the patient’s illness experience, if offered at all.
Researchers have documented evidence of improved
outcomes for patients with metastatic lung cancer through
the inclusion of palliative care clinicians at the patient’s
initial visit to a cancer centre. In light of such evidence,
and the desire to better address the whole person needs
of our patients and their families, a collaborative practice
between members of the oncology and palliative care
services was inspired. The design of this initiative was to
offer the services of the expanded care team (oncology
plus palliative care) to this patient population from the
initial assessment visit at the cancer centre. An innovative
process was developed in triaging new referrals to the
cancer centre, followed by the cancer patient navigator
conducting an ESAS screening, and subsequently an inperson cancer centre assessment of the patient and family
with both oncology and palliative care services.
This presentation will describe the initiative, its benefits and
challenges, and the valuable insights we have gleaned with
its implementation and the subsequent transformation of
clinical practice.
Innovative Use of Morbidity and Mortality
Rounds: Palliative Care Leads the Way to
Inspire and Transform Oncology Nursing
Practice
Wendy L. Petrie, RN, BScN, MScN, CON(C),
CHPCN(C), Sylvie C. Bruyere, RN, BScN, CON(C),
CHPCN(C). The Ottawa Hospital, Ottawa, ON, Canada.
Oncology nursing is a challenging, dynamic field, with the
evolution of new and complex treatments. With increased
patient complexities and reduced resources, a major
challenge is ensuring patient safety and quality of care.
Because of the multitude of oncology interventions, errors
and adverse events are often inevitable. Nurses have a
unique opportunity to lead the way by embracing creative
and innovative strategies to enhance patient safety.
Bringing Academic and Practice Together to
Transform Nursing Care for People at the End
of Life
Kelli Stajduhar, PhD1, Carolyn Tayler, RN, BN, MSA2.
1University of Victoria, Victoria, BC, Canada, 2Fraser
Health Authority, Surrey, BC, Canada.
The challenges of bridging the gap between nursing
research and practice are well known. While nurse
researchers sometimes lament that their study findings
are not taken up in practice, practitioners similarly suggest
that nurse researchers are too far removed from practice
to understand that which is relevant in the “real world”.
Members of our academic-practice team have been
working to create a culture of scholarship that allows
partnerships to flourish, research capacity building to
thrive, and knowledge exchange to become the norm.
Our collaborative work addresses the questions: How and
in which contexts can a palliative approach better meet
the needs of patients with advancing illness and guide
the development of innovations to better support nursing
practice and the health system? This applied health
services nursing research initiative - iPANEL (Initiative for a
Palliative Approach in Nursing: Evidence and Leadership)
- aims to contribute to understanding how the nursing
profession can help people with advancing illness benefit
from a palliative approach. Our presentation will highlight
our iPANEL initiative, the strategies used to engage in a
collaborative partnership in order to demonstrate how the
challenges that sometimes exist between nursing research
and nursing practice can be minimized to realize the full
potential that nurses have to ensure research is informed by
and informs clinical practice.
9:45 AM - 11:15 AM | Port Alberni
Invisible practices: Nursing in a Nurse-Run
Clinic
Lorelei Newton, RN, PhD, Sally Kimpson, PhD(C),
Mary Ellen Purkis, PhD, Maxine Alford, PhD. University of
Victoria, Victoria, BC, Canada.
Nurses often claim their day-to-day work activities with
patients are ‘invisible’ in acute care organizations. One
organizational strategy to address this concern is to create
nurse-run patient support clinics (PSC). The aims of PSCs
are to: create time and space for nursing assessment and
intervention; enhance inter-professional communication;
and assist patients navigating the complexity of healthcare
systems. Benefits of PSCs to patients and their families are
documented in the literature. However, nurses currently
working in one such clinic in a cancer care agency continue
to express concerns regarding the invisibility of their work.
Drawing from recent research describing nursing practices
in a PSC, this paper explores social and political influences
on nursing practice within contemporary cancer care
practice environments. In particular, we discuss process
and structural aspects of patient referrals to the PSC
within the context of a medically-dominated organizational
culture. Tracing the referral practices of other healthcare
practitioners to the PSC reveals significant insights into
taken-for-granted organizational processes of patient
care in this setting. We also explore organizational and
professional factors that influence how nursing practice is
accomplished in the PSC setting, in particular ‘evidence’
upon which nursing practice is based. Together referral
practices and the nurses’ understanding and use of
evidence reveal how power is enacted, as well as its effects
on nursing practice, including invisibility, in a PSC setting.
Effective Use of Advanced Practice Nurses
(APNs) in Cancer Control
Denise Bryant-Lukosius, RN, PhD1, Roxanne Cosby,
na1, Debra Bakker, na2, Vanessa Burkoski, na3, Craig
Earle, na4, Barbara Fitzgerald, na5, Esther Green, na6,
Saadia Israr, na1. 1McMaster University, Hamilton, ON,
Canada, 2Laurentian University, Sudbury, ON, Canada,
3McGill University, Montreal, QC, Canada, 4Ontario
Institute for Cancer Research, Toronto, ON, Canada,
5Princess Margaret Hospital, Toronto, ON, Canada,
59
Morbidity and Mortality (M&M) rounds have traditionally
been physician-oriented and focused on rare, fascinating
cases, rather than adverse outcomes from routine care. In
our tertiary care hospital, a new M&M rounds model has
been introduced that focuses on identifying and correcting
system and cognition issues that lead to adverse events.
Our Supportive and Palliative Care Consult Team has
embraced this model by instituting inter-professional M&M
rounds with discussions, case selections and presentations
by all team members including nurses, physicians,
pharmacists, and social workers. The aim is to prevent future
adverse outcomes and improve quality of care by examining
our collective experiences. We will illustrate this model by
discussing examples of M&M rounds presented by our team
that led to improved patient safety. Through this process,
we hope to illuminate the key role of oncology nurses and
inspire them to transform their patient care practice.
Evidence-informed approaches are required to optimize
healthcare planning and decision-making about the
utilization of APNs in cancer control. A systematic review
was conducted to answer this question: In which patient
populations and situations (need types, practice settings,
phase of cancer continuum) have advanced practice
nursing roles demonstrated equivalence, improved
outcomes or reduced harms in studies of cancer care?
Key terms (APN, clinical nurse specialist (CNS), nurse
practitioner (NP), oncology etc.) were used to search
Medline, Embase, Healthstar and CINAHL databases
(1980-2012). The search was limited to English studies and
randomized controlled trials or comparative studies with
a control group. Reference lists of retrieved papers were
hand-searched for additional studies. Included studies
had a sample size of > 30 and evaluated cancer services
or interventions provided by a master’s prepared CNS or
graduate from an accredited NP education program.
The review identified 3983 unique papers. Following title/
abstract and full paper review, 57 eligible studies were
identified. Only 16 of 57 studies described the APN’s
education. Next steps include quality assessment of the
studies and data extraction. A secondary analysis will
compare outcomes of studies that have or have not described
APN education requirements. Findings will be used to develop
practice guideline recommendations about the utilization of
advanced nursing roles for specific patient populations in
varied practice settings across the cancer continuum.
Redefing Value - How Much is a Nurse
Worth?
Much of what Oncology Nurses do is the ‘Science’ of
Nursing but a great deal of our professional life is also
based upon the ‘Art’ of Nursing. How to measure and then
successfully communicate the value of both spheres of
our profession becomes the issue. Inspiring professional
anecdotes combined with cold hard facts provides
stakeholders with a more fulsome picture of Nursing
today and utilizing a Balanced Scorecard measurement
approach, it is evident that Nurses, and Oncology Nurses
in particular, are a most reasonable and cost-effective
healthcare resource. The literature search confirms what we
have known our entire careers: Nurses inspire our patients
to achieve better healthcare outcomes; and, we are a most
cost efficient healthcare resource. Innovative approaches
to care are not new to Nurses and mesuring the successes
relating to patient care, professional opportunities,
healthcare business processes and resultant financial
impact are beginning to truly transform the healthcare
60
system. Oncology Nurses have tremendous value as
noted in the literature and when we quantify and apply
those findings to professional practice magic happens
for our patients. We can measure the ‘Art and Science’ of
Nursing which reflects upon the overall value of a Nurse.
Together, both spheres of Nursing are working alongside
other stakeholders in an effort to inspire and transform our
national healthcare system. Nursing counts - check the
evidence and do the math!
9:45 AM - 11:15 AM | Port McNeil
Utilizing Survivorship Care Plans:
Understanding the Barriers in a Canadian
Environment
Margaret I. Fitch, RN, PhD1, Holly Bradley, MA2,
Geoff Eaton, BBA3, Janine Giese-Davis, BS, MA, PhD4, Jeff
Sisler, MD, MCISc, FCFP5, Jill Taylor-Brown, MSW, RSW5.
1Odette Cancer Centre, Sunnybrook Health Sciences
Centre, Toronto, ON, Canada, 2Wellspring, Toronto, ON,
Canada, 3Young Adult Cancer Canada, St. John’s, NL,
Canada, 4Alberta Health Services, Calgary, AB, Canada,
5CancerCare Manitoba, Winnipeg, MB, Canada.
Background: The Institute of Medicine recommended that
patients finishing treatment receive a survivorship care
plan to assist in their coping. Few cancer centers utilize
survivorship care plans in Canada.
Objectives: Our purpose was to create sustainable survivorship
care plan approaches and identify barriers to implementing the
plans in the Canadian health care environment.
Methods: Four jurisdictions were selected for survivorship
care plan projects including a community-based agency,
a cancer centre, a cancer-centre/community-based
consortium, and national volunteer organization. Each
designed a unique approach for survivorship care plans
based on a template. Evaluations included patient and staff
satisfaction as well as program utilization.
Results: Survivors reported that the plans helped them
understand the next steps in their cancer journey. The
following elements were important factors for successful
implementation: leadership, teamwork and collaboration,
tailoring the care plan, education and training,
communication and dissemination, and conceptualization
of survivorship. Barriers included infrastructure support
(information technology in particular), process for
developing the actual care plan, access to services, and
engaging in robust evaluation.
Workshop II-01
Lymphedema is a progressive chronic condition requiring
life-long management. Although the incidence is unknown,
it affects a significant number of Canadians. It is estimated
that between 3 and 5 million Americans suffer from
lymphedema. The most common cause for the development
of lymphedema is believed to be a consequence of cancer
surgery and/or radiation treatment. Oncology nurses have
the responsibility to be familiar with early recognition of
lymphedema and the many treatment options available.
Innovation in After Cancer Care: Investigating
the Relationship Between Health Literacy and
Patient Satisfaction Among Cancer Survivors
Shari L. Moura, RN, MN, CON(C)1,3, Joyce Nyhof-Young,
PhD2, Edwin Cheung, RA3, Hilda Ulloa, RA3, Malcolm J. Moore,
MD, FRCPC1, Barbara Fitzgerald, RN, MScN1, Carol Townsley,
MD, MSc, CCFP3, Gillian Hawker, MD, MSc, FRCPC3. 1Princess
Margaret Hospital -University Health Network, Toronto, ON,
Canada, 2University Health Network, Toronto, ON, Canada,
3Women’s College Hospital, Toronto, ON, Canada.
Background: As the survival rates for many cancers
continue to increase, developing suitable follow-up
and survivorship care beyond tertiary cancer centres
is important. Cancer survivors have unique needs due
to the psychosocial stressors and late effects of cancer
treatment. The literature indicates that poor health
literacy correlates with low patient satisfaction (Garcia
et al., 2010). However, little is known about the impact
of patient health literacy on patient satisfaction in the
context of cancer survivorship care.
A dedicated cancer survivorship follow-up clinic, developed
in partnership with a cancer centre and ambulatory care
hospital, has examined the impact of health literacy on
patient satisfaction in the unique cancer survivorship
population. The findings from this project will help to
improve the healthcare services offered to cancer survivors.
Purpose: This study investigated the relationship between
health literacy, patient satisfaction and reported level of stress
cancer survivors transitioning to the after cancer clinic.
Methods: Using Dilman’s (2000) Total Design Survey
Method, a self-administered patient experience
questionnaire including health literacy questions was
mailed to cancer survivorship patients after receiving care
at this after cancer clinic.
Outcomes: Survey response rate was 61.3%, (257 of
419). Wilcoxon rank sum analyses were used to determine
the relationship between health literacy and the patient’s
transition experience. Analysis will be shared and
implications to practice to address the stress of transitions
and level of emotional support required will be explored.
Transforming Lymphedema Management
Martina A. Reddick, RN. Dr. H. Bliss Murphy Cancer
Centre, St. John’s, NL, Canada.
This 3 hour workshop will begin with a review of the
important aspects of lymphedema for clinicians in the
oncology setting. This will include basic anatomy and
physiology of the lymphatic system, early recognition,
risk reduction and general management of lymphedema.
Participants will be provided the opportunity to learn the
various application techniques of a new 2 layer cohesive
compression bandaging system that is improving patient’s
quality of life and transforming lives.
This workshop will highlight recent advances in
lymphedema management in Canada. The new Best
Practice Document will be reviewed, emphasizing the
essential role of oncology nurses in caring for individuals
coping with this often unrecognized chronic condition.
With earlier identification and management, oncology
nurses can help those patients with or at risk for
lymphedema maintain their quality of life.
Nurse-Led Newsletter in Surgical Oncology:
Promoting Interprofessional Communication
and Relationships
Tracyann Machado, RN, Rosemarie Rivera, RN, BScN, MN.
In a busy inpatient surgical oncology unit, formal and
informal structures are in place to facilitate communication,
collaboration and teamwork. Two nurses who are co-chairs
of the unit practice council identified the need to enhance
communication and relationships within the surgical
oncology unit in a fun and creative way.
61
Conclusions: The projects streamlined the transition from
treatment to survivorship and increased the capacities
of health care providers to address this gap in care.
Community, cancer centre, and on-line approaches could
work as complementary systems to bridge the transition for
cancer survivors offering care plan services at various times
and places to suit individual needs.
This guided the development of a nurse-led newsletter
to raise awareness on initiatives, staff recognition and
achievements, current research, and updates among
interdisciplinary team members in surgical oncology
using an interprofessional collaboration approach. This
engaged staff to participate in the naming of the newsletter
and contributing written articles. Since 2012, four issues
have been disseminated quarterly via email, hard copy
and on the oncology program portal. Past contributors
included registered nurses, physicians, chaplain, dietitian,
the director of operations and regional planning, a new
graduate nurse, pharmacist, and advanced practice nurses.
priorities identified to go forward to the CANO/ACIO board
for further action: standardized education and maintenance
of competencies; quality nursing indicators; and marketing,
awareness and dissemination. Recommendations evolving
from the phase three evaluation guide CANO/ACIO’s next
steps to move forward the NSCA strategy.
This presentation will discuss the development of the
surgical oncology newsletter; showcase the different topics
and contributors, how feedback from staff and the leadership
team have shaped the newsletter, and key learnings to date.
We also hope that this will motivate oncology nurses to lead
in the creation of a newsletter that will inspire, engage and
strengthen communication and relationships.
Chemotherapy Appointment Reservation
Manager (CHARM): Innovative Technology to
Advance Scheduling and Communication
CANO/ACIO’s National Strategy for
Chemotherapy Administration: Evaluation
Results Driving Action
Renée Hartzell, RN, BScN, CON (C)1, Laura Rashleigh,
RN, MScN, CON(C)2, Tracy Truant, RN, MSN3, Sally
Thorne, RN, PhD, FA AN, FCAHS4. 1Centre de santé et de
services sociaux de Chicoutimi, Chicoutimi, QC, Canada,
2de Souza Institute, Toronto, ON, Canada, 3University
of British Columbia School of Nursing, Vancourver,
BC, Canada, 4University of British Columbia School of
Nursing, Vancouver, BC, Canada.
The National Strategy for Chemotherapy Administration
(NSCA) is a three-phased special initiative of CANO/ACIO
that developed and implemented national standards,
competencies, and educational resources specific to
cancer chemotherapy care by Registered Nurses (RNs)
in Canada. The third phase of the initiative aimed to
evaluate the implementation and uptake of the standards
and competencies and resulted in the development
of recommendations and action plans for long-term
evaluation. The evaluation strategy was developed by a
working sub-group of CANO/ACIO’s Research Committee
and utilized a multi-pronged approach that included a
national electronic survey, stakeholder interviews and an
expert validation workshop. The survey and qualitative
stakeholder interviews were completed in both national
languages with participants providing feedback from
across Canada. In addition to validating the standards
and competencies importance for RNs, the results provide
insight into best practices for implementation and challenges
encountered during that process. Seven themes emerged
from the expert validation workshop, with three primary
62
This presentation provides an overview of the method
and results of the phase three evaluation along with
recommendations for next steps and action plans.
Kirsty Albright, RN, BScN, MScN, Sherri Rotenberg,
RN, BScN, CON(C), Angela Boudreau, RN, BScN,
MN, CON(C), Kathy Beattie, RN, CON(C), Philomena
Sousa, HB.S.B.A., B.E.D., B.S.N.S. Odette Cancer Centre,
The Chemotherapy Appointment Reservation Manager
(CHARM) was originally designed to address ambulatory
chemotherapy patient scheduling issues. Developed
and implemented in 2009, this system created a flexible
schedule based on space and time, protocol timing,
medication processing time, bloodwork necessity,
patient acuity and nursing time. The next goal of this
innovative technology was to implement an electronic
communication system between nursing and pharmacy. Its
successful implementation addressed the up to 75 phone
calls per day between nursing and pharmacy within our
chemotherapy process. This aspect of the tool inspired
further development of email alerts to physicians regarding
discrepancy between orders and chemotherapy bookings.
Additional development of nurse to nurse and pharmacist
to pharmacist communication occurred. With a newly
expanded chemotherapy unit in 2012 nurse to patient
communication commenced. Based on a successful 2012
pilot, the use of Radio Frequency identification (RFID)
technology was implemented for all patients receiving
chemotherapy in 2013. This presentation will share an
overview of this innovative technology’s success in its
application to interprofessional practice with a specific
focus on the RFID technology implementation. Successes
and challenges along the way will be discussed. Grounded
in a collaborative interprofessional approach throughout
its development, CHARM has achieved many successful
outcomes. These successes have resulted in future
implementation to all other areas within our cancer centre
and will provide opportunity to leverage communication to
other technologies in the future.
Transforming Nursing Assessment and
Documentation in the Care of People
Receiving Chemotherapy
Karen Janes, RN, MSN1, Caroline Ehmann, BSc, MA2,
Michelle Moore, RN, BSc, BSN1, Judy Oliver, RN, BSN,
MEd3. 1BC Cancer Agency, Vancouver, BC, Canada, 2BC
Cancer Agency - Vancouver Island Centre, Victoria, BC,
Canada, 3BC Cancer Agency, Victoria, BC, Canada.
Nurses throughout our provincial cancer organization
recognized the need to improve assessment and
documentation in the care of people receiving
chemotherapy - in settings with space, time, complexity,
staffing and communication challenges. Inspired and
supported by the Canadian Association of Nurses in
Oncology’s National Chemotherapy Standards and
Competencies, nurses in direct care, education, and
leadership developed innovative resources and embarked
on the work of transforming assessment, documentation,
and care through practice change. This work included
addressing ways to meaningfully invite and include patient
perspectives in assessment and priority setting, and engaging
nurses in direct care in the development, implementation, and
evaluation of assessment and documentation resources that
meet standards of care and safety.
This presentation will describe the challenges faced, the
opportunities identified, and the resources developed to
support innovations in chemotherapy assessment and
documentation. Implementation strategies and evaluation of
resulting practice change will be described. The collaboration
and key contribution of all team members will be highlighted.
Lessons learned and practical wisdom gained to move from
inspiration to transformation will be shared.
Translating Practice(s): Promises and Perils
of Adopting Best Practice Guidelines
Sally Kimpson, RN, PhD(C)1, Lorelei Newton, RN,
PhD1, Maxine Alford, RN, PhD2, Mary Ellen Purkis,
RN, PhD1. 1University of Victoria, Victoria, BC, Canada,
2BCCA, Victoria, BC, Canada.
Best practice guidelines, aimed at improving contemporary
healthcare delivery and patient outcomes, are currently
being developed (and implemented) as knowledge
translation activities in all Canadian healthcare arenas.
In particular, many expert nurses in cancer care settings
are being enlisted in organizational projects of instituting
symptom management guidelines (SMGs), designed as
“best practices,” which operate as a set of standards by
which nurses can both practice and assess their practice.
Our interview-based qualitative research into nursing
practice in a “nurse-run” ambulatory patient support clinic
in a western Canadian cancer agency, both previous
to and during the implementation of SMGs, reveals the
unintended consequences of introducing knowledge
translation processes into expert practice contexts.
Nurses find themselves balancing both the “promises”information readily at hand, being more thorough, with the
“perils”-using detailed standards within time constraints,
considering the complexity of cancer patients’ lives
beyond symptoms, exposing nurses’ practice to increased
surveillance-produced by the introduction of SMGs.
Drawing from this qualitative research, in this paper we
describe some of the detail (and consequent difficulty)
inherent in the adoption of the SMGs into practice. We also
discuss what is at stake for nurses to incorporate SMGs
into their practice in this setting, as they balance existing
expertise with the “expert knowledge” of the guidelines,
revealing the promises and perils of doing so.
New CVAA Guidelines 2013 - Occlusion
Management for Central Vascular Access
Devices (CVADs)
Jocelyn A. Grecia Hill, MN, RN, OCN®, CVAA(C), VABC™, Providence Health Care-St. Paul’s Hospital, Vancouver,
BC, Canada, President – CVAA National (2013-2014)
The Canadian Vascular Access Association (CVAA) is the
only organization with a clinical focus on vascular access
in Canada. Based on feedback from national members
and other key clinical opinion leaders who work with
central vascular access devices (CVADs), there was an
identified need for clinical guidelines to assist clinicians to
standardize care and minimize variation of clinical practice
to obtain positive outcomes for patients with CVADs. CVAA
was able to obtain an education grant to develop practice
guidelines for occlusion management for CVADs.
This presentation will provide a brief overview of the project
and the national guidelines. CVADs are devices commonly
used in the oncology setting - from tunneled, implanted
and PICC catheters - for chemotherapy administration
and symptom management. CVAD occlusions can
have a significant impact on therapy: delay of therapy,
unscheduled hospital visits for troubleshooting and overall
patient inconvenience and discomfort due to device
removal and replacement if occlusion management not
performed. The goal for this presentation is to increase
awareness and knowledge of best, evidence-based practice
guidelines for occlusion management of CVADs.
63
Addressing Fear of Cancer Recurrence
Among Women with Cancer: A Pilot Study
of A 6-Week Group Cognitive-Existential
Intervention
Eliminating “I Never Knew that was
Available!”: Development of My Survivorship
Map Initiative
Ai Tanimizu, RN, BScN1, Maurene McQuestion, RN, BA,
BScN, MSc, CON(C) 1,2, Aronela Benea, RN, MScN, BScN1,
Scott Secord, RSW, MSW1,2,Carolyn Plummer, RN, BScN,
MHSc3. 1Princess Margaret Cancer Centre – University
Health Network, Toronto, ON, Canada, 2University of
Toronto, Toronto, ON, Canada, 3University Health Network,
Problem: Head and neck cancer (HNC) survivors
(includes patients, their families, and important others)
are known to experience great adversity when trying to
access information and support resources despite their
well-documented psychosocial needs. While resources
are available and advertised in both the hospital and
community, HNC survivors are not accessing them and
they have difficulty understanding their trajectory of
care. This presentation outlines an innovative strategy to
address this issue.
Initiative: Following a literature review, consultation with
HNC survivors and clinicians, and review of existing
resources, an innovative navigational tool called My
Survivorship Map was developed incorporating survivors’
voices to improve awareness of and access to available
resources, and to help them understand their care
trajectory. An interactive educational workshop for
clinicians about the various resources available to patients
and strategies to integrate the map into routine clinic
teaching is being implemented.
Impact: The map will be made available to all HNC
survivors at this hospital. Feedback from HNC survivors
and clinicians during map development has been positive.
The goal is for HNC survivors to access resources more
readily. Initial evaluation results will be presented.
Conclusion: This initiative is relevant to clinicians,
educators, and leaders in cancer care. Although this
innovation is focused on HNC survivors, outcomes of this
initiative can be applied to other cancer disease sites.
Christine Maheu, PhD1, Sophie Lebel, PhD2, Monique
Lefebvre, PhD3, Scott Secord, MSc.4, Christine Courbasson,
PhD5, Mina Singh, PhD6, Lynne Jolicoeur, MScN3, Aronela
Benea, MScN7, Pamela Catton, M.D.7, Pamela Catton, M.D.7.
1McGill University, Montreal, QC, Canada, 2University
of Ottawa, Ottawa, ON, Canada, 3The Ottawa Hospital,
Ottawa, ON, Canada, 4Canadian Partnership Against
Cancer, Toronto, ON, Canada, 5Cognitive Behavioural
Therapy Centre, Toronto, ON, Canada, 6York University,
Toronto, ON, Canada, 7Princess Margaret Hospital,
Evidence suggests that fear of cancer recurrence (FCR)
is one of the most frequently cited unmet needs among
cancer survivors and is associated with impairment in
functioning, psychological distress, stress-response
symptoms, and lower quality of life, as well as increased
use of health care resources. Despite these factors, few
manualized interventions exist to address FCR among
cancer survivors. Purpose: To develop, manualize,
and pilot-test a 6-week cognitive-existential (CE) group
intervention designed to address FCR in women with
breast or ovarian cancer. Methods: single-arm multi-site
study with pre- and post-measures of FCR, cancer-specific
distress, uncertainty, coping, and quality of life. Results: A
total of 37 breast or ovarian cancer survivors completed the
CE group intervention. The intervention reduced both the
primary study outcome measure of FCR and the secondary
measures of cancer-specific distress and uncertainty and
improved quality of life and coping. The improvements were
sustained at 3-month follow-up. The effect sizes were 0.76
(FCR), 0.34 (cancer-specific distress), 0.37 (uncertainty),
0.28-0.41 (coping strategies), and 0.56 (quality of life).
Conclusion: This brief intervention has shown promising
results in addressing FCR; however, it should be further
tested using a randomized controlled study design to more
definitively assess its contribution in reducing FCR, cancerspecific distress, and uncertainty and improving quality of
life and coping in cancer survivors.
Perspectives from the ‘The Desk’ and ‘The
Corporate Office’ on the Return to Work
Experience
Tracy L. Powell, BScN, RN, MN, Lori Buchart, CD,
CHRP. Mount Royal University, Calgary, AB, Canada.
64
The Survivorship Conversation with South
Asian Breast Cancer Patients - A Nursing
Perspective
Colleen S. Sherriff, RN, Dr. Savitri Singh-Carlson, Dr.
Frances Wong. BC Cancer Agency - Fraser Valley Centre,
Surrey, BC, Canada.
The Survivorship Conversation with South Asian Breast
Cancer Patients - A Nursing Perspective
Focus: More people are living longer after a cancer
diagnosis due to aging population, earlier diagnosis and
improved oncology care. As a result, survivorship has
become a focus of patient care.
Scope: Our centre initiated a pilot study implementing
a survivorship care plan for South Asian breast cancer
patients who completed their oncological care at the centre
and were to be discharged to the care of their Family
Physicians. To date twenty patients have seen the Breast
Cancer Care Coordinator (BCCC) to review information
about their oncological care and prepare them for transition
to community based care.
The survivorship conversation imparts information to
ensure patients understand their diagnosis and completed
treatments, recommended follow up and potential
for; ongoing or late onset side effects, recurrence and
psychosocial impacts of their diagnosis and treatment(s).
Implications: During the process of conveying information
and assessing readiness to successfully navigate the
transition to survivorship care the BCCC noted multiple
factors impacted the discussion and contributed to
alterations in presentation and information provided,
transforming future survivorship conversations. This
presentation will review multiple factors including: use of
interpreters, time of day, appointment length, transportation,
family role in the appointment, presenting information and
discussing psychosocial impact of disease and treatment
in a culturally sensitive way and patient readiness for
terminating their relationship with the centre.
Successful Implementation of the Multidisciplinary Collaboration in the Development
of a Chinese-Speaking Cancer Patient
Survivorship Program
Sandy Kwong, MSW, RSW, Esther Chow, RN, MSN,
CON(C). BC Cancer Agency, Vancouver, BC, Canada.
Cancer patients experience many challenges in
transitioning to the post-treatment survivorship. BC Cancer
Agency’s Patient and Family Counseling Program had
completed a number of psychosocial studies pertaining
to the needs of this transition on a culture specific cancer
population, Chinese- Canadian. Due to the language and
cultural specific nature, Chinese-speaking cancer patient
support programs are limited. These studies indicated
that this population embraces a strong value of “self
reliance” in managing health and illness; it is challenging
for them to find reliable and evidence-based self care
information that is coherent to their cultural beliefs. “Be
Active” is a post treatment survivorship program that
provides education workshop series to address those
needs. The program was successfully delivered in 2012.
Popular response and extra funding has made rerun of
this program possible in 2013.
Factors that contributed to the success of this program
include collaborative efforts in the development of this
program by multi-disciplinary team, variety of topics,
different presentation strategies and choices of speakers.
The collaborative experience in the multi-disciplinary
program development will be briefly presented. Evaluation
data on expected and unexpected outcomes will be
presented. Comparison of the 2012 and 2013 evaluation
data analysis will be reported. The important nursing
contribution towards the success of the program will also
be emphasized.
65
The purpose of this qualitative study was to gain an
understanding of the experience of cancer survivors in their
return to work following cancer treatment, and to understand
the perspective of Human Resource (HR) practitioners
involved with an employee’s return to work. A convenience
sample was utilized to recruit the cancer survivor participants
for this study. The sample consisted of five individuals who
had been diagnosed with cancer, had received treatment
and who had/were returning to some form of employment.
A convenience sample was also used to recruit the five
HR practitioners for this study. The HR practitioners that
participated were all employees of governmental or nongovernmental organizations and had been involved with
employee’s return to work. Data for both groups was
collected using unstructured interviews each lasting a
minimum of one hour and were transcribed verbatim. Sociodemographic information was also obtained using a survey.
The three themes that emerged included: assumptions and
expectations, hidden costs and financial burden, and the
new normal. The focus of this paper will be to discuss these
themes in relation to how they were experienced by both
the cancer survivor and HR professional in the return to
work experience. The findings from this study will also assist
healthcare professionals to better understand and support
cancer survivors in their return to work experience.
Return to Work Following Cancer:
Perspectives of Survivors, Employers, and
Insurance Agencies
Margaret I. Fitch, RN, PhD. Odette Cancer Centre,
Background: It is increasingly evident that treatment effects
compromise quality of life, increase the burden of suffering
for survivors, and create challenges returning to work.
Objectives: We explored the perspectives of cancer
survivors (employees), employers, and insuring agencies
about returning to work after cancer treatment.
Methods: An environmental scan identified existing
programs and resources to assist survivors in their
return to work. A literature review and on-line survey
documented perspectives of cancer survivors and their
family caregivers about challenges returning to work after
cancer treatment. Focus groups were held with employers,
human resource representatives, and insuring agencies
to gather perspectives about employees returning to work
after cancer.
Results: 8,385 websites were scanned and 90 were
identified with resources to support patients in returning to
work after illness. Patients (N=410) described reduction
in income, both positive and negative experiences in
returning to work, and work-related issues with fatigue
and cognitive changes. Caregivers (N=60) described
work-related challenges including reduction in income,
loss of concentration and productivity, stress and lack of
support from colleagues. Employers acknowledged issues
but reported very few employees at any one point in time
returning to work after cancer.
Conclusion: There is a need for resources to help
survivors, health care professionals, and employing
agencies become more aware of the challenges cancer
survivors experience in returning to work after treatment.
Using the Transitional Care Model to Inform
Practice Innovation in Well Breast Follow Up
Colleen P. Campbell, NP-PHC, MN. Simcoe Muskoka
Regional Cancer Program, Barrie, ON, Canada.
66
Cancer programs across the country struggle with the
volume of patients seen in surveillance care. Many patients
have routine appointments with surgeons, radiation
oncologist, medical oncologist, primary care providers and
supportive care. There is frustration by patients due to long
wait times, fractionated care, and poor communication
between providers. The cost to the health care system
is exponential with each specialist visit and unnecessary
diagnostic tests ordered. There has been inspiration for
change. The Transitional Care Model has been used in
pediatric and geriatric care demonstrating improvement
in patient outcomes and health care costs. This innovative
project used the model to transition patients from active
cancer treatment through surveillance and discharge to
primary care providers utilizing a Nurse
Practitioner-led clinic. A number of new initiatives have
evolved from the clinic, including an interdisciplinary
‘wellness’ class, improved linkages with community
partners and a resource library. Interim evaluation has
shown a strong degree of patient satisfaction with the clinic,
care given and attention paid to psychosocial issues. We
have transformed breast cancer follow up visits to focus
on holistic patient centered care and health promotion,
combined with monitoring for disease recurrence.
Evidenced based guidelines are used. This successful
nurse-led model can easily be modified for use in other
disease sites upon completion of adjuvant treatment.
Inspired by Patient Delirium: Management
Transformed through an Interdisciplinary
Approach
Janice Dirksen, BSN, Arlyn Heywood, BScN, Elizabeth
Beddard - Huber, MSN, Karen Janes, BSN, MSN. British
Inspired by Patient Delirium: Management Transformed
through an Interdisciplinary Approach
Throughout their cancer journey, for various reasons,
patients may be at risk for developing delirium. On an acute
oncology unit, recent chart audits revealed that 67% of
patients were at risk for experiencing delirium. Inspired to
provide optimal patient care around the management of
delirium, an interdisciplinary working group was established
consisting of physicians, a clinical pharmacist, and nursing
leaders. The goal of our working group was to develop an
evidence based clinical pathway to ensure the identification
of patients at risk for developing delirium, and to establish
a standard of care for the ongoing monitoring and
management of delirium that engaged all three disciplines.
In this presentation we will share how we transformed our
approach and share audit results post implementation.
Innovative Implementation of Standards in a
Resource Challenged Country
Zahra Lalani, RN, BSN. BC Cancer Agency, Vancouver,
BC, Canada.
In India, efforts are being made to improve cancer care
and treatment, but oncology nurses have little or no access
to specialized education and are expected to mix and
administer chemotherapy, as well as manage patient’s
symptoms and side-effects.
Volunteering at a regional cancer centre in Hyderabad,
India, presented many challenges to sharing innovations. In
Canada there is a common level of basic nursing education
to build upon in the clinical setting. This level of education
does not exist at the Hyderabad Regional Cancer Centre.
Therefore, going back to the basics was imperative.
Strategies that were implemented to improve processes
and standardize care took into account the cultural,
physical and educational aspects of nurses’ experience.
The nursing process was used to gather data, and then
nurses were engaged to promote and facilitate change.
Some of the transformations included introduction of the
use of personal protective equipment (PPE) using low
resource strategies to help minimize exposure to cytotoxic
agents, instituting the use of sharps disposal at the bedside
to decrease needle-stick injuries, and promoting hand
hygiene on a 60-bed ward that had access to only one sink
with intermittent running water and no hand towels.
This presentation will discuss strategies used to inspire
nurses to transform nursing practice and patient care in
challenging circumstances.
Transforming Silos of Care into an Integrated
Regional Hospice Palliative Care Program: A
Two Year Long Journey
Lynn Kachuik, RN, BA, MS, CON(C), CHPCN(C).
Palliative Care is a key component of oncology programs
due to its focus on complex symptom management, quality
of life and support of patients and families living with
advanced, incurable disease. However, Palliative Care is not
well integrated into the cancer care system, often accessed
only after completion of cancer treatment. Cancer Care
Ontario (CCO) made Palliative Care a priority in their 2006
document “Improving the Quality of Palliative Care Services
for Cancer Patients in Ontario”.
Although our region had Palliative Care consult teams and
Palliative Care beds, this did not translate into the CCO
vision, wherein: Every person, when faced with a cancer
diagnosis, has the opportunity to live life fully; to receive
timely and appropriate symptom management; to be
supported along with his/her family with dignity and respect
throughout the course of his/her illness; and in the face of
incurable disease, to have the opportunity to die in a setting
of his/her choice.
This presentation will describe the establishment of a Regional
Hospice Palliative Care Program, with the funding and
authority to develop, implement, evaluate and oversee an
innovative model of integrated service delivery designed to
address the needs of these vulnerable patients and families.
We will share our strategies, processes, successes and
challenges on our journey of innovation and transformation.
An Innovative Approach to Clinical trials
Nursing: Transforming Care to Inspire
Change.
Valerie Bowering, RN, CON(C), Marcia Flynn-Post,
RN, B.A. CON(C). Princess Margaret Cancer Center,
While Canada has an outstanding reputation for its
contributions to cancer care through clinical trials, accrual
of patients has diminished over the past 5 years while the
acuity of clinical trials continues to increase. The challenge
at Princess Margaret Cancer Centre has been that accruals
have actually remained stable while acuity has increased
and the model of clinical trials nursing was no longer
sustainable. One of the busiest disease sites for clinical
67
An existing protocol, focused on a subset of patients at
the end of life, but did not meet the needs of all patients
identified at risk. Using the results of an environmental scan
we developed a practical protocol that guides practitioners
to safely manage delirium across our diverse patient
population. The innovative protocol provides direction
through screening tools, assessment guidelines, and
non-pharmalogical as well as pharmalogical treatment
strategies to meet the individual patient’s needs through a
shared approach. The protocol was presented at a shared
discipline and program rounds by members of the working
group, and subsequently implemented.
trials embarked on a transformative and innovate process
to look at how to balance quality of patient care, clinical
data, workload and job satisfaction. Limited literature and
models exist around clinical trials nursing so in May 2012,
the gynecology clinical trials nurses held a retreat and
began to develop a framework for a model of care with
the goal to address work-life balance, increasing clinical
trials and patient acuity, and manage workload volumes.
The resulting pilot consisted of the model and supporting
processes that the entire team agreed to work through
over a set timeframe. Communication was provided to the
interprofessional team to allow them to understand the
impetus for change and expected outcomes. Despite some
“ups and downs” along the path, the resulting change has
motivated us to want to continue to be innovative in how we
are able to transform our model of care and inspire other
clinical trial disease sites to adapt our work.
Supporting Advance Care Planning for
Patients through Oncology Professional
Education
Elizabeth Beddard-Huber, MSN, Angela Bedard, MS.
BCCA, Vancouver, BC, Canada.
In Canada there is a growing aging population, and at
the same time the incidence of cancer is also increasing.
Advance care planning is a process of reflection and
communication to identify the values, wishes and beliefs of
an individual’s future healthcare plans, for if a time comes
when they cannot speak for themselves.
In British Columbia, the Ministry of Health announced
Advance Care Planning as new legislation on September 1,
2011. The legislation allows for a process that may result in
an Advance Directive and/or Representation Agreement.
Our facility continues to streamline communication,
strengthen discharge planning and enhance quality and
continuity of care across the cancer care continuum for
patients. An Advance Care Planning education program
for physicians, nurses and allied healthcare providers was
implemented. Simultaneously the PRISM (Patient-Reported
Information and Symptom Measurement) questionnaire was
introduced which assesses all patients on their knowledge
of advance care planning. The education program includes
both a compulsory introductory eLearning module and an
advanced module consisting of in-person facilitated group
sessions on enhancing communication skills. Staff will
evaluate their knowledge and skills discussing advance
care planning with patients and families. Along with staff
performance, patient-reported outcomes will be analyzed.
Through education our hope is to increase comfort and
capacity to address advance
68
Workshop II-05
Building on the Basics: Practical Tips in
Oncology Nursing Systemic Cancer Therapy
Practice
Kim Chapman, MScN1, Caroline Devereux, MHST2,
Eleanor Getson, RN, BN, CON(C), CHPCN(C),
ONDEC 20083, 1Horizon Health Network, Area 3,
Fredericton, NB, Canada, 2Horizon Health Network, Area
1, Moncton, NB, Canada, 3Saint John Regional Hospital,
Saint John NB, Canada.
Significance and Background: Oncology nursing practice
is continually evolving within the dynamic environment
of cancer care. Nurses are constantly learning new skills
and gaining new knowledge to keep their practice relevant
and patient-focused. Yet, sometimes there is a a lack of
consistency in many of our daily practices and this has the
potential to place patient safety at risk. It is always a good
time to “pull up our socks” and make a conscious effort to
eliminate bad habits and unsound practices from our work
environment. Ultimately, we need to focus on minimizing
risk to our patients, maximize quality, and ensure that
nursing practice has a solid foundation.
Purpose: To share evidence-informed “pearls of wisdom”
and “tricks of the trade” that are relevant to nurses in the
clinical setting.
Interventions: Mock scenarios and interactive case studies
will be used to share “Pearls of Wisdom” and “Practical
Tips” about meeting professional standards, caring for
vulnerable patients, cultivating a high level of curiosity
about practice, fostering investigative skills for patient
assessment, and much more.
Discussion: Sharing evidence-informed practical tips and
pearls of wisdom is a way to create and sustain quality
clinical practice settings and improve patient care. This
interactive presentation will highlight clinical opportunities to
safely deliver systemic cancer therapy, effectively manage
key chemotherapy-induced side effects and toxicities, and
address psychosocial concerns.
Tailoring the Disease Self-Management
Model for Cancer: A Mixed-Methods
Evaluation
Cancer survivors experience multi-factorial
consequences of disease and treatment. Consequently,
the need for quality self-management support to activate
patients in the recovery and optimization of health is
essential. This study generated evidence from practice
and the system to inform a disease self-management
model for cancer.
Method. A concurrent mixed-method study design was
used to characterize the quality of self-management
support in the cancer system, measured as patient
outcomes across sentinel disease sites. Cross-sectional
surveys assessed symptom experience, perceived
confidence in performing self-management behaviours,
perceptions of self-management support, health status
and service use. Quantitative data were collected from
breast, prostate, and colorectal cancer survivors at
Princess Margaret Hospital (N = 428). Qualitative data
were collected from a subset of the sample (n = 32) to
explore their unique perspectives of self-management
support in the cancer system.
Results. Quantitative data were analyzed using
descriptive and multivariate analyses. The major
qualitative themes from focus group interviews were
derived from content analysis. This presentation
will focus on the quantitative data and higher order
qualitative themes.
Conclusions. Patients report poor quality of selfmanagement in the ambulatory cancer system and low
self-efficacy for managing cancer symptoms and the
psychological effects of disease. A significant theme that
emerged from the qualitative data was the challenge
of navigating information in the cancer system. This
“information overload” (e.g., print materials, websites) was
experienced as an instrumental barrier to self-management.
Factors Influencing the Information and
Decision Making Preferences of Prostate
Cancer Patients on Active Surveillance
B. Joyce Davison, PhD. University of Saskatchewan,
Saskatoon, SK, Canada.
This study was conducted to assess the information
and decision-making preferences of patients on active
surveillance (AS), and the factors having an influence on
their decision. A cross-sectional sample of 180 patients on
AS for < 10 years completed a survey exploring the role
men assumed with their physician in treatment decision
making (TDM), factors influencing their decision to go on
AS, and information preferences. Thirty-five percent of
patients reported assuming an active role in TDM, 38%
a collaborative role and 27% a passive role. Levels of
anxiety were not found to have an influence on the role
patients’ reported assuming in treatment decision making.
Information on receiving information about available
treatment options, diet, and non-traditional therapies
were identified as the top three information preferences.
Patients with higher levels of anxiety wanted access to
more information compared to those with lower levels of
anxiety. The urologists’ recommendation was rated as
the most important factor influencing patients’ decisions
to go on AS. No significant differences were identified
across assumed roles in treatment decision making and
information preferences. The urologist’s recommendation
for treatment continues to have the most influence
on the decision to go on AS. Our results suggest that
patients with higher levels of anxiety want access to more
information. Assessments of patients’ information and
decision preferences, and levels of anxiety are suggested
for all prostate cancer patients considering AS.
Person-Centred Virtual Navigation in Cancer
Care: Pathways to Patient Empowerment?
Carmen G. Loiselle, N., Ph.D.. McGill University,
Objective: The advent of the information age in health care
means that stakeholders are increasingly reliant on e-health
tools to add to their knowledge, make decisions, and
access services. Virtual navigation is defined as a proactive
and intentional process of seeking guidance from internetbased resources. In cancer care, it is increasingly seen as a
promising means to complement professional and peer-led
navigation. However, to date, very few studies have relied
on a theoretical foundation to document tangible e-health
contributions. Using concepts related to self-determination
theory and empowerment, our team has been gathering
data on the potential contributions of the Oncology
Interactive Navigator (OIN™) – a web-based tool produced
by a Canadian firm - that provides information and support
to individuals diagnosed with various forms of cancers.
Method: The series of qualitative and quantitative studies
undertaken to date indicate positive contributions of the
tool in domains of perceived cancer competence, support
for patient autonomy, and optimal health care service use.
An ongoing multisite randomized controlled trial is now
testing its effects on patient empowerment and its costeffectiveness in 4 cancer centers from across Canada.
69
Doris Howell, PhD, RN, Amy Kossert, PhD candidate,
Jennifer Jones, PhD, Audrey Friedman, MSW, Samantha
Mayo, PhD candidate, Shan Mohammed, PhD candidate,
Joan Bottoroff, PhD. University Health Network, Toronto,
ON, Canada.
Conclusion: Evidence so far supports the multidimensional
contributions of the OIN™ to health care. Pragmatic (e.g.,
participant accrual, information updating, contextual
demands) and measurement issues periodically arise.
Nevertheless, e-health tools remain a productive means
to test theoretical/clinical propositions and document their
impact on patients and providers alike.
Over the past two years a transformational change requiring
a shift in culture, behaviour, and mindset has begun at a large
comprehensive cancer centre. Teamwork and collaboration
provides an opportunity to exercise creativity and innovation
leading to improved processes in patient care.
Developing Comprehensive Supportive Care
Resources to Address the Information and
Support Needs of Patients Attending a Rapid
Diagnostic Centre for Breast Abnormalities
Aronela Benea, BScN, MScN1, Christine Maheu, PhD2,
Bridgette Lord, MN, NP1, Scott Secord, MSW3, Janet
Papapdakos, MEd1, Pamela Catton, MD, MHPEd, FRCPC1,
Nazek Abdelmutti, MSc1. 1Princess Margaret Cancer
Centre, Toronto, ON, Canada, 2Ingram School of Nursing,
McGill University, Montreal, QC, Canada, 3Canadian
Partnership Against Cancer, Toronto, ON, Canada.
Background: The interval between the detection of
suspicious breast abnormalities and diagnosis is typically a
complex process characterized by multitude consultations
and anxiety among patients and their families. The
expedited diagnosis of breast abnormalities considerably
reduces the diagnostic waiting time, but requires a
necessary parallel rapid response to the information and
support needs of patients facing the sudden diagnosis
news, especially when cancer is confirmed.
Initiative: A scripted telephone intervention was developed
to help patients attending the Gattuso Rapid Diagnostic
Centre (GRDC) at the Princess Margaret address
uncertainty and psychological distress associated with
undergoing the rapid diagnostic process and assimilating
the diagnosis news. This presentation will focus on the
design of the telephone intervention that was informed
by a review of current literature, theories explaining the
contributors to psychological distress and uncertainty in
illness, adult learning principles, and the results from the
needs assessment conducted with GRDC patients. This
project was supported by the Registered Nurses’ Association
of Ontario through an Advanced Practice Fellowship.
Impact: The supportive care telephone intervention is
being tested in a pilot research project. The research
results will inform the nursing practice in rapid diagnostic
centers and contribute to the development of evidence
based standards of care for patients undergoing an
expedited diagnostic process.
Conclusion: The lessons learned from this project may
provide guidance to oncology nurses, educators, and leaders
interested in developing supportive care interventions.
70
Creating and Implementing a Team-Based
Approach to Breast Cancer Care
Leslie M. Cameron, RN, CON(C), Neda A. Soltani, RN.
The Breast Site Specific Team Model relies on clinical nursing
expertise in breast cancer with ongoing collaboration and
communication amongst the breast site nurses to ensure patients
receive safe, effective, high quality, patient-centered care.
This presentation will outline the approach to become a
dedicated breast site nursing team in which specialized
oncology nurses continuously work to build an environment
that values initiative, innovation, trust, and communication
related to all aspects of patient care.The focus of the
presentation will highlight the nurses’ experience of moving
to a team-based approach including the opportunities,
challenges, and successes. Understanding the elements of
what formulates the basis for a successful nursing team is
critical and will be discussed during the presentation. Key
factors that improve communication, foster collaborative
relationships, and provide opportunity for growth within the
nursing team will also be highlighted. The presentation will
discuss the benefits, challenges, and lessons learned in the
approach to build a team of dedicated breast site nurses.
“I Can Do it Myself”; Transforming Patient
Centred Bone Health Care.
Colleen Graham, RN, BNSc, CON(C), Donna
Van Allen, RN, BHScN, CON(C), Patricia Bieronski,
BScN, CON(C), Anna Grani, Pharmacist and, Theresa
Underwood, Pharmacy Technician. Grand River Regional
Cancer Centre, Kitchener, ON, Canada.
Ambulatory oncology patients are constantly managing
multiple treatment regimes that are given in different
institutions and by multiple health care providers. As a
result, patients have been forced to fit into a system and
schedule that meets the needs of the institutions, and
not necessarily the needs of the patients. The patients
frequently lose their independence and sense of control.
Our health care system is challenged with resources to
support the delivery of injections.
To address these challenges, a task force within the Grand
River Regional Cancer Centre identified the need for
transformation within the current system. The team’s focus
The data collected has shown that this is a multidimensional
success. Patients within this group have a renewed
sense of freedom and control as reported through patient
satisfaction data. Multiple patients have been successfully
transitioned to independent care and chemotherapy suite
chair time has been realized. The data has also shown that
there are several groups of patients, including expected
groups of independent and dependent patients, as well as
an unexpected group of interdependent patients.
Results: The data analysis is ongoing and preliminary
results strongly suggest that barriers to men’s’ participation
in cancer rehabilitation is related to five central themes:
• The Stone Age Man – ‘Fix it yourself’
• Staying in control and strong – ‘Be a man’
• Fear - ‘Confrontation with death’
• Anxiety - ‘Being an outcast’
• Striving normality - ‘Forget and move on’
• The Body – ’Treatment making ill’
Final results will be ready for presentation at the conference.
Perspective: To develop a researched based strategy for
development of rehabilitation for male cancer survivors.
The Canadian PORT (Psychosocial Oncology
Research Training) Program Reaches to
International Partners
Carmen G. Loiselle, N., Ph.D.. McGill University,
Male Cancer Survivors; Barriers Towards
Participation in Cancer Rehabilitation – A
Qualitative Study
Charlotte Handberg, PhD student, MPH, RN1, Kirsten
Lomborg, Professor, PhD, MSN, RN1, Claus Vinther Nielsen,
Professor, PhD, MD,1, Julie Midtgaard, PhD, Psychologist,
Associate Professor2. 1Aarhus University, Aarhus, Denmark,
2University of Copenhagen, Copenhagen, Denmark.
Objective: To describe male cancer survivors’ perspectives
on their lack of participation in cancer rehabilitation and to
establish a specific research-based strategy for male cancer
survivors in rehabilitation.
Background: Epidemiological studies indicate that men
develop and die sooner from cancer than women.
Men have rehabilitation needs, but are underrepresented in
cancer rehabilitation where only approximately 16-25% of
the participants are male.
Methodology: The study was designed as a qualitative
ethnographic field study. Data were generated in three
oncology departments and three municipalities in Denmark
and includes semi-structured and ad hoc individual
interviews, participant observation and documents.
The theoretical frame is Symbolic Interactionism and data
were analysed by means of Interpretive
Description: The informants are 43 male cancer survivors
with an average age of 64 and representing nine varies
types of cancer.
Connecting cancer care researchers and graduate
students through an innovative research training initiative:
The Canadian PORT (Psychosocial Oncology Research
Training) program reaches to international partners
Background: Cancer is a leading cause of physical
and psychological suffering. Psychosocial oncology
is increasingly attracting young researchers seeking
rigorous training. Established in Canada in 2003, the CIHR
funded Psychosocial Oncology Research Training (PORT)
program described herein builds research capacity through
enhanced mentoring, innovative research, and proactive
dissemination of findings.
Methods: Through six Canadian universities, PORT
offers research training and financial support to masters,
doctoral and post-doctoral fellows. Partnership with the
National Institute of Mental Health and Neurosciences
(NIMHANS in Bangalore, India) adds richness and crosscultural relevance. Advanced multi-media technology is
utilised to promote information exchange and networking
opportunities. An annual 3-credit 13-week videoconference
graduate seminar in psychosocial oncology research is a
mandatory component of the curriculum. The annual faceto-face scientific meeting is linked to a national conference.
Yearly applications for PORT are encouraged from qualified
international and national candidates.
Results and conclusion: To date, the program has hosted
39 mentors and 63 fellows. Fellows’ output totals 336 peerreviewed publications and 460 scientific presentations.
Research interests include patient experiences with cancerrelated services, early physical exercise effects on cancer
recovery, and tailored survivorship care plans and their
impact on health outcomes, patient empowerment and
71
was to transform the patient experience to being more
patient centric. A group of patients receiving treatment to
support bone health was identified as having the capacity to
independently care for themselves at home. An innovative
educational nurse-led clinic was developed to support
patients learning the skill of self-injection.
psychosocial adjustment. By training the next generation
of promising psychosocial oncology researchers, PORT
continues to build a critical mass of scholars in this field.
A Nursing Approach to Prevention and Early
Detection of Secondary Malignancies in
Patients with CLL
Erin Streu, RN, MN, CON(C)1, Jayne Kopala, RN, BN1,
Donna Hewitt, RN2. 1CancerCare Manitoba, Winnipeg, MB,
It is known that secondary malignancies are common in the
CLL patient population, with men and women of all ages
having a two fold increase compared with general population,
age and sex-controlled matches (Royle, 2011). This increased
risk is due to the significant immune suppression associated
with the disease and its treatments (Morton, 2010, Molica,
2005). The CLL clinic at CCMB currently follows and manages
over 600 patients across the province and aims to provide the
most current, comprehensive and evidence-based care which
includes a role for nurses in health promotion and disease
prevention. The Canadian Association of Nurses in Oncology
identifies prevention, screening and patient education as
key standards and competencies(CANO, 2006). In the CLL
clinic, nurses have begun to actively identify patients who
are at increased risk for secondary malignancies and provide
education and information regarding risk reduction.
Oncology nurses can ensure that all patients are aware of,
and adhere to current provincial screening guidelines for
malignancy, and educate patients about the importance of
early reporting of new or persistent symptoms worrisome
for malignancy. This presentation will provide a review
of the literature, discuss key points to focus on during
the nursing history, current screening recommendations
and specific interventions and areas of education nurses
should address with patients. Specific cases of secondary
malignancies from clinical practice will also be highlighted.
Dignity Conserving Care: The Heart of
Oncology Nursing
Susan E. McClement, RN, PhD1,2. 1CancerCare
Manitoba, Winnipeg, MB, Canada, 2Faculty of Nursing,
University of Manitoba, Winnipeg, MB, Canada.
72
One of the most significant psychological factors affecting
people in the face of advanced malignancy is the compromising
of their perceived personal dignity. Such compromise is
associated with patient experiences of anxiety, depression,
hopelessness, loss of will to live, and desire for hastened death.
Therefore, nurses caring for oncology patients with advanced
disease ought to be concerned with the issue of patient dignity
and how best to support it in the provision of end of life care.
Drawing on programmatic research examining the issue of
dignity in patients with advanced cancer, this presentation will:
i) examine the construct of dignity as understood from the
perspective of terminally ill cancer patients; ii) identify the factors
that both bolster and erode patient dignity, and iii) provide
concrete examples of how the findings of research examining
dignity conserving care can be applied in practice.
A Hospice Ethnography of Delirium
David Wright, PhD, RN, CHPCN(C)1, Susan Brajtman,
PhD, RN2, Mary Ellen Macdonald, PhD3, Betty Cragg, PhD,
RN2. 1Jewish General Hospital, Montreal, QC, Canada,
2University of Ottawa, Ottawa, ON, Canada, 3McGill
University, Montreal, QC, Canada.
Delirium is a disturbance of consciousness and cognition
that affects many advanced cancer patients before death.
While much has been written about end-of-life delirium
from a biomedical perspective, there has been less focus
on delirium as a relational phenomenon that affects
the moral experience of patients and families in end-oflife care. The purpose of this research project was to
study end-of-life delirium within a framework of hospice
caregiving culture. Ethnographic fieldwork was conducted
at a freestanding residential hospice over a period of 15
months in a suburban community in eastern Canada.
The research methods included participant observation
(320 hours over 80 field visits), interviews with 28 hospice
caregivers (nurses, physicians, counselors, volunteers,
managers), and document analysis. Findings illustrate how
a commitment toward providing for a ‘good death’ prevails
within the cultural community of a hospice, and how the
conceptualization, assessment, and management of endof-life delirium are organized within such a commitment.
This study highlights some important differences between
nursing and medical conceptualizations of end-of-life
delirium, and the implications of these differences for
ethical end-of-life care. Ultimately, this study demonstrates
the relevance of considering the contextual and cultural
features of individual end-of-life care settings that wish to
examine, and perhaps improve, the ways in which care of
delirious patients and their families is provided.
Breast Cancer 101: Understanding Pathology
and Treatment, the Basics
Krista Rawson, RN, BScN, MN. Alberta Heatlh
Services, Cancer Care, Red Deer, AB, Canada.
Do you ever struggle to understand the pathology of breast
cancer? Do you wonder why certain treatments are offered
for some individuals and not others? Welcome to “Breast
Cancer Pathology 101” where you will learn the basic
subtypes of breast cancer, their typical treatment options
and why not all breast cancers are created equal. This 45
minute session is geared for the novice to expert nurses
who wishes to improve their understanding of breast cancer
pathology and what is new in our understanding of the
subtypes of this common cancer.
Results: Twenty new roles within a multidisciplinary
context of practice were grounded from the perspectives
of innovation in health care led by the implementation of
rapid diagnostic clinics. The majority of new roles were
related to the domain of information dynamics reinforcing
the practice standards and competencies in the area of
Evidenced Based Care. The introduction of diagnostic
method is accompanied by new challenges increasing
responsibility of patient education, providing social support,
and coordinating multi-professional care.
Conclusion & Implications: The adoption of diagnostic
innovation associated to oncology nurse’s practice provides
new base for the wide incorporation of the CANO standards
and redesigned innovative competencies. By embracing
such new roles, oncology nurses will pursue the integration
of the scientific base of their practice.
Innovative, Prospective Roles for Canadian
Oncology Nurses in Breast Cancer Rapid
Diagnostic Clinics
An Introduction to Oncology Nursing for
Bachelor of Science in Nursing (BSN)
Programme Students
Lorena Baku, BScN-RN1, Margareth Zanchetta, PhD-RN2,
Christine Maheu, PhD-RN3, Patrice Nembhard, BScN-RN4,
Manon Lemonde, PhD-RN5. 1Ryerson University, Toronto, ON,
Canada, 2Ryerson University & Community of Practice-Nursing
Research (CCO), Toronto, ON, Canada, 3McGill University &
Community of Practice-Nursing Research (CCO), Montreal,
ON, Canada, 4St.Joseph Healthcare, Hamilton, ON, Canada,
5University of Ontario Institute of Technology & Community of
Practice-Nursing Research (CCO), Oshawa, ON, Canada.
Shellie Steidle, MSN Advanced Nurse Practitioner,
Sarah Johanson, BSc in Adult Cancer and Palliative
Care Nursing. University of the Fraser Valley,
Chilliwack, BC, Canada.
Background: This paper was generated as an outcome
of E-Mentorship Oncology Nursing Program, McMaster
University from two mentees and supervisors.
Student nurses are encountering cancer patients in all
areas of clinical practice. Whilst the Bachelor of Science
in Nursing (BSN) education programmes are preparing
these students for general practice, an educational gap
exists concerning the underlying principles of oncology
nursing. This presentation will discuss the development
and implementation of an Introduction to Oncology
Nursing elective course for BSN students. Through this
innovative course the aim is to provide nursing students the
opportunity to recognize the challenging needs of cancer
patients in order to enhance the care this specific group of
patients receives in any clinical practice setting.
Method: Oslo Manual Concept Framework of Innovation
inspired the conception of prospective roles of
oncology nurses within the scope of Canadian nurses in
oncology- Practice Standards and Competencies for the
Specialized Oncology Nurse. The conceptual domains of
innovation (e.g. conditions, science base, transfer factors
and information dynamics) shaped the vision of new
competencies mobilizing nurses’ professional expertise in
care management.
The educational aspect of the course allows for the
utilization of case studies as an avenue for the students to
explore specific concepts within cancer care and the lived
cancer experience. Carper’s Ways of Knowing were used
as a framework for the development of each case study so
that students can integrate the art of nursing alongside the
science, ethics, sociopolitical and environmental aspects
that are included in the cancer continuum. The diverse
evaluation methods allow students to utilize their creativity,
Focus: Inspire Canadian oncology nurses to examine the
proposed new professional roles in the innovative practice
of rapid diagnostic clinics for breast cancer.
73
knowledge and clinical experiences; and by facilitating a
selected case study, students are able to build on their
leadership skills and expand their critical thinking and
critical reflective practice.
ON, Canada, 3BC Cancer Agency, Vancouver, BC, Canada,
4McGillUniversity Health Centre, Montreal, QC, Canada,
6Saskatchewan Cancer Agency, Saskatoon, SK, Canada.
Purpose: To explore remote symptom support training
programs provided to nurses in ambulatory oncology
programs across Canada.
Enhancing Oncology Nursing Education
Through Innovation and Technology
Komal Patel, RN, BScN, CON(C), CHPCN(C), Jiahui Wong, PhD,
Tracy Soong, BSc(C), Shanna Brisebois, BA, Mary Jane
Esplen, PhD, RN. de Souza Institute, Toronto, ON, Canada.
With the increasing incidence of cancer and advances
made to screen for and treat these disease, the demand
for nurses with specialized cancer knowledge is imperative.
Nurses - whether it is in a cancer centre, general hospital or
community setting - require expert critical thinking, problem
solving and decision making abilities to effectively care for
cancer patients and their families.
Nurses learn best through case-based discussions with
peers and mentors. To increase accessibility via eLearning
and mobile learning while preserving the valuable
classroom interactions between the educator and learners,
an Ontario based oncology nursing education Institute
incorporated innovative teaching and learning modalities
in their curriculum. Rather than commonly used text based
online reading and video-taped speeches, the Institute’s
curriculum included interactive activities, avatars, audio
and video case studies, projects and discussion forums,
and evaluations creating a “virtual classroom”. Uptake has
been impressive- with 4700 RNs, RPNs, NPs engaging in at
least one of the 30 courses. Different modes of learning with
the same content were compared for their effectiveness in
learner outcomes, i.e., study group offered by synchronous
videoconferencing in 2009 was compared to asynchronous
online learning in 2010 and onwards. Results indicate high
levels of satisfaction in online learning, and comparable
high CNA success rate. The presentation will showcase
examples of eLearning and mobile courses, along with
advantages and outcomes.
Methodology: A survey-methods environmental scan was
conducted targeting individuals in oncology programs
in Canada that provide chemotherapy and radiation
therapy. Procedures were: identify which programs
provide telephone training; collect data; extract data using
standardized forms; validate data extracted; and synthesize.
To enhance response rates, reminders were sent at 2, 4 and
6 weeks. Descriptive analysis was used.
Results: Of 37 email invitations, 28 responded (77.8% response
rate), 8 didn’t respond, and 1 was undeliverable. Respondents
represented all 10 provinces. Of 28 respondents, 25 indicated
nurses provided telephone support in their organization. For
these 25 organizations, 15 orient nurses to the telephone
support role, 2 provide resources only, 7 do not provide either,
and 1 no answer. Preliminary analysis of training materials
shared by 4 programs indicated that 3 were formulated recently
and 1 was relatively older. Elements included: provincial
telephone standards (n=4), local procedures for telephone
support (n=4), symptom protocols (n=4), documenting calls
(n=4), communication skills/etiquette (n=3), case studies
applications (n=2), and evidence the training program is
effective (n=0). Formats were: presentation only, paper-based
resources only, presentation with paper-based resources, or
e-learning modules.
Conclusions: Although national and provincial nursing
guidelines require that nurses who provide telephone support
are trained, training across oncology programs is variable.
Opportunities exist to share best practices across programs.
Telephone Support Training for Oncology
Nurses in Canada: An Environmental Scan
Ligne Info-Onco : ligne téléphonique d’urgence
pour des conseils spécialisés en cancérologie
Dawn Stacey, RN, PhD CON(C)1, Myriam Skrutkowski,
RN, M.Sc., CONC(C)4, Meg Carley, BSc2, Jagbir Kohli,
RN, MN3, Astride Bazile, BScN, MEd, CON(C), NPDE4,
Arlene Court, RN, BScN, CON(C)5, Denise Budz, RN,
BSN, MN6, Jonathan Avery, PhD student1, For the PanCanadian Oncology Symptom Triage and Remote Support
(COSTaRS), Team1. 1University of Ottawa, Ottawa, ON,
Canada, 2Ottawa Hospital Research Institute, Ottawa,
Cécile Bergeron, infirmière clinicienne1, Sonia Joannette2.
1CSSS Champlain Charles-Lemoyne, Greenfield Park, QC,
Canada, 2Ministère de la santé et des services sociaux, QC,
Canada.
74
Au centre intégré de cancérologie de la Montérégie (CICM)
pour obtenir des services de santé, des renseignements, des
conseils ou de soins immédiats, les personnes atteintes de
I am a Nurse in a Radiotherapy Department
Maryse Carignan, M.Sc. , CON(C), Isabelle Tremblay,
B.Sc., Michèle Daigneault, B.Sc.. CSSS de Laval, Laval,
QC, Canada.
According to the position statement of CANO, the “
Radiation Oncology Nurse is an integral member of the
radiation oncology team and has the knowledge, skills,
and judgment to provide assessment, interventions, and
monitoring of patient and family needs (physical, emotional,
social, spiritual, practical, and informational).” With the
opening of the radiotherapy department at the Centre
intégré de cancérologie de Laval (CICL) du Centre de
santé et de services sociaux de Laval (CSSSL), Quebec
in February 2012, the health care team has strived to
provide quality care to patients and their caregivers. At the
CICL, two nurses are members of the radiation oncology
interdisciplinary team. We know that patients treated
with radiotherapy need direct care, close monitoring and
teaching. This workshop will discuss the role of these
nurses within the interdisciplinary team which combine
autonomous and collaborative practices. We will present
the systematic nurse’s evaluation, which is part of the care
plan according to the patient’s needs. Through examples
and case reports, the nurses will demonstrate how their
skills and expertise contribute to the security and the
quality of care of patients receiving radiotherapy. We will
also discuss the development of collaborative approaches
to improve the security and quality of care. Finally, we will
outline the oncology information system that supports the
integration of care to the benefit of patients.
Le leadership infirmier: un levier vers de meilleures
pratiques contemporaines en oncologie
Louise Compagna, B Sc, Caroline Provencher, M Sc,
Francine Grondin, B Sc, Odette Roy, Ph D, M Sc, MAP.
Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.
Orientée vers une prestation sécuritaire et de qualité offerts
à la clientèle, l’équipe de gestionnaires du programme
clientèle en oncologie a développé en partenariat avec
le Centre d’excellence en soins infirmiers, une approche
fondée sur le leadership infirmier. Grâce à une telle
approche, ces gestionnaires ont atteint des résultats
exceptionnels dans le développement professionnel
infirmier. En valorisant le questionnement au chevet et
le transfert des meilleures pratiques « sur le terrain »,
ils ont permis aux infirmières d’améliorer leur exercice
professionnel au profit des patients. Un environnement de
travail offrant une multitude d’occasions de parfaire leurs
connaissances, une culture valorisant l’intégration des
savoirs, une approche participative axée sur l’amélioration
des processus cliniques et organisationnels sont autant
d’avenues responsables du rehaussement des compétences
infirmières. L’innovation dans les stratégies soutient cet
esprit novateur en matière de changement. Notre mission
axée sur la pratique, l’enseignement et la recherche, ainsi
que la qualité des soins aident également à définir nos
orientations et nos défis. Nous vous offrons un regard sur
notre approche de leadership infirmier, la démarche ainsi
que les moyens mis de l’avant afin d’orienter notre pratique
en soins infirmiers vers l’excellence basée sur des hauts
standards issus de la recherche et la pratique permettant
l’atteinte des normes de notre domaine.
Contextualizing Complementary and
Alternative Medicine (CAM) Education for
Oncology Professionals: Lessons Learned
from a Provincial Pilot
Brenda Ross, RN, BScN1, Lynda Balneaves, RN, PhD2,
Tracy Truant, RN, MN, PhD(C)1, Marja Verhoef, PhD3,
Antony Porcino, PhD2. 1BC Cancer Agency, Vancouver, BC,
Canada, 2UBC School of Nursing, Vancouver, BC, Canada,
3University of Calgary, Calgary, AB, Canada.
75
cancer sous traitements actifs et leurs familles ont accès à la
ligne Info-Onco. Cette pratique prometteuse par son processus
d’évaluation est soutenue par une équipe d’infirmières
spécialisées en cancérologie. Cette innovation unique au
Québec contribue à maintenir et améliorer l’état de santé et la
qualité de vie en intervenant précocement par une gestion des
symptômes sécuritaires et une optimisation des auto-soins.
L’offre de services, la composition et les compétences requises
de l’équipe interdisciplinaire, les outils utilisés, le soutien
organisationnel requis, les facteurs facilitants l’implantation
et la pérennité, les résultats des études des besoins et de la
satisfaction de la clientèle et du personnel, les coûts/bénéfices
seront discutés. La ligne Info-Onco contribue à réduire le
nombre d’hospitalisation, d’admission en salle d’urgence,
d’appels/visites au médecin de famille et à l’infirmière pivot en
oncologie. Cette ligne téléphonique d’urgence en cancérologie
est une avenue efficiente pour soutenir les personnes atteintes
de cancer et leurs familles.
Over fifty percent of patients surveyed at a regional
cancer center used some form of CAM during their
cancer experience, yet most did not talk with their health
professionals (HPs) about their CAM use. Patients cited lack
of HP knowledge about CAM therapies as one reason. A HP
survey confirmed deficits in CAM knowledge, and clinical
and information-seeking skills. To determine the feasibility
and impact on HP CAM knowledge and practice, an on-line
CAM education program was piloted to improve HPs’ CAM
knowledge, clinical and information seeking and evaluation
skills. HP CAM knowledge, attitudes, and practices related
to CAM and cancer were surveyed at baseline and one
month after course completion. Feasibility was measured
by program completion rates and participants’ reports of
ease of use, and barriers and enablers to access. Sixty HPs
recruited from the provincial cancer network have completed
the course. Preliminary analysis has revealed significant
increases in CAM knowledge and practice, significant
changes in CAM attitudes, and acceptability of the program
to a diverse HP population. This study supports the use
of an open and accessible online education program in
changing HPs reports of practice. Results of the final analysis
will be reported and will be of interest to those translating
knowledge in their own clinical settings.
Using mixed methods, the pilot study evaluated a)
participants’ CAM decision support needs, b) how the
CAM DSCI affects select patient outcomes, and c) CAM
DSCI feasibility (time, resources, expertise). Participants
demonstrated improvements post CAM DSCI in CAM
knowledge, decision quality, and decisional regret and
described reduced anxiety and confusion when making
CAM decisions. A range of CAM decision support
needs were identified and practice setting feasibility was
established, including development of a practice-ready
CAM assessment and decision support tool for health
professionals.
Although much has been written about home versus
hospital death, and the benefits and shortcomings of
both, the concept of the physical environment as a
healing intervention tends not to be considered. What is
a healing environment? What can healing at the end of
life look like? What role do nurses have in ensuring that
the patient is in an optimal place for healing as they are
dying? This presentation will address these questions, in
part by referring back to the work of Florence Nightingale
whose Notes on Nursing (1860) describes Nursing’s
responsability to provide the best conditions possible for
patient to heal.
Decision Support for Making Complex
Complementary Medicine (CAM) Decisions:
An Innovative Nurse-led Intervention
Tracy L. Truant, RN, MSN1, Lynda G. Balneaves, RN,
PhD1, Brenda C. Ross, RN, BSN2, Margurite E. Wong, RN,
MSN3, Carla Hilario, RN, MSN1, Marja Verhoef, PhD4,
Antony Porcino, PhD1. 1UBC School of Nursing, Vancouver,
BC, Canada, 2BC Cancer Agency, Vancouver, BC, Canada,
4Department of Community Health Services, University of
Calgary, Vancouver, BC, Canada.
Up to 80% of cancer patients use complementary
medicine (CAM), yet most do not receive adequate
decision support from health professionals to safely
integrate CAM into their cancer treatment plan. This gap in
care leads to concerns about safety when combining CAM
with cancer treatments, and possible missed benefits from
CAM therapies for which positive evidence exists.
This study offers preliminary support for feasibility and
effectiveness of the CAM DSCI to meet complex patient
CAM decision support needs. This intervention also
highlights an innovative role for nurses in the growing
field of CAM/Integrative Medicine.
Healing Places and Spaces: Dying in Context
Vasiliki Bitzas, N, PhD(C), CHPCN(C). S.M.B.D.
Jewish General Hospital, Montreal, QC, Canada.
As patients are dying, their physical world, as
represented by the space they find themselves in, is
invariably shrinking. Consequently it is imperative that
Nurses have the knowledge and tools available to
provide a place of healing for their patients and families.
This presentation will include concrete examples of
how this was done in one hospital’s Palliative Care Unit,
and what the outcomes were, not only for patients and
families, but also for staff.
This presentation outlines the development and pilot
testing of a nurse-led intervention to address this gap in
care. The one-on-one CAM decision support coaching
intervention (CAM DSCI) offers cancer patients with
complex CAM decision support needs a structured
approach to accessing and contextualizing evidenceinformed CAM information to their unique clinical and
personal situation.
76
Research Workshop: “Speed Dating” with the
Experts: Networking and Consulting Toward
Research Development
Sally Thorne, RN, PhD1, Carmen Loiselle, BScN, MScN,
PhD2, Greta Cummings, RN, PhD3, Kelli Stadjuhar, RN,
PhD4, John Oliffe, RN, PhD1, Denise Bryant-Lukosius, RN,
PhD5, Margaret Fitch, MScN, PhD6, Doris Howell, RN, PhD7,
Roberta Woodgate, RN, PhD8, 1University of British Columbia,
Vancouver, BC, Canada, 2McGill University, Jewish General
Hospital, Montreal, QE, Canada, 3University of Alberta,
Edmonton, AB, Canada. 4University of Victoria, Victoria,
BC, Canada, 5McMaster University, Hamilton, ON, Canada,
6Odette Cancer Centre. Toronto, Canada, 7University Health
Network, Toronto, ON, Canada, 8University of Manitoba,
In this workshop, we invite conference participants to
spend one-on-one time with established oncology nurse
researchers. Using a “speed dating” format, participants
will sign up for a rotating series of 10-15 minute sessions
with expert researchers willing and able to put their minds
to solving your current project problems, figuring out ethical
or funding challenges, or even just taking your first steps
on the path toward building research into your nursing
career. Imagine the benefit of having some of the great
scholars you have been reading about put their minds to
your research questions and interests. You never know
what great ideas will materialize! Oncology nurses at every
career stage, regardless of prior experience or research
training are welcome to take advantage of “free advice” and
enthusiastic career cheerleading. Come with your questions
and curiosities. We guarantee a lively dialogue!
Improving Assessment and Care for People
Receiving Chemotherapy: There Has to
Be a Better Way…Inspiration, Innovation,
Transformation and Perspiration!
Brenda J. LaPrairie, RN, BSN, CON(C)1, Michelle
Moore, RN, BSN, CON(C)2, Karen Janes, RN, MSN2,
Caroline Ehmann, OT, MA1. 1BC Cancer Agency, Victoria,
BC, Canada, 2BC Cancer Agency, Vancouver, BC, Canada.
CANO National Chemotherapy Administration Standards
identify the need for all patients to receive a comprehensive
nursing assessment prior to the administration of
chemotherapy. In a regional cancer center, an estimated 5080% of patients were arriving in the chemotherapy treatment
area with unmet care needs, resulting in treatment delays,
cancellations, and disruption to patient flow.
This presentation will report on the an innovative project
done by a provincial group of professional practice and
operational nursing leaders. The goal of this project was to
meet the CANO chemotherapy standards without additional
space or nursing resources. The idea was to move the
assessment upstream. This required a patient flow change
and buyin from all stakeholders: patients, nurses, physicians,
clerks, patient care aides and volunteers.
This model was trialed at one centre and compared to
the original care model being used at 5 other centres. A
pre-chemotherapy assessment/documentation tool was
developed that allowed symptoms and side effects to be
graded for severity and documented in a flow-sheet format.
The assessment tool was linked to Symptom Management
Guidelines. This model resulted in consistent assessments,
improved documentation, more efficient care provision, interprofessional collaboration and enhanced patient experience.
Meeting the Standard: Striving for Excellence
in Chemotherapy Education
Bernadine O’Leary, RN, MN, CON(C). Dr. H. Bliss
Murphy Cancer Centre, St. John’s, NL, Canada.
The Canadian Association of Nurses in Oncology
Standards and Competencies for Cancer Chemotherapy
Nursing Practice (2011) clearly delineates the
educational requirements for developing competence
in cancer chemotherapy administration. Our Provincial
Regulatory body classifies chemotherapy administration
as a specialty nursing competency and has stipulated
that agencies need to provide the appropriate education
to ensure that nurses are prepared to safely and
competently to administer chemotherapy and provide
comprehensive care to those receiving chemotherapy.
Guidelines for the development of educational programs
for specialty nursing competencies have also been
outlined by our regulatory body. Similarly, our health
authority also has a number of chemotherapy policies
and guidelines regarding the preparation of Registered
Nurses for chemotherapy administration. The Adult
Chemotherapy Course for our regional health authority
has been accessed by other regions of the province to
prepare Registered Nurses in those jurisdictions. This
presentation will detail the work done over the past two
77
Workshop IV-01
years to improve adult chemotherapy education within
our regional health authority and our province. The
presentation will detail ongoing, collaborative processes
for content review and delivery that have been
implemented to ensure standards and competencies for
chemotherapy administration are met.
Raising the Bar: An Innovative Oral
Chemotherapy Program Designed to
Promote Patient Safety, Education and
Adherence
Terry MacKenzie, RN. Northeast Cancer Centre,
Sudbury, ON, Canada.
Inspiring, promoting and managing change requires hard
work, ongoing monitoring and evaluation. In 2010 a cancer
centre commenced an in-depth analysis of their approach
to oral chemotherapy. Multiple areas for improvement
were identified and an all-encompassing change was
made. These changes included mandatory electronic
prescriptions, blister packaging, nursing checklists, creation
of patient teaching tools and adherence aids, standardized
charting for assessment and the addition of pharmacy
support. This new program was launched in January 2012.
Evaluation of the program consisted of a nursing survey,
a chart audit, monitoring of physician compliance with
generating electronic prescriptions, and regular committee
and nursing meetings to discuss issues. Education of
nursing staff regarding processes and documentation is
ongoing. Engagement of retail pharmacies has resulted in
heightened awareness and enhanced pharmacy support for
patients. We are now in our second year of the program and
continue to make modifications. During this presentation,
we will provide the results of multiple surveys and audits
conducted since initiation, demonstrating how well the
changes have been incorporated into practice. We will
discuss the successes and challenges of transforming
behaviour in a culture that often perceives oral chemotherapy
to be less toxic than intravenous chemotherapy.
4:00 PM – 5:30 PM●| Junior Ballroom C
Assessing the Need in Alberta for a Virtual
Breast Cancer Survivorship Clinic
78
Cindy Railton, RN, MN, NP1, Sasha Lupichuk, MD1,
Barbara Walley, MD1, Janine Geise-Davis, PhD1, Anil Joy,
MD2. 1Tom Baker Cancer Centre, Calgary, AB, Canada,
2Cross Cancer Institute, Edmonton, AB, Canada.
Follow-up of breast cancer patients is largely transferred to
primary care due to limited tertiary resources plus evidence
supporting the acceptability/safety of this. It is unknown
how survivors are faring in the community with treatment
and surveillance goals, and if there is an unmet need for
access to specialist care.
Objectives: To examine: concordance with treatment and
follow-up recommendations; perceived need for help with
achieving these recommendations, perceived need for a
nurse-run virtual breast cancer follow-up clinic.
Methods: Cross-sectional study of women with stages I-III
invasive breast cancer in Alberta. Date of diagnosis is 1-4
years prior to the study start date. 960 potentially eligible
women were invited to participate via mail-out. Consenting
participants completed a structured telephone interview.
Treatment and surveillance data was also obtained from
various cancer care databases.
Results: 240 participants completed the structured telephone
interview and had usable data from chart review. 87% had
received a clinical breast examination within the past year.
97% with remaining breast tissue had a mammogram within
the past year. Concordance with endocrine therapy varied
between pharmacy dispensing records (95%) versus selfreport (82%). 6.5% of participant records demonstrated
non-adherence and 16% demonstrated non-persistence of
endocrine therapy. 71% reported that they would have used a
post-treatment virtual clinic.
Conclusions: Concordance with measurable follow-up
goals (i.e. clinical exam) was better than expected. Despite
this, interest in a virtual follow-up clinic was high.
Adjuvant Endocrine Therapy in Breast
Cancer: Personal, Social and Structural
Factors Influencing Adherence
Leah K. Lambert, RN, PhD Candidate, Lynda G.
Balneaves, RN, PhD, Sabrina T. Wong, RN(C), PhD. The
Breast cancer is a major cause of premature mortality in
Canadian women. The use of adjuvant endocrine therapy
(AET) has dramatically reduced breast cancer recurrence
and mortality. Although AET has made a radical difference
in breast cancer outcomes, a remarkable 50% of women do
not take their AET regimens as prescribed.
The study is currently ongoing and preliminary results will
be presented that explore the personal, social and structural
factors influencing AET adherence. We will be looking at how
factors such as the personal circumstances of women’s lives,
social support, patient-physician communication and the
delivery of healthcare impact adherence.
The identification and prioritization of strategies that
address the needs of survivors struggling to adhere
to AET and empower HCPs’ clinical practices hold
real promise in improving adherence rates and, more
importantly, saving women’s lives.
Shaking Up the System - A Patient Centred
Approach to Transformational Change
Changes to the Canadian healthcare landscape are coming
and they will be dramatic. Already discussions are occurring
that make us shake and shudder but the time to hold on to the
past is over - Oncology Nurses need to leverage our positions
as leaders in healthcare, as the experts of our domain to inspire
and innovate for our future. Placing the patient and the family
at the core of our Oncology system re-design we dovetail the
best practices of the public healthcare system and leverage the
fast paced, innovative culture of the private sector. The result is
providing Canadian patients exceptional Oncology care closer
to home. The current pilot project is complex yet inspiring,
however the outcomes are exceptional. Patient system access
is improved; quality is sustained; patient and staff satisfaction
is high; and, overall healthcare costs drop significantly. Patients
are inspired to stay on treatment; healthcare team members
are accepting of the innovations that make their lives more
seamless; and, the entire Oncology structure is transformed into
a transparent, patient-centred system. The current pilot project
is re-defining not only how we think about Oncology Nursing
but it is also daring us to craft a future with endless professional
opportunities for ourselves and, most importantly, for our
patients and their families. Yesterday is History and Tomorrow is
a Mystery so let’s be inspired to Shape Health Together today!
Infection Prevention & Control Project for
Surgical Oncology Patients - A Best Practice
Champion Initiation
Philiz Goh, RN, BScN, CON(C), Anita Long, RN,
MSN/ED, CON(C), Mary Glavassevich, RN, BA, MN.
Cancer patients are at high risk of acquiring nosocomial
infections, causing significant mortality and morbidity
due to their immunosuppression. Nurses on a Surgical
Oncology unit at a large Toronto hospital identified the
need to clarify the Infection Prevention & Control (IP+C)
protocols on their unit with the assistance of a Best
Practice Champion to implement evidence-based best
practice guidelines. Two measurements were obtained
from pre and post interventions. They helped illustrate
the progress of the project: 1) An audit was done on the
frequency of completing the Antibiotic Resistant Organism
(ARO) hospital screening tool and 2) Nurses completed a
survey to assess their current knowledge regarding IP+C
protocols. One of the interventions consisted of centralizing
IP+C screening tools, documentation, and equipment. A
checklist flow chart was created to assist nurses with the
“next steps” in the protocol when a patient was suspected
to need isolation. Small group and individual education
sessions were held to review both the surveyed results,
intranet resources, and the centralized IP+C cupboard.
The implemented interventions have demonstrated an
increase from 60% to 90% of patients being proactively
placed on isolation precautions. The developed tools and
resources will be shared corporately to standardize the
process used in initiating isolation precautions. This project
has illustrated how staff champions can lead initiatives and
generate change at the unit level that can be translated to
the corporate level as well.
Implementing the Safe Handling of
Hazardous and Cytotoxic Drugs
Lollita Rahaman, RN, MScN, CON(C), CHPCN(C).
Willliam Osler Health System, Brampton, ON, Canada.
In 2004, the National Institute for Occupational Safety and
Health (NIOSH) made the recommendation that employers
provide appropriate personal protective equipment (PPE)
to protect workers who handle cytotoxic and hazardous
drugs in the workplace. Hazardous and cytotoxic drugs
prescribed to patients create potential risks to staff
79
This 2-year study will be conducted in two phases: Phase
1) Qualitative semi-structured interviews with breast cancer
survivors and health care providers (HCPs), and Phase
2) A Delphi study to develop and prioritize strategies for
optimizing AET adherence. Analysis of Phase 1 results will
render an understanding of the complexities underlying
adherence and identify strategies to improve AET adherence.
The Delphi study will explore and prioritize these strategies,
which will provide a foundation for future research focused
on developing interventions to support adherence.
that prepare, handle, administer and dispose of them.
Additionally, staff are at risk of exposure from excreta from
patients who have received certain hazardous drugs.
Cytotoxic medications, anesthetic agents, anti-viral agents,
and others, have been identified as hazardous. These
hazardous medications are capable of causing serious
effects including cancer, organ toxicity, fertility problems,
genetic damage, and birth defects. This organization is
committed to ensuring a safe work environment for all staff.
However, because of increased use of hazardous agents
for non-oncology indications a Hazardous Drugs Advisory
Committee was developed to do the following:
Provide criteria for classifying drugs as hazardous or
cytotoxic:
specific oral chemotherapy agents as a pilot project.
The Self-efficacy theory (Bandura, 1986) was chosen
to guide patient education and self management. The
MASCC teaching tool for patients receiving oral agents
for cancer (MOATT) has been utilized to improve
adherence to treatment. The Oncology Nurse, with
specialized knowledge and skill is instrumental in
teaching, supporting and navigating the patient through
treatment using collaborative linkages with physicians
and the interdisciplinary team.
Indicators of success include improved patient
experience, improved communication/documentation,
utilization of evidence based guidelines and
transformation to safer, patient centered care.
●• Identify all hazardous and cytotoxic drugs within the
organization and create a list to post for all employees.
• Develop a policy for nursing staff on safe handling
of hazardous drugs, wearing appropriate personal
protective equipment, handling contaminated excreta,
and safe disposal to minimize exposure (policy already
exists for pharmacy preparation).
•●Redesign labels to identify hazardous and cytotoxic
drugs with prompt on how to handle.
Innovations in Quality Improvement: Daily
Management Rounds in Chemotherapy
●•Implement employee training
Nancy Runzer, RN, MSN, Mary Flaherty, RN, MSc(A),
MA. BC Cancer Agency, Vancouver, BC, Canada.
Lean methodology was introduced in the regional cancer
centre to empower staff to redesign their work processes.
The goal of redesign is to reduce waste and improve patient
safety, quality and outcomes. As the experts in their clinical
work staff identify opportunities for improvement and
engage in team problem-solving.
Improving Patient Safety and Adherence
Through a Nurse-led Oral Chemotherapy Clinic.
Mary S. Gorr, RN, CON(C), CHPCN(C), Colleen
Campbell, NP MN CON(C). Simcoe Muskoka Regional
Cancer Centre, Barrie, ON, Canada.
Clearly oral chemotherapy has taken off in the
oncology treatment field, representing 30% of all
cancer treatments given by the end of 2013. Aging
population, number of concurrent therapies, physical
limitations and adverse effects along with drug cost all
significantly impact adherence and therapeutic benefit.
Current literature echoes patients need more information
concerning adverse effects, interaction with other drugs
and proper handling.
The aim of our innovative project is to assess
and provide guidance to patients receiving oral
chemotherapy to improve safety and compliance. This
is achieved through a theory based model in a nurse-led
clinic utilizing evidenced based guidelines.
Following an initial chart audit, this quality improvement
project selected several populations of patients on
80
Daily management rounds were introduced this year
for nurses and other team members working in a large
chemotherapy unit. The rounds focus on the dimensions of
care including safety, quality, delivery and efficiency. Indicators
identified by staff are tracked including patient safety events
and near misses, treatments booked and delayed, reasons for
patient treatment delays, numbers of same day cancellations,
and numbers of patients who complete group chemotherapy
education. During the brief daily discussions data is reviewed,
issues are identified and this information is tracked on the daily
management board posted on the unit. Nurses and leaders
search for the root cause of issues, identify corrective actions
and ultimately improve care.
This presentation will describe the experience of the
implementation of daily management in the chemotherapy
unit. Trends in data collected and innovative solutions to
identified issues will be discussed. In addition both the
benefits and challenges inherent to the implementation
process will be outlined.
Harnessing the Wisdom of New Nurse
Navigators: Learning from Experience to
Enhance Role Integration
Jennifer Anderson, RN, MN, CON(C)1, Robbi Allen,
RN2, Shannon Groff, BSc1, Andrea Williams, BA1, Linda
Watson, RN, PhD(C), CON(C)1. 1Community Oncology,
AHS Cancer Care, Calgary, AB, Canada, 2Community
Oncology, AHS Cancer Care, Bonnyville, AB, Canada.
Cancer Patient Navigation has been identified as a
key driver to improve integration of care and person
centredness, which enhances health system effectiveness,
efficiency and patient experience. While Cancer
Patient Navigation is an innovation that holds great
potential, introducing a new role into existing complex
interdisciplinary teams and diverse communities is not
without challenges. Role implementation and integration
requires the development of a nuanced understanding
of each community’s services, supports, providers, and
programs, and a familiarity with the cultural diversity
present in the population to be served. Next, an active
phase of relationship building is required to create a
network of resources/supports to meet the diverse and ever
changing needs of patients. This essential contextualization
means that the navigator role will look different in each
community, and each navigator needs to achieve their own
role clarity, promote collaboration among their team, and in
many ways, orchestrate their own role implementation and
integration. This presentation will examine the challenges
of integrating new Cancer Patient Navigator roles in 15 rural
sites across a provincial cancer care system, highlighting
strategies that enabled successful role integration. Powerful
video vignettes capturing the wisdom gained through their
role implementation will be utilized to convey key learning’s.
As more navigation programs are being implemented
across the country, understanding the implementation
experience of one jurisdiction can provide valuable learning
to enhance future role integration.
Clinical Practice Change: Transforming
Response to Conditions or Phenomena,
Sustaining the Change and Improving Patient
Outcomes
Angela D. Boudreau, RN, BScN., MN, CON(C), Elaine
Walker, RN, CON(C), CVAA (C), Kirsty Albright, RN,
BScN., MScN. Odette Cancer Centre, Sunnybrook Health
Sciences Centre, Toronto, ON, Canada.
Clinical Practice change can be generated through a
research or clinical question or may arise in response
to situational conditions. An interprofessional approach
to practice change can contribute to its overall success
and sustainability. Within our chemotherapy unit some
nursing practice changes have emerged from both
questions and situations and have been implemented
using an interprofessional approach. The purpose of this
presentation is to discuss two practice changes that we
at our cancer centre have made; 1) the discontinuation of
premedication with Paclitaxel based regimens following
two treatments without hypersensitivity reactions and 2)
the use of intravenous Ranitidine to prevent vein irritation
and extravasation to peripherally given Vinorelbine. Our
first practice change arose from a situational condition of a
drug supply shortage which necessitated interprofessional
innovative thought and strategies while maintaining
patient safety. Our second practice change arose from
observation of a phenomena (extravasation distal to the
peripheral intravenous site) followed by a literature search
and extrapolation to our situation. Both changes involved
ongoing assessment and Interprofessional collaboration
leading to a successful sustainable outcome. Our
presentation will provide participants with a description of the
processes involved in each of the changes, the collaborative
approach and decision-making involved and the successful
outcome of safe, effective care. Sharing practice changes
can be an effective strategy in practice transformation as new
knowledge is attained and advanced.
Transition Care Clinic for Patients with
Colorectal Cancer and Lymphoma: An
Innovative Approach
Debbie Miller, RN, BScN, MN, CETN(C); Angela
Boudreau, RN, BScN, MN, CON(C); Dr. Matthew
Cheung, MD, FRCPC, SM; Dr. Lisa Del Giudice, MSc, CRCP
& Dr. Simron Singh, MD, MPH, FRCP (C)
In May 2012 an ambulatory cancer centre in Metropolitan
Toronto launched an innovative Transition Care Clinic
(TCC) for patients with colorectal cancer and lymphoma
who completed active treatment. This clinic, funded as a
pilot project through the Ambulatory Services Strategy,
was conceptualized as two distinct entities, an actual clinic
visit and an interactive -virtual care component.
The clinic run by two site specific advanced practice
nurses and a primary care physician was designed to
transition follow up care, assessment and surveillance
81
from the ambulatory cancer centre to primary care
physicians utilizing consensus and evidence based
guidelines. Clinic activities include a review of the
patient’s treatment summary, symptom screening, the
provision of education about treatment related side
effects and sign/symptoms of possible recurrence and an
overview of guidelines for routine follow up. Additionally,
educational material and the offering of community
supports are provided on an individualized basis. Physical
examinations and a review of diagnostics test results may
also occur. The virtual care component includes patient
education, peer support and empowerment, tracking
milestones and a research aspect. This presentation
will provide participants with an overview of the clinics
evolution, highlighting the successes to date and areas
for improvement. The experiences of both patients and
clinicians will be shared, noting the similarities and
differences between both patient populations. Future
strategies will be discussed based on experiences to date.
Breast Cancer in Young Women in Canada: A
Needs Assessment
Alison Gordon, MA, Vice President, Rethink Breast
Cancer, MJ Decoteau Exective Director Rethink Breast Cancer
Rethink Breast Cancer undertook Canada’s first qualitative
survey to determine if younger women (age 20-45)
diagnosed with breast cancer have a more difficult
experience during diagnosis, treatment and post-treatment
than their older counterparts.
While breast cancer is challenging for all women, the results
of the bilingual survey indicate that younger women had
more difficult breast cancer experiences.
Younger women were more likely to feel their doctor did not
take them seriously, were more likely to be dissatisfied with
the diagnostic process and had more difficulty navigating
the health care system. Of women 20-39 who expressed
concerns about the impact of treatment on fertility, less than
half were referred to a fertility specialist. Younger women
rated very highly the importance of connecting with another
women their own age with breast cancer , but only 64%
of younger women made this connection. In addition to
needing support for their partners and children, younger
women were more likely to require support for their parents.
Younger women had a more difficult time transitioning
from regular to occasional medical monitoring and were
more likely to report a reduced interest in sexual activity
due to treatment Rethink Breast Cancer recommends the
development of a Standard of Care for Younger Women
with Breast Cancer to ensure that all young women with
breast cancer receive the necessary treatments and
supports to meet their unique needs.
82
“It made me feel like I still existed”: Awesome
interventions to inspire and be inspired by
Young Adults in transition with cancer
Virginia Lee, N, PhD1, Scott Adams, MSc2, Jennifer
Finestone, MA, CCC3, Doreen Edward41McGill University
Health Centre, Montreal, QC, Canada, 2Hope & Cope
Wellness Centre, Montreal, QC, Canada, 3Cedars
CanSupport Royal Victoria Hospital, Montreal, QC,
Canada, 4VOBOC (Venturing Out Beyond Our Cancer).
Awesome interventions to inspire and be inspired by Young
Adults in transition with cancer
Every year in Canada, approximately 7000 young adults
(18-39 yo) are diagnosed with cancer. As survivorship
increases, YA cancer survivors will constitute a sizeable
portion of the community. When prematurely confronted
with their mortality, normative life transitions and age-related
developmental tasks are elevated to existential proportions.
The meaning and purpose of a life that is just coming of
age is often complicated by the effects of cancer treatment
on self-identity and social integration, fertility and sexuality,
vocational and financial independence.
Oncology nurses have recently teamed up with other
committed professionals, young adult survivors, and
community supporters (Hope & Cope, CanSupport,
VOBOC) in Montreal, Quebec, who have spear-headed
a series of creative and convenient ways to “fight the
fright” of cancer. Opportunities for gaining cancerrelated information, psychosocial support, and social
networking are at the heart of these initiatives. Among
these are a 24/7 online resource (CancerFightClub(CFC),
www.cancerfightclub.com), weekend retreats, exercise
programs, and interactive psychoeducational support
groups and workshops.
This presentation will showcase the dominant themes that are
emerging from these ‘awesome’ initiatives. We will highlight
nurse- sensitive issues and where nurses can take a leading
role towards better delivery of care and future research initiatives
tailored to the unmet needs of young adults with cancer.
Workshop V-01
Inspiring Innovative Care for the
Transformation of Psychosocial Nursing for
Young Adults with Cancer
Anne Katz, PhD, RN. CancerCare Manitoba, Winnipeg,
MB, Canada.
Adolescence is a time when education and socialization are
priorities and cancer treatments interrupt both. Challenges
to fertility, body image and sexuality are often ignored in the
rush to begin treatment.
Young adults with cancer stand at the cross roads of life
as they face an often uncertain future but with their hopes
and dreams intact. Who to be and where to be that are
developmental milestones that have to be achieved for
healthy young adults as they take on family and work
responsibilities; this is much more complicated for the
young adult who has faced cancer and will continue to be
challenged by the aftermath of the cancer and its treatments
for the rest of their life.
No one is ever prepared for the words “you have cancer”
and this takes on even more meaning for someone who has
likely never experienced serious ill health in their own life or
in their family. This is for most uncharted territory, and they
need more than a GPS to navigate this journey.
This workshop will identify key psychosocial challenges for
the young adult with cancer and will provide evidence-based
interventions for the most common including: sexuality and
body image issues, fertility and contraception challenges,
dealing with family and friends, and prevention of late effects.
Leading with Patients and Family Members:
Moving from the “Doing to” model to “Doing with”
Esther Green, BScN, MSc(T), Joanne MacPhail.
Cancer Care Ontario, Toronto, ON, Canada.
Barbara Balik (2012) wrote that health care professionals
have a well-established model of ‘doing to’ where patients
are the recipients of care planned and implemented by
providers alone; some organizations have moved to
‘doing for’ which is oriented to patient focused care; and
some have moved to a position of true engagement and
partnership with patients and family members described
as the ‘doing with’ model. A long-standing philosophy of
nursing is patient and family centred care; yet more often
we practice from a provider-centred perspective. As nurses
we need to change and find our place of leadership to
enact our philosophy of patient and family centred care.
A fundamental step is to create, implement and sustain
patients and family members as advisors, partnering on
system, and organizational change. To support the cancer
patient journey we established the first provincial Patient
and Family Advisory Council to ensure a consistent patient/
family centred approach to the planning and delivery of
cancer services; and be the internal experts on patient
engagement and improving the patient experience.
This presentation will focus on building skills amongst
the patient and family advisors and staff to participate
effectively; applying the model of ‘doing with’ through
examples and case studies; and sustaining/embedding the
partnership with patients and family members.
Ref. Balik, B. Patient-and family-centredness: Growing
a sustainable culture. Healthcare Quarterly, 15(Special
Issue) 2012: 10-12.
Person-Centred Perspective and Canada’s
National Strategy for Cancer Control
Scott Secord, MSW, RSW, Andrea Reed, Larry Librach,
MD, Margaret I Fitch, RN, PhD, Irene Nichol. Canadian
Partnership Against Cancer (CPAC), Toronto, ON, Canada.
Created in 2007, the Canadian Partnership Against
Cancer (CPAC) is an independent organization funded
by the federal government to accelerate action on a
national cancer control strategy. CPAC collaborates with
experts, organizations and stakeholders across Canada
on models of care, best practice, research, evidence
based guidelines that improve the cancer experience.
CPAC’s new mandate began April 2012. The
organization’s 2012-2017 strategic plan, ‘Sustaining
Action Toward a Shared Vision,’ reflects the evolution of
Canada’s national cancer strategy building on lessons
learned to address key emerging needs and priorities.
This interactive workshop will be of interest to oncology
nurses from across Canada or other jurisdictions who
are interested in learning more about the National
Cancer Control Strategy. Specific focus will be placed
on the CPAC’s Person-Centred Perspective Portfolio,
including the importance of embedding this perspective
within the Partnership’s work across the continuum
of cancer control. The workshop will begin with an
overview of the Partnership’s Strategic Plan and
discussion of the CPAC Logic Model, including how
the person-centred perspective is embedded within the
logic model.
Participants will participate in knowledge exchange
and share cancer workforce experience, including
implementing evidenced-based guidelines, distress
screening, survivorship care, psychosocial support,
navigation and palliative care. Participants will leave
83
Inspiring Innovative Care for the Transformation of
Psychosocial Nursing for Young Adults with Cancer
with greater clarity and understanding of Canada’s
Strategy and how the Partnership’s efforts will
contribute towards our shared goal of improving the
cancer experience for all Canadians.
10:30 AM – 12:00 PM●| Junior Ballroom C
Supporting the Foundation: Development
of an Innovative Orientation Program for
Oncology Nurses
Theressa Zapach, RN, BSN, CON(C)1, Ava Hatcher,
RN, BSN2, Lindsay Schwartz, RN, MSc(A)3, G. Anne Hughes,
RN, BSN, MN, CON(C)1, Jagbir Kohli, RN, MN4, Esther Chow,
RN, MN, CON(C)3, Andrea Knox, RN, BSN, CON(C)5. 1British
Columbia Cancer Agency, Victoria, BC, Canada, 2British
Columbia Cancer Agency, Prince George, BC, Canada,
3British Columbia Cancer Agency, Vancouver, BC, Canada,
4British Columbia Cancer Agency, Surrey, BC, Canada,
5British Columbia Cancer Agency, Kelowna, BC, Canada.
The movement away from behaviorist models of
learning towards approaches grounded in emancipatory
ideology established the foundation for the development
of an innovative oncology orientation program for nurses
working within a large provincial cancer care organization.
Aligned with emancipatory philosophy and principles of adult
learning, the orientation program is designed to be flexible
and individualized, placing high value on a learner centered
approach and participatory learning environment.
The Oncology Nursing Orientation Program is comprised
of multiple components coordinated in three distinct parts
designed to support learners’ reflection on how existing
and new knowledge help to inform the care provided to
people with cancer. Learners are introduced to various
organizational and nursing policies and practices, interactive
electronic modules that support safe, evidence based
oncology care, and acquire the clinical skills necessary
to practice within an ever changing practice environment.
The overall goal of the program is to provide experiences
which enable the learner to gain knowledge to support
practice development and practice preparedness within the
oncology setting. Desired learning outcomes include placing
emphasis on team work, building professional collaborative
relationships, engaging in lifelong learning, and recognizing
that the patient and their family are central to the team.
This presentation will describe the evolution of the program,
introduce the various components and materials, and
discuss facilitation techniques and mediums used to support
the learning needs of oncology Registered Nurse employees.
84
Quality Improvement: Using Data Can Lead
to Many Positive Outcomes
Vicki Lejambe, MN. Saint Elizabeth Health Care,
Barrie, ON, Canada.
Despite the advancements of palliative care services,
quality monitoring and performance measurement has
not always been imbedded into everyday operations.
This workshop describes the method one community
organization adopted to support the organization’s
performance and the role it played in enhancing the
culture of quality and patient safety within the Oncology
Palliative Care program. Outcomes will be shared
included how this new approach improved client
outcomes, team relationships, staff engagement and
resource use. The objectives of this presentation are:
1. Describe possible quality indicators and outcomes
and data tools.
2. Describe factors that assist to gain credibility and
adoption within organizations.
3. Describe strategies to engage front line staff in using
data to improve client outcomes
10:30 AM – 12:00 PM●| Junior Ballroom A-B
Transforming the Patient Experience of
Malignant Pleural Effusions with Innovative
Healthcare
Shawne P. C. Gray, RN, BScN, CON(C), Larissa Day,
RN, BScN, MSc, CON(C), Harvey H. Wong, MD, FRCP(C).
Recurrent malignant pleural effusions (MPE) are a common
complication of advanced malignancy and can significantly
impair respiratory function and worsen quality of life.
In recent years the insertion of tunneled pleural catheters has
become recognized as a safe and highly efficacious means
of symptom management for these patients. The Odette
Cancer Centre established an innovative Effusion Procedure
Intervention Clinic (EPIC) where tunneled catheters are
inserted to provide symptom relief for patients on an outpatient
basis which reduces hospital admissions and lengths of stays.
For some patients, malignant pleural effusions can cause fear
and anxiety about prognosis and quality of life. Experienced
oncology nurses are well positioned to provide psychosocial
This presentation will share how the EPIC clinic has
transformed the way we provide care and manage MPE at the
Odette Cancer Centre and how this has impacted our patients’
quality of life. We will also discuss the importance of the
nursing expertise in managing patients with tunneled catheters
for malignant pleural effusions.
PleurX Catheter Can Help Improve Quality of
Life for Patients with End Stage Cancer
Margaret H. McGregor, RN, MCLin N, CON(C), Patti
Marchand, RN, MN CON(C). Lakeridge Health/Durham
The introduction of the PleurX® program in Cancer services
has allowed patients with pleural effusions the opportunity
to minimize recurring clinic visits and decrease repeated
invasive procedures.
As an oncologic emergency, the development of a pleural
effusion in the setting of cancer often indicates end stage
disease and short life expectancy. This can impact the
quality of life of the patient’s final days.
The clinical presentation of pleural effusions may include
dyspnea, cough, as well as chest pain and weight loss.
Management of pleural effusions include repeated
thoracentesis, or chemical pleurodesis. Unfortunately,
at this point in the disease trajectory, patients often find
recurring appointments for thoracentesis very challenging.
Chemical pleurodesis is an option for some, but may result
in only partial pleurodesis with problematic loculations.
The successful collaboration among the community
care access centre and our team has resulted in the
availability of a PleurX® program for this patient population.
The PleurX® catheter is a palliative treatment, a safe
option for patients with recurrent pleural effusion whose
respiratory symptoms are related to the pleural effusion.
It is effective for ongoing relief of symptoms and prevents
reaccumulation of pleural fluid. It allows patients to function
more independently at home.
Innovation in Cancer Survivorship Care:
Application of the Chronic Care Model to
Design Nursing Roles in New Models of Care
Denise Bryant-Lukosius, RN, PhD1, Ruth MartinMisener, RN, PhD2, Saadia Israr, MMI1, Alan Katz,
MBChB, MSc, CCFP3, Linda Watson, MN, PhD (C)4, Nancy
Carter, PhD1, Ruta Valaitis, PhD1. 1McMaster University,
Hamilton, ON, Canada, 2Dalhousie University, Halifax,
NS, Canada, 3University of Manitoba, Winnipeg, MB,
Canada, 4Alberta Health Services, Calgary, AB, Canada.
There is a paucity of frameworks for designing innovative
models of cancer survivorship care (CSC). Increased
survival rates, personalized medicine, and improved
understanding of late treatment effects have led to
recent recognition of cancer as a chronic condition. This
provides opportunity to apply evidence about effective
chronic disease management (CDM) to develop nursing
roles in new models of CSC. This presentation describes
application of the Chronic Care Model (CCM) to design new
models of CSC in three provinces.
A patient-centred, participatory approach was used
including: 1) stakeholder meetings to identify gaps,
priority goals, and strategies for model of care redesign;
2) integrative literature reviews on self-management and
care coordination; and 3) development of provincial and
national inventories of CDM resources for CSC.
Meeting participants included patients (n=9),
researchers (n=11), providers (n=29), and decisionmakers from cancer and primary healthcare (n=18).
Three CCM elements (decision support, selfmanagement, care coordination) were perceived
priorities for improving patient, provider and systems
outcomes. There are few cancer-related studies but
growing evidence about the effectiveness of selfmanagement and care coordination interventions in
other chronic conditions. Existing resources focus
on patient self-management. Few decision-support
resources are available for healthcare providers.
Recommendations for designing and evaluating
decision-support, self-management, and care
coordination interventions for CSC are provided.
Implications for nursing practice in cancer and primary
healthcare settings are reported.
This presentation will discuss the development and
implementation of our program, incorporating details of the
PleurX® catheters placed to date as well as feedback from
the provider and patient experience.
85
support in collaboration with other members of the
interdisciplinary team. Nurses also provide an essential role
in symptom assessment and management of these patients.
In the EPIC clinic we have utilized the COSTaRS algorithms,
ESAS screening tool and ECOG assessment at regular
intervals. We have focused on shortness of breath, fatigue,
anxiety, and activity level which has allowed for standardized
assessment and evaluation of symptom control.
10:30 AM – 12:00 PM●| Port Alberni
It Takes a Village: Adopting a Complementary
and Alternative Medicine Decision Support
Strategy in a Provincial Cancer Center
Kathleen Yue, RN, BSN, MN1, Brenda La Prairie,
RN, BSN, CON (C)1, Brenda Ross, RN, BScN2, Lynda
Balneaves, RN, PhD3. 1BC Cancer Agency, Victoria, BC,
Canada, 2BC Cancer Agency, Vancouver, BC, Canada,
3UBC School of Nursing, Vancouver, BC, Canada.
Health professionals (HPs) at one provincial cancer
center learned through surveys that patients frequently
ask questions about CAM and cancer. While HPs
generally reported a lack of knowledge and resources
to support patients to make evidence-informed
CAM decisions, there was collective interest in
responding more effectively to the needs of patients.
An interdisciplinary team agreed to champion the
implementation and evaluation of a multi-layered CAM
information and support program in collaboration
with a research team using a pre-post intervention
design. Following a baseline assessment, all staff
and volunteers were offered education about CAM
appropriate to their role. The goal of the project
was to utilize volunteer and professional staff’s
skills appropriately to respond to patients’ questions
in a coordinated and consistent fashion. Specifically,
volunteers would direct patients to sources of credible
CAM information, while HPs would assess patients CAM
use and help patients critique research evidence. HPs
with enhanced knowledge and skill would hold patient
seminars to answer frequently asked questions about CAM
and cancer, as well as provide decision support to patients
whose questions about CAM are more complex. The team’s
experience, their innovative implementation and evaluation
strategy will be described and will be applicable to others
considering implementation of a systematic approach to a
complex problem.
Bereaved Families’ Perceptions of Massage
Therapy Services for Paediatric Oncology
and Palliative Care
Andrea M. Laizner, Ph.D.. McGill University Health
In Quebec, massage therapists provide support to children
diagnosed with cancer and their families in hospital and
at home. Families are referred by nurses, physicians and
86
social workers. This presentation will discuss results of a
research study that explored family members’ perceptions
of massage therapy services in the context of paediatric
oncology and palliative care. Survey questionnaires were
mailed to bereaved families served by the program. Parents
and siblings were invited to comment about massage
therapy services during the illness trajectory and/or the
bereavement period.
RESULT. Twenty-six families responded to the invitation
to participate three years after the death of an ill child.
Twenty questionnaires were returned, including responses
from four siblings. Location of massage depended
upon context for the ill child, parent or sibling. 93.8% of
parents and 93.8% of ill children had received massage
but differed as to phase of illness trajectory. Parents’
prioritized their ill child’s needs over their own. Massage
was reported as beneficial for most ill children but not
all. Parents reported that massage provided comfort
and relaxation for them when at home compared to
hospital, where the child was the focus of care. Massage
therapy was also used by certain family members during
bereavement when available.
The presentation will provide nurses information about
the potential and appropriate use of massage therapy
for patients and family members during a child’s illness
trajectory and in bereavement.
10:30 AM – 12:00 PM● Port McNeil
J’ai subi une importante intervention
chirurgicale et je ne suis restée que 24 heures
à l’hôpital! Hytérectomie assistée par robotique
Lynne Jolicoeur RN, MScN, CON(C); Wendy HicksBoucher RN, BScN, CON(C); Ann Schibli RN, BScN; Catherine
Adamson RN, BScN; Elizabeth Contestible RN, BScN, NCMP;
Kristen Dupuis RN, BScN;; Barbara D’Entremont RN, BScN;
Wylam Faught MD; Laura Hopkins MD; Robert Weber RN;
Joanne Weberpals, Tien Le, MD, Michael Fung Kee Fung, MD.
La chirurgie assistée par robotique a fait ses preuves en tant
que méthode chirurgicale efficace et efficiente pour le cancer
de l’endomètre. Par comparaison avec la laparotomie, cette
technique réduit la perte de sang peri-opératoire et les
complications chirurgicales – ainsi que la durée du séjour –
sans compromettre la stadification par chirurgie. Dans le cas
de séjours plus courts, les équipes de soins ont le défi de
dispenser les meilleurs soins de soutien possible en très peu
de temps, surtout pour ce qui est du soutien et de l’éducation.
Sur les 110 femmes invitées à participer, 61 ont rempli
l’enquête. Dans l’ensemble, elles étaient très satisfaites
de l’intervention chirurgicale (moyenne de 9,3 sur
une échelle de 0 à 10), et peu de femmes ont signalé
d’effets secondaires. Les femmes ont apprécié l’absence
d’importantes incisions et la rapidité du rétablissement.
Treize des femmes (21 %) ont signalé un degré de douleur
élevé à très élevé, et certaines ont trouvé trop rapide leur
congé donné dès le lendemain de l’opération.
Durant cette présentation, l’auteure : 1) décrira la trajectoire
du traitement des femmes qui subissent une chirurgie
assistée par robotique pour le cancer de l’endomètre;
2) présentera les outils produits pour orienter les soins
(cheminement clinique, livret d’éducation des patientes et
ordonnances préétablies; et 3) résumera les résultats de
l’enquête auprès des patientes.
Patients at the Table - Engaging Patients
in the Design and Development of an
Orientation Program for Newly Diagnosed
Cancer Patients
Manon Allard, MBA, Rosana Faria, Psychology.
St.Mary’s Hospital, Montreal, QC, Canada.
St. Mary’s Hospital was funded through the Canadian
Health Services Foundation’s Patient Engagement Project.
The objective was to engage patients as partners in the
design of an orientation program for new cancer patients.
This presentation will:
• Share results and lessons
• Underline the value of patient experiences in improving
services.
Eight cancer patients participated in panel discussions to
review the trajectory of care from the patients’ perspective,
and to brainstorm the content of an orientation session.
A separate session with the same objectives was held
with professionals from the Cancer Care program. Both
groups then met together to decide on the content of an
orientation tool.
Brainstorming sessions with patients and staff yielded
similar results. Both prioritized: the need for information
about health and safety; general information; “what to
expect”; and an overview of the resources available
to patients. Notable differences included: concerns
among staff about limited resources to run sessions and
overloading patients with information; and a preference
among the patients to speak with a person versus
watching a video.
Patient engagement in the design and development of
an orientation program has contributed to more relevant
and patient-centered information for new cancer patients.
Furthermore, it revealed other unexpected ways to enhance
patients’ experience.
Implementation of a New Model of Nursing
Practice in Radiation Oncology in a University
Hospital Center
Catherine Derval, RN, MScN Centre hospitalier de
l’Université de Montréal, Montréal, QC, Canada.
Patients undergoing radiation therapy for cancer face
a series of challenges that require support from an
interdisciplinary team which includes radiation oncology
nurses. In fact, more than half of all cancer patients will
receive radiation therapy at some point during their
cancer experience. Today, the majority of patients are
treated in an outpatient setting, resulting in an ongoing
need for direct patient care, close monitoring, and
teaching of self-management strategies. However, the
specific contribution of nursing in radiation oncology is
not well described and documented.
In order to improve the care provided to patients,
the radiation oncology team of the Centre hospitalier
de l’Université de Montréal (CHUM) has revised its
process of care delivery. A committee composed of
radiation oncology technologists, advanced practice
nurse and radiation oncologists was formed to review
practices and propose an updated of current structure.
This presentation details the different implementation
stages of the new model. The implications for clinical
practice as well as the challenges encountered are
reviewed. Process analysis enables continuous
improvement leading to optimal nursing practice and
interdisciplinary efficiency.
87
Un an après l’introduction de la chirurgie assistée par
robotique, nous avons mené une enquête sur l’assurance
de la qualité. Elle visait à obtenir l’opinion des patientes
relativement aux points suivants : 1) le rétablissement
après la chirurgie (temps nécessaire au retour à l’activité
normale); 2) les effets secondaires post-opératoires
(infection des plaies, infections urinaires, douleur, nausée);
3) la qualité de vie après la chirurgie (QV générale,
ménopause induite par le traitement); 4) la satisfaction par
rapport aux soins; et 5) les domaines à améliorer.
Workshop VI-01
Nursing Interventions in Cardiovascular Risk
Reduction Among Adult Cancer Survivors
Edith Pituskin, PhD(C). University of Alberta,
The leading cause of death in developed countries is
cancer, influenced by negative lifestyle factors including
obesity, unhealthy diet, physical inactivity and addictive
habits such as smoking and alcohol. These established
cancer-promoting behaviors are also well-known as
causative factors of cardiac disease. While improved
treatments have led to improved cancer-specific
outcomes, many cancer survivors are now at increased
risk of death from cardiovascular disease, as a result
of pre-existing cardiometabolic syndrome and additive
toxicities of anti-cancer therapies. The purpose of
this workshop is to review the current knowledge and
discuss nursing interventions in cardiovascular risk
reduction among adult cancer survivors.
Developing Interdisciplinary Research
Partnerships within the Clinical Setting
Savitri Singh-Carlson, PhD1, Frances Wong, MD2,
Kris Trevillion, RN3, Colleen Sherriff, RN4.
1California State University Long Beach, Long Beach,
CA, USA, 2Fraser Valley Centre, British Columbia Cancer
Agency, Surrey, BC, Canada, 3Abbotsford Centre, British
Columbia Cancer Centre, Abbotsford, BC, Canada, 4Fraser
Valley Centre, British Columbia Cancer Agency, Surrey,
NB, Canada.
Focus: This presentation will explore innovate avenues that
create dialogue for research with interdisciplinary health
professionals in the clinical setting.
Scope of this paper: Oncology nurses are the primary care
providers for cancer patients and their families. They act as
patient advocates; listen to their stories of suffering; deliver
treatment by adhering to protocols and guidelines; report
on impact of the treatment among other tasks. Oncology
nurses in clinical settings have a wealth of knowledge and
can identify gaps in the services provided to patients. Given
88
the appropriate environment and support, nurses can
innovate and develop research projects that can improve
patient care.
Results: British Columbia Cancer Agency-Fraser Valley
Centre houses a Breast Research Team led by an oncologist.
This interdisciplinary team has oncologists, nurse manager,
clinical oncology nurses and nurse navigators, family
physician, research assistant, and university academicians
including a nurse researcher and a Psychologist. Any
member of the team is welcome to bring a research topic
that needs to be examined to the weekly team meeting. Most
of the research projects pursued have been identified by the
oncology nurses. Evidence from these projects has been
published and presented at conferences.
Outcome: This model of interdisciplinary research
team-work challenges oncology nurses to continuously
examine their patient care approaches and develop
evidence that will transform practice. Knowledge from
these multidisciplinary projects serves to enhance nursing
profession and transform practice.
Inspiring Change: Using Nursing Vignettes to
Highlight how Screening for Distress Impacts
Cancer Care Delivery
Sydney Farkas, RN, BN, CON(C)1, Shannon Groff,
BSc1, Brent Schaitel, RN2, Andrea Williams, BA1, Barry
Bultz, BA, MA, PhD, R. Psych3, Linda Watson, RN, PhD(C),
CON(C)1. 1Community Oncology, AHS-Cancer Care,
Calgary, AB, Canada, 2Community Oncology, AHSCancer Care, Edmonton, AB, Canada, 3AHS-Cancer Care
and the University of Calgary, Calgary, AB, Canada.
A diagnosis of cancer is always an unexpected and
distressing event; however, the degree of distress patients
and families experience is unique. Research has shown that
early identification of distress and timely tailored interventions
can improve patient outcomes. It is also well established
that nurses play a crucial role in identifying, assessing, and
managing distress. Currently Screening for Distress is one
of four initiatives moving forward in Alberta with the aim
of enhancing person-centred care. Screening for Distress
provides a mechanism for rapid identification of distress. A
subsequent purposeful nurse-patient conversation allows
a tailored system response to distressing symptoms and
issues. The implementation of this practice change includes
educational and process interventions as well as pre
and post evaluations across four key components: early
identification of distress, staff education, teamwork and
collaboration, and patient engagement. This presentation will
examine the implementation strategies used and the insights
A Chemotherapy Unit Transformation Journey
Kirsty Albright, RN, BScN, MScN, Angela D. Boudreau,
RN, BScN, MN, CON(C). Odette Cancer Centre,
As cancer treatment options increase and become more
complex there is a corresponding need for increased
chemotherapy unit capacity. In 2011 our chemotherapy
unit received final approval to begin renovations to address
our capacity need. Over the course of a year three moves
took place splitting the unit into two physical spaces; first
floor and basement. Examination of all processes involved
in chemotherapy was integral to the success of each of the
physical moves. Processes addressed included identifying
“safer” protocols for the basement population, addressing
unique basement challenges and developing and designing
a staffing assignment to address safety, consistency and
satisfaction in two areas. Developing patient flow and
drug delivery processes inspired an improved use of our
Chemotherapy Appointment Reservation Manager (CHARM)
tool for communication. During the final move modification
of established workflows was required to address a new
working environment. Workflow strategies focusing on
patient assessment, medication processes and staffing
assignment were developed. A major success was the
innovative communication features of our CHARM tool; using
technology to assist with nurse to nurse and nurse to patient
communication. The purpose of this presentation is to share
our journey of transformation from a visibly busy, cramped
unit to a spacious, calmer environment with patient and
nurse satisfaction. We will discuss valuable lessons learned
at each step of our journey and elaborate on our next steps
as our innovation continues.
Existential Challenges in Children with
Cancer
Roberta L. Woodgate, PhD1, Christina West, PhD1,
Ketan Tailor, MEd2. 1University of Manitoba, Winnipeg,
MB, Canada, 2Faculty of Nursing, University of Manitoba,
Winnipeg, MB, Canada
Until now, the majority of existentially-focused cancer
research has been conducted within adult populations. Only
a handful of qualitative investigations have captured the
experiences of children with cancer relative to themes such
as existential fear and finitude, meaning/meaninglessness,
uncertainty, authenticity and inauthenticity. This paper
aims to provide a deeper understanding of the existential
challenges faced by children living with cancer. The findings
of this paper are part of a qualitative study that sought to
identify and describe feeling states experienced by children
with cancer via a computer diary. Thirteen children (8-17
years) undergoing treatment for cancer participated in the
study. In addition to participating in individual open-ended
interviews, children had the opportunity to journal their
experiences via a computer diary that had a drawing tool
for children to express how they were feeling. The drawing
tool within the computer diary was found to be particularly
beneficial in assisting children to express existential
challenges that they had previously been unable to articulate
in words. The very process of drawing pictures gave children
a therapeutic space to explore and work at understanding
the existential challenges that they were experiencing. The
four main themes which emerged in relation to challenges
experienced by the children participating will be presented:
1) existential worry; 2) existential vacuum; 3) existential
longing; and 4) existential growth. Recommendations for
nursing practice and research will be presented.
Parental Restitution, Chaos, and Quest
Narratives: Their Value in Pediatric Oncology
Nursing
Jill M. G. Bally, RN, PhD1, Lorraine F. Holtslander, RN,
PhD1, Wendy Duggleby, RN, PhD2. 1College of Nursing,
University of Saskatchewan, Saskatoon, SK, Canada,
2Faculty of Nursing, University of Alberta, Edmonton, AB,
Canada.
89
and learnings gained from front line nurses involved in the
screening program. Engaging video vignettes will be utilized
to explore the nurses’ experiences and their perception of
the impact on practice and patient outcomes. As cancer
care institutions across Canada strive to meet this new
accreditation standard, leveraging these experiences and
learnings from one jurisdiction will hopefully inspire other
jurisdictions to engage in this important practice change.
As well it will enhance the success and sustainability of this
exciting provincial initiative.
Background: Childhood cancer affects approximately 850
children and families per year in Canada. Advancements
in pediatric cancer treatment regimes has led to enhanced
cure rates. However, this comes at the cost of a long, painful,
stressful, and anxiety provoking treatment phase that creates
profound life changes for children and their families.
Purpose: To develop an enhanced understanding of
the unique experiences of parents who have children
diagnosed with cancer.
Methods: Thirty-three interviews and written entries from 14
journals from 16 parents who had children in active cancer
treatment were analyzed and organized using Frank’s
narrative analysis and typology.
Findings: The findings from this study revealed that Frank’s
restitution, chaos, and quest narrative types were all
present in parental experiences gained from caring for their
child who was in active treatment for cancer. The transitions
during treatment exposed families to a roller coaster of ups
and downs filled with uncertainty. These experiences were
individualized, unique, and contextualized.
Implications for Nursing Practice: Attending to parents’
narratives in an open manner can help clinicians honor
and validate their stories, and thus, their experiences.
Consequently, innovative interventions in oncology
nursing can be developed. Oncology nurses are in a
unique position to transform their care by recognizing and
using parents’ different narrative types to support parents
effectively through their rollercoaster ride of uncertainty.
When You Think it’s Over, There is More: How
Nursing Care Can Create Hope in Cancer
Patients’ End of Life Treatment.
Émilie Gravel, R.N. Cert. Mental Health and
Community Health, Marie-Graitha Personna, R.N,
BScN, Tracy Regimbald, R.N. BSc.N., Antoinette Ehrler,
R.N. DESS, Dina Linardos, R.N. BSc.N. Jewish General
Hospital, Montreal, QC, Canada.
Hope is seen as an important need in patients with cancer.
Nurses are in a privileged position of being able to listen
to patients talking about their hope and fears. In the out
patient oncology department of our institution, the primary
nurse is pivotal in coordinating care of patients and their
families over the entire trajectory of illness. Nurses have a
key role to play in helping people not only toward end of life
care but also to find hope in life.
90
When news about termination of standard chemotherapy
treatments happens, a patient’s level of hope can be
compromised. Fortunately for some, it can mean that
there exists a transformation of standard treatment into a
clinical trial. The clinical research unit in our institution is
an innovative setting that is integrated with the outpatient
oncology clinic. This setting gives new inspiration to
patients in their treatment plan and provides new hope.
This presentation will describe the unique way in which
primary nursing helps a patient transition from standard
treatment into a research setting. There will also be a
discussion about how continuity of nursing care between
our two clinics inspires hope to patients and families. Our
innovative setting enables an easy transformation that is
appropriate for the patient as they move from one care
setting to another. Nurses can help keep hope alive.
Mind the Gap: Creating an Environment for
Comprehensive Care in Pain and Symptom
Management; Palliative Care
Jagbir Kaur Kohli, MN1, Elizabeth Beddard-Huber,
MSN2, Megan Stowe, MSN2, Anne Hughes, MN3, Heather
Watson, BSN3, Ava Hatcher, BN4. 1BC Cancer Agency,
Surrey & Abbotsford, BC, Canada, 2BC Cancer Agency,
Vancouver, BC, Canada, 3BC Cancer Agency, Victoria, BC,
Canada, 4BC Cancer Agency, Prince George, BC, Canada.
Most cancer centres excel at providing treatment for cancer
that meet with good health outcomes. However, nurses
are aware that amidst excellent treatment, issues related to
pain and symptom management and palliative care may be
overlooked resulting in patients experiencing an increased
illness burden. While nurses want to bring pain and
symptom management and palliative care from the margins
of care to the centre of care, they often encounter barriers
in their efforts.
This presentation will describe the approach taken to
integrate pain and symptom management and palliative
care into daily practice at a provincial cancer care
organization. Presenters will report on the results of their
efforts in multiple centres to improve patients’ access to
supportive care both during treatment and at the end of
life, to contribute to the professional development of nurses
by introducing a pain and symptom management and
palliative care nursing education program and decrease
siloed care practices through efforts to increase interprofessional collaboration. Components of the nursing
education program, key goals of the program, and nurses’
feedback will also be shared. This innovative, collaborative
program was informed by existing gaps and motivated by
a desire to transform patients’ access to supportive care
within an environment of constrained financial resources.
Transforming the Ways in which Oncology
Nurses Support Family Caregiver Coping in
End-of-life Cancer Care.
Kelli I. Stajduhar, RN, PhD1, Wanda Martin, RN, MN,
PhD (C)1, Doris Barwich, MD2, Gillian Fyles, MD3, Kristine
Votova, PhD1. 1University of Victoria, Victoria, BC, Canada,
2Fraser Health Authority, Surrey, BC, Canada, 3BC Cancer
Agency, Kelowna, BC, Canada.
Many family caregivers (FCG) neglect their health when
providing end-of-life (EOL) cancer care at home. The purpose
of this multi-site study was to determine why some FCGs cope
better than others when providing EOL cancer care in order to
identify strategies that could inform (and transform) oncology
nursing practice. We are reporting on phase 2 of our mixedmethods study. A questionnaire was administered to eligible
FCGs (n=337). We used step-wise regression to test two
dependent variables (QOL and depressive symptomology)
and 23 independent variables. Of the 337 eligible FCGs,
317 completed the questionnaires. Mean age was 58 years,
41% were retired, 53% provided care for >50 hours/week,
52% provided spousal care. We found that FCGs of highneed patients reported lower QOL and greater depressive
symptoms. These FCGs also had health problems, higher
perceived stress and life interference. Higher QOL was seen
among FCGs who report greater resilience, more family
support, greater optimism and positive relationships. Higher
QOL was also found among FCGs who were satisfied with
health services and had better caregiving preparedness.
Oncology EOL care in the home would benefit from capacity
building. A good start is to build relationships with FCGs
to identify and strengthen generalized FCG traits, such as
optimism and resilience. Health-compromised FCGs require
extra attention when planning EOL care.
Workshop VI-05
Inspiring Nurses to Share Innovations by
Writing in the Canadian Oncology Nursing
Journal (CONJ) Let us help you get started
Margaret I. Fitch, RN, PhD1, Jeanne Robertson, RN,
MBA2, Pat Sevean, RN, PhD3, Sharon Thomson, RN, MSc4,
Sally Thorne, RN, PhD5, Janice Chobanuk, RN6. 1Odette
Cancer Centre, Sunnybrook Health Sciences Centre, Toronto,
ON, Canada, 2Eastern Health, St. John’s, NL, Canada,
3Lakehead University, Thunder Bay, ON, Canada, 4BC
Cancer Agency, Vancouver, BC, Canada, 5University of
British Columbia, Vancouver, BC, Canada, 6Alberta Health
Services, Calgary, AB, Canada.
The CONJ Editors at this instructional session will
begin by explaining the guidelines for writing a
manuscript using examples from a selection of CONJ
journals. Copies of the guidelines will be available at
the workshop. Suitability of topics for the CONJ will
be explored by the group. Next, the CONJ peer review
process will be outlined including timelines for each
section of the process and a bio sketch of a typical CONJ
reviewer. There will be a question and answer period to
conclude this part of the presentation. Then the editors
will be available for individual discussions with attendees
of their topics or projects/theses. This is the working part
of the conference so please bring your ideas for articles,
drafts of projects, and academic theses with you for
this instructional session so that you can transform your
ideas productively. The intent of this session is that each
attendee will be inspired to leave with a clear plan toward
the preparation of a manuscript. We know that every
oncology nurse has a story or has done something she/
he is proud of in cancer care. Let us help you publish
your innovation so others can be inspired to learn from it.
Perceptions of Illness and Self-efficacy for
Coping Behaviours in Advanced Stage Lung
Cancer Patients
Doris Howell, PhD, RN, Gerald Devins, PhD, Julie
Trudel, PhD, Andrea Bezjak, MD, Natasha Leighl, MD,
Samantha Mayo, PhD candidate. University Health
Network, Toronto, ON, Canada.
Lung cancer patients experience high levels of symptom
distress not fully explained by objective disease or
demographic variables. Little research has examined
the contribution of beliefs activated in response to
the threat posed by lung cancer on self-efficacy for
coping behaviours. We examined inoperable lung
cancer patients’ perceptions (also called cognitive
representations or beliefs) held about cancer and
their relationship to self-efficacy for behaviors related
to coping with cancer. Methods: As part of a larger
path analysis theory testing study, 104 patients with
advanced stage lung cancer completed the Brief
Illness Perception Questionnaire (IPQ) to assess their
beliefs about the illness and the Cancer Behavior
Inventory (CBI-B) for self-efficacy for coping with
cancer. Results: The mean age (± SD) was 62.8 ±
10.9 years. Patients reported strong beliefs about the
negative consequences and the chronicity of lung
91
cancer. Although they reported higher perceived levels
of treatment control and coherence (understanding)
about illness, low scores were noted for personal
control beliefs. Negative consequence beliefs were
strongly negatively correlated (r=-0.632, p<0.001) with
their confidence (self-efficacy) in the use of coping
behaviours. Discussion: Illness perceptions including
beliefs about the personal consequences of the illness,
as well as the extent to which the illness is amenable
to personal control or to control by treatment may
be influential in health and behavior outcomes and is
emerging as an important area for future psychosocial
nursing research.
A Narrative Practice Model: Attending to Loss
and Life Restoration in Cancer Care
Christina H. West, RN, PhD1, Janice M. Bell, RN, PhD2,
Roberta L. Woodgate, RN, PHD1. 1University of Manitoba,
Winnipeg, MB, Canada, 2University of Calgary, Calgary
AB, Canada
Ill children and their families experience intense illness
suffering while living with cancer. Central to this illness
suffering are complex experiences of loss and grief, which
include physical, relational, and symbolic losses, as well
as anticipatory and survivor grief. Family members can
experience a disenfranchisement of their loss and grief
when health care professionals focus primarily on fostering
hope, and assisting families to live well in the face of cancer.
Within this presentation, qualitative research findings
from a family intervention study which analyzed research
interviews, clinical documentation, and videotaped clinical
sessions of therapeutic conversations between nurses (3)
and family members (18) will be presented. The qualitative
research approach was informed by philosophical
hermeneutics and family process research. The therapeutic
conversations studied were guided by the Illness Beliefs
Model (Wright & Bell, 2009), an advanced nursing practice
model for family intervention. Within this presentation, the
illness grief experienced by children and family members
living with cancer will be presented. Based on these
research findings, a narrative practice model which will
assist nurses to attend to the processes and experiences
of loss and grief, as well as those of life restoration, will
be proposed. This model represents an adaptation of the
Dual Process Model of Coping with Bereavement (Stroebe
& Schut, 1999, 2001, 2010) to childhood cancer care.
Research findings from this study may also be highly
applicable for adult cancer populations.
Concurrent Session VII–01
A Recruitment and Retention Strategy to
Transform Nurses into Specialized Oncology
Nurses in Clinical Trials
Marcia Flynn-Post, RN, BA, CON(C). University
Health Network, Toronto, ON, Canada.
Our goal was to inspire nurses to join our oncology
clinical trials team whose role is instrumental in
transforming care for our patients. Long gone are the
days when a hallway conversation with an oncologist
led to a job as a clinical trials nurse. Oncology clinical
trials nurses are now highly trained and regulated
specialized oncology nurses who navigate patients
through their cancer journey on a clinical trial. With
the complexities of care for these patients, increasing
numbers of nurses retiring and lack of exposure
to clinical trials in nursing curricula, recruitment of
oncology clinical trials nurses has been challenging
at the Princess Margaret Cancer Centre. This reality
along with increasing acuity of clinical trials leading
to escalating workload for trials nurses has led the
nursing leadership and the Cancer Clinical Research
Unit leadership teams to collaboratively develop a
retention and recruitment strategy. Initiatives including
‘road shows’ at nursing leadership forums across the
organization, nursing focus groups, job description
revision, an environmental scan, developing a model
of care and orientation pathway, creating student and
mentorship opportunities were developed as part of this
strategy. With limited literature to demonstrate effective
retention and recruitment strategies for trials nursing,
the collaboration of nursing and research teams support
the implementation and evaluation of this unique
approach to recruit oncology clinical trials nurses.
Formalising Cancer Care Coordination into
Nurses’ Daily Practice: A Pilot Study
Heather Watson, RN, BScN1, Catherine van Mossel,
MA, PhD (C)2, G. Anne Hughes, RN, BSN, MN, CON(C)1.
1British Columbia Cancer Agency, Victoria, BC, Canada,
With an interest to improve people’s experience of cancer
care, nurses at our cancer centre have participated in several
research projects in the past ten years. The most recent
study examined models and features of supportive care
92
We are conducting a pilot study of care coordination.
Rather than creating a new role, this study will examine
which features of care coordination can be integrated
into daily nursing practice within the ambulatory care
environment. We are focusing on three distinct processes
of coordination facilitated by RNs: assessment, care plan
development and implementation, and follow up. This
presentation reports on our efforts to date, including
supports and barriers to formalising new processes to
enhance supportive care for people receiving treatment
and/or care at our centre.
Oncology Nursing - Where is it Heading?
Redesigning and Implementing a Nursing
Delivery Model to Improve Teamwork and
Patient Care
Neda A. Soltani, RN, Leslie Cameron, RN, CON(C).
Sunnybrook Hospital, Toronto, ON, Canada.
At a large regional cancer centre in Toronto, ambulatory
oncology nurses have undergone a major transformation.
Nurses have recently converted from a primary nursing
model to a team-based nursing model. Previously, nurses
worked in a collaborative partnership with an oncologist
across one or more disease sites. Over the past year, a
group of specialized oncology nurses have been deployed
to work only in the breast site and have had to learn how
to work together in an interprofessional team alongside a
group of oncologists. The change to a team-based model
of nursing care with dedicated breast site-specific nurses
has led to a group of nurses having specialized knowledge
in breast surgery, systemic therapy, and radiation across
the patient’s treatment trajectory. This approach has allowed
the nurses to focus their knowledge and skill in the area
of breast cancer and has allowed them to better support
patients and families within the realm of breast cancer.
This presentation will outline the critical learning that
has taken place over the past two years since the
implementation of this new model of care. Benefits of a
team-based approach, along with some of the challenges
will be highlighted during the presentation. Implications
for nursing practice and important next steps in the
transformation will also be discussed.
“Expert” Novices: Innovation, Inspiration
and Transformation of Mid-Career Radiation
Oncology Nurses
Corsita T. Garraway, RN(EC), MScN, CON(C),
CHPCN(C), Joanne Duggan, RN, CON(C), CHPCN(C),.
Stronach Regional Cancer Centre, Newmarket, ON, Canada.
Nurses according to Benner (1984), move along a trajectory
from novice to expert. Individual oncology nurses must go
through these stages regardless of experiences. Experiences
of novice oncology nurses have been documented in the
literature as have experienced oncology nurses. No literature
exists about nurses who have chosen radiation oncology
nursing as a “mid-career” nursing change (read : challenge)
and are now considered Novice Specialized Oncology nurses.
In a suburban Regional Cancer Centre, an inspiring group
of mid-career nurses with varying nursing experiences have
decided to work in an innovative Radiation Oncology program
with a commitment to transforming their careers and ultimately
the patient experience. Nurses were encouraged to voluntarily
participate through story-telling, formally and informally about
years in number of years in nursing, nursing experience, years
in oncology and specifically radiation, reasons for selecting
speciality, job satisfaction, and educational requirements were
among areas explored. Confidentiality was assured. lusions:
Novice Mid-Career Radiation Oncology Nurses experience
satisfaction with the education received to practice effectively,
are inspired by their patient experiences and would certainly
chose Oncology nursing again.
Inspiration, Innovation and Transformation:
Support for Children When a Family
Member Has Cancer
Jagbir Kaur Kohli, MN1, Karen Janes, MSN2. 1BC
Cancer Agency, Surrey, BC, Canada, 2BC Cancer
93
in both cancer and non-cancer care contexts, nationally
and internationally. Emerging from our analysis was the
notion of care coordination, a fundamental component
of supportive care. Care coordination is an approach to
care that attends to the unique needs of people along
the cancer care trajectory across the following domains:
practical, relationships, emotional, spiritual, physical, social,
informational, and psychological. While components of this
work is undertaken by Registered Nurses (RN) at our cancer
centre, missing is the ability to attend to these domains
consistently and in a coordinated fashion.
When cancer “joins” the family, the impact touches children
as well as the diagnosed family member. An inter professional
initiative involving nursing, counseling and art therapy at
the BC Cancer Agency has been underway since 1994
providing support to children who have a family member
with cancer. Evaluation feedback and anecdotal experiences
reveal the important benefits of encouraging dialogue and
sharing knowledge amongst parents and children about
the cancer diagnosis. This presentation will aim to share our
experiences and lessons learned with the children’s support
program at the BC Cancer Agency and inspire nurses to
consider ways to support cancer patients and their children
in their clinical settings. The presentation will describe: the
key role of education and information about cancer as a way
of supporting children, the impact of unmanaged symptoms
on families and children, common questions children are
concerned with and strategies for clinicians to answer those
questions. We seek to share our experiences and increase
awareness of available resources to transform the discomfort
some oncology nurses may experience in engaging in
the cancer dialogue with patients and young children. In
collaboration with the healthcare team, patients and families,
nurses can play a role in helping to create a positive legacy of
cancer in families with young children.
10:30 AM – 12:00 PM | Junior Ballroom A-B
Inspiring Person-Centred Care through the
Integration of Screening for Distress and
Navigator Roles into practice
Jennifer Anderson, RN, MN, CON(C)1, Sydney Farkas, BN,
RN, CON(C)1, Shannon Groff, BSc1, Brent Schaitel, RN2,
Andrea Williams, BA1, Barry Bultz, BA, MA, PhD, R. Psych3,
Linda Watson, RN, PhD(C), CON(C)1. 1Community
Oncology, AHS-Cancer Care, Calgary, AB, Canada,
2Community Oncology, AHS-Cancer Care, Edmonton, AB,
Canada, 3AHS-Cancer Care and the University of Calgary,
Calgary, AB, Canada.
Enhancing person-centred care is a priority for many cancer
care systems. Historically cancer care has predominately
focused on the physical aspects of care, but patients,
families, survivors and society are advocating for an
improved person-centered cancer system. Shifting care
delivery models is complex, requiring a multi-faceted
approach that supports both a practice change and a
culture shit. In Alberta, Screening for Distress (SFD) and
navigation are being implemented in cancer centres across
the province as mechanisms to shift the system and ensure
the delivery of integrated person-centred care. A cancer
94
diagnosis produces a range of practical, psychosocial
and physical concerns that can significantly impact quality
of life. Navigators support patients in negotiating these
concerns but in order for interventions to be effective they
must address patient’s most pressing needs. SFD acts as a
navigation aide identifying priority concerns and interventions
that will be most meaningful. Providing nurses with tools
and supports to enhance care allows nurses to leverage
change forward and ultimately support a culture shift
towards a person-centred model of care. Nurses consistent
interactions with patients make them the logical group to
lead system change through the integration of supportive
practice changes. This presentation will examine how
strategically linking these two initiatives supports nurses in
leading practice chance and shifting the system towards a
more person-centred model through enhanced coordination
and continuity, standardized documentation, interdisciplinary
collaboration and community engagement.
Transforming the Ambulatory Oncology
Clinic Interdisciplinary Model of Care
Mary Flaherty, RN, MSc(A), MA, Jen Rosychuk,
RN, BSC, BSN, Nancy Runzer, RN, MSN. BC Cancer
Nurses working in a complex Systemic Therapy Ambulatory
Care Unit in a major urban cancer centre collaborated
with the interdisciplinary team to design a tumor site clinic
model of care. With increasing volumes of patients and only
incremental increases in nursing positions over recent years,
it was imperative to redesign service delivery to maximize
nurses’ skills and abilities.
The goal of the redesign was to improve patient outcomes
by increasing access to nursing care, aligning staff skills and
education to the work, and improving coordination of care, team
communication and collaboration. Using lean methodology, the
interdisciplinary team trialed a tumor site model and based
on preliminary outcome data adopted this new model.
Physician clinics were rescheduled based on tumor site
and nurses and other staff were assigned according to site.
Appointments were leveled across days of the week. The
schedule also included preplanned nurse appointments
for new patients. Team triage of patients on treatment was
initiated at the huddle at the start of clinic to determine the
need for the patient to see a nurse. Telephone follow up and
scheduled nurse appointments outside of the physicians’
clinic day were also included in the model.
This presentation will describe the redesign of the
model of care, the process of staff and physician
engagement and evaluation findings.
Factors Perceived to Influence Nurses’
Use of Evidence-informed Protocols for
Remote Cancer Treatment-related Symptom
Management: A Qualitative Study
Dawn Stacey, RN, PhD, CON(C)1, Meg Carley, BSc2,
Myriam Skrutkowski RN, M.Sc., CONC(C)3, For the
Pan-Canadian Oncology Symptom Triage and Remote
Support (COSTaRS), Team1. 1University of Ottawa,
Ottawa, ON, Canada, 2Ottawa Hospital Research
Institute, Ottawa, ON,Canada,3McGill University Health
Purpose: To assess factors perceived to influence
nurses’ use of evidence-informed protocols when
providing remote symptom management for patients
undergoing cancer treatments.
Methods: A descriptive qualitative study was guided by
the Knowledge-to-Action Framework. Oncology nurses
and other key stakeholders were eligible. Focus groups
and individual interviews were conducted with key
questions and role play using the protocols. Content
analysis was used.
Results: Six interviews and five focus groups (n=33)
were conducted in oncology programs within three
provinces. Some participants indicated there were no
barriers, while others identified barriers at the level of
protocols (too long, not for symptom clusters, additional
documentation to complete, not enough space for
comments, already know how to manage symptoms),
nurses (learning curve, unsure which to use, time),
patient responses, and organizational (requires
approval for integration into health record, no electronic
application). Facilitators were identified at the level of
protocols (use for general assessments, standardized
approach, consistent with distress screening, good
flow, comprehensive, colour-coding (green/yellow/red),
evidence-based), nurses (training/orientation with role
playing and video; performance appraisal), patients
(may reduce number of calls), and organizational
(available as paper copies, shortcut on computer,
apps, pocket guide; add protocols to EMR and to
documentation form; include outreach/satellite settings;
chart reviews feasible).
Conclusions: Several barriers and facilitators were
identified as influencing the use of these protocols in
nursing practice. To enhance their use, interventions are
needed to overcome these identified barriers.
The MUHC Ovarian Cancer Patient Guide: An
Innovative Approach to Patient Education
Joanne Power, RN, MScN, CON(C)1, Nancy Posel, N,
PhD2, Julia Thomas, RN, MSc(A)1, Enza Ambrosio, RN,
BScN, CON(C)1, Nadine Al-Hawari, RN, MSc(A)1, Virginia
Lee, N, PhD1. 1McGill University Health Centre, Montreal,
QC, Canada, 2McGill University, Montreal, QC, Canada.
The Ovarian Cancer Patient Guide is an online-teaching tool
that uses highly visual multimedia images, minimal text, and
plain language to deliver comprehensive, relevant content
to women newly diagnosed with ovarian cancer and their
families. This innovative approach ensures that patients and
families with varying levels of health literacy are informed
about their disease, are prepared for treatments such
as surgery or chemotherapy, are aware of when to call a
clinician and/or when to return to the hospital, and have
access to reliable repositories of information recommended
by their treati ng team.
The content of the guide was developed by the
interdisciplinary Gynecologic Oncology Team in
collaboration with the institution’s patient education office.
It can be easily updated in response to feedback and
changes in practice. The guide can also be used to support
student and staff learning.
With the aim to complement and enrich clinician/patient
dialogue at initial teaching and assist the self-directed and
self-paced search for information at follow-up, the guide is
introduced to patients by the treating team and is available
through the Internet for patients to access at home. This
presentation will communicate the lessons learned from
development to implementation of the guide into clinical practice.
The Development of an Interprofessional
Clinical Pathway for Gynecological Oncology
Patients Undergoing Abdominal Surgery
Mary Glavassevich, BA, MN, Elaine Avila, BScN,
Ivy Henry, BScN. Sunnybrook Health Sciences Centre,
It is well established that discharge planning involving the
patient and family should start as early as possible, either
before admission or on admission. However this is not
consistently done within our surgical oncology unit. Due to
advances in surgery and ongoing budgetary constraints,
patients are being discharged sooner, and therefore, may not
95
be adequately prepared. Anecdotal evidence from nurses
and the interprofessional team indicate that patients are
not always prepared for and aware of their discharge date.
The interprofessional team of care providers conducted
three surveys to explore discharge needs from the patients’
perspective. The first survey explored the patients’ knowledge
and understanding of their discharge; the second focused on
readiness for discharge; and the third identified patients’ care
needs 7 to10 days at home following discharge.
The results of the survey guided the development of a
comprehensive and evidenced based clinical pathway
to provide information to patients, families and staff
throughout the continuum of care.
This presentation will outline the process utilized in the
development and implementation of the clinical pathway.
The evaluation component will be highlighted.
Qualitative Exploration of Families’
Experience Caring for Loved Ones with
Advanced Ovarian Cancer
Margaret I. Fitch, RN, PhD1, Tracey DasGupta, RN,
MN, CON(C)1, Alison McAndrew, BA, R AP1, Marilyn
Sapsford, BA, M.Div.2, Shari Moura, RN, MN, CON(C),
CHPCN(C)1, Kalli Stilos, RN, MScN, CHPCN(C)1, Kim
Barrow, MSW, RSW1, Lynn Faltl, RN1. 1Odette Cancer
Centre, Sunnybrook Health Sciences Centre, Toronto, ON,
Canada, 2Ovarian Cancer Canada, Toronto, ON, Canada.
Background: Ovarian cancer is challenging because of the
advanced nature of the disease at diagnosis, side effects
of treatment, and impact on roles and responsibilities.
The family plays an integral role in providing physical and
emotional support. The purpose of the study is to explore
family members’ experiences of caring for a loved one with
advanced ovarian cancer.
Methods: Convenient sampling was used to recruit
13 study participants. Eligible patients were invited to
participate until data saturation was reached. In-depth
interviews were audio recorded, transcribed verbatim and
subjected to standardized qualitative descriptive content
and theme analysis.
Results: The participants described an intensely
emotional experience from diagnosis to end of life. Family
members experienced on-going challenges with access to
information, management of advanced symptoms, and the
transition from active medical management to end of life
care. All described a point of recognizing that their family
member was “truly dying” and felt a transition to needing to
be present on a 24 hour basis, providing care and support.
The lack of information about what was happening and
what would happen created distress for family members.
96
Implications: Insight regarding the families’ experiences
has implications for nurses and physicians caring for the
women and their families at end of life in terms of provision
of relevant information, supportive communication, and
anticipatory preparation.
Awakening From The Cocoon: Family
Members Transitioning Through 100 Days
Post Stem Cell Transplant
Daniel J. Gagné, Masters of Nursing1, Roberta
Woodgate, Ph D2. 1Universite de Saint-Boniface, Winnipeg,
MB, Canada, 2University of Manitoba, Winnipeg, MB,
Canada.1Universite de Saint-Boniface, Winnipeg, MB,
Innovations in stem cell transplantation (SCT) have been
made overtime resulting in significant improvements
in patient survival rates. The psychological and
psychosocial effects of a SCT on the family unit have
received less attention. A qualitative phenomenological
study using van Manen’s human science method
was conducted to gain insight into the family’s lived
experience as they transitioned through one hundred
days post SCT.
Three families were recruited from a bone marrow
transplant unit in a tertiary hospital located in a city in
central Canada. Individualized open-ended interviews
and field notes were employed to arrive at a detailed
description of the lived experience of patients and
family members. Data collection took place from day 0
to 5 years post HSCT. Themes were isolated using van
Manen’s (1990) selective highlighting approach.
Awakening from the cocoon emerged as the main
essence of patient’s and family members’ experiences.
Patient and family members come out of this experience
as a transformed person and family incorporating a
new worldview. Three themes supporting the essence:
the losses, the chrysallis, and a new beginning. This
study will provide healthcare professionals with a
deeper understanding of the lived experiences of these
families and help better anticipate and fulfill their diverse
demands and needs. Finally, the findings will provide the
groundwork for future intervention studies.
“You Do What Needs to Be Done”: Transition
Experiences of Male Spouses of Female
Partners with Breast Cancer
Innovative “All-Inclusive” Breast Cancer
Support: The Patient’s Perspective.
Kris J. Trevillion, RN1, Savitri Singh-Carlson, PhD2,
Frances Wong, M.D.1. 1B.C. Cancer Agency- Abbotsford
Centre, Abbotsford, BC, Canada, 2California State
University, Longbeach, CA, USA.
Focus: To obtain feedback from breast cancer patients
on their experiences with a Breast Cancer Care Nurse
Coordinator (BCCNC) who provides specialized support
from the beginning of diagnosis and onwards.
Goal: To learn from patients’ experience with the aim of
program improvement.
Design:The BCCNC provides comprehensive care to
breast cancer patients within the BC Cancer Agency’s,
Abbotsford Centre’s catchment area. With extensive
knowledge and experience in systemic, radiation and
surgical treatment modalities the BCCNC provides
“all-inclusive” support to the patient at any point in their
care pathway. This may begin with understanding the
pathophysiology of their breast cancer through cancer
treatments and into survivorship.
Methods: Patients supported by the BCCNC between
January 20, 2012 and September 13, 2012 were mailed
a one page introduction letter and a 2 page survey
inviting them to share their ideas and opinions on the
BCCNC service.
Outcome: 90 surveys were mailed with 48 responses
completed and returned. Overall, responses indicated
that the cancer care information and support given
by the BCCNC was perceived to be excellent, useful,
understandable, readable and adequate. Participants
expressed they would feel comfortable contacting the
BCCNC in the future and would recommend this service
to other patients.
Kelly Struthers Montford, M.A.1, Wendy D. Duggleby,
PhD1, Cheryl Nekolaichuk, PhD, RPsych2, Sunita
Ghosh, PhD, P.Stat2, Ceinwen Cumming, PhD2, Katia
Tonkin, PhD2. 1Faculty of Nursing, University of Alberta,
Edmonton, AB, Canada, 2Department of Oncology,
University of Alberta, Edmonton, AB, Canada.
Background: Limited research exists regarding the
transition experiences of male spouses of female partners
with breast cancer. However, their experiences and quality
of life can impact their physical and mental health, and
can affect their ability to care and provide support for their
spouses (Duggleby et al., 2011, 2012).
Objective: The purpose of this study was to provide a
nuanced understanding of the transition experience of male
spouses of persons with breast cancer.
Methods: As part of a larger study, six hundred survey
packages were mailed to women diagnosed with breast
cancer and their spouses; 65 male spouse participants
completed and returned an open-ended question transition
survey. Interpretive description analysis was used to
analyze the qualitative data of the spouses’ responses.
Results: These caregivers experienced transitions
regarding their roles and relationships, their outlook on
life and values, and their physical and mental health. Male
spouses experienced increased strain and powerlessness;
and were responsible for planning and managing treatment
issues, such as transportation to appointments and side
effects. In contrast, others noted no changes to their way
of life and distress levels, as they perceived that their wives
did not need assistance.
Conclusion: Nurses need to consider these diverse
perspectives when supporting male caregivers of women
with breast cancer.
Conclusion: Feedback from patients who received
specialized “all inclusive” support indicates that this
service was valuable in meeting their breast cancer care
needs in an efficient manner. Specific suggestions will
be reported.
97
Inspiring Hope and Increasing Capacity to
Cope for Patients and Caregivers
Heather Sinardo, BScN, MN1, Sandra Krueckl,
PhD2. 1Canadian Cancer Society, Toronto, ON, Canada,
2Canadian Cancer Society, Vancouver, BC, Canada.
The need for information and support services among those
dealing with cancer is well-documented (e.g., Supportive
Care Framework: A foundation for person-centered care,
2008; Breaking Down the Barriers, 2003). There is evidence
that informational and emotional support helps improve
coping skills and improves capacity to manage a cancer
experience. To gauge impact on coping and a series
of other factors associated with empowerment, a large
national not-for-profit commissioned a University-based
research institute to evaluate three of their information and
support programs. This session will describe key features
of the 3 programs and focus on the 2013 impact evaluation
results. The findings indicate that the organization’s
services helped clients understand and feel informed about
living with cancer and helped them feel more comfortable
talking to health care providers and family. The majority of
respondents (n= 438 who completed the survey) reported
that the programs helped them cope and helped them feel
more in control of their lives, two measures that have been
associated with empowerment. Patients and caregivers tell
us they want nurses to tell them about trusted programs
that can help. This session will provide the information
and materials needed to help patients get the support they
want, when they need it.
2:00 PM – 3:30 PM●| Junior Ballroom D
A Systematic Follow-up of Patients
receiving Palliative Radiotherapy; The Story
of a Team Effort
Maryse Carignan, M.Sc. , CON(C), Stéphanie Nunès,
B.Sc.. CSSS de Laval, Laval, QC, Canada.
In February 2012, an ambulatory palliative care clinic was
created at the Centre intégré de cancérologie de Laval
(CICL) of the Centre de santé et de services sociaux de
Laval (CSSSL), Québec. The clinic is led by a full time
baccalaureate degree nurse with palliative care experience
and the presence of a palliative care doctor half a day
per week. The nurse assigned to the clinic has many
roles and responsibilities. These include evaluating the
98
patients’ needs and providing consultation services to the
interdisciplinary team members on palliative and end of life
care. A systematic follow-up of patients receiving palliative
radiation therapy was implemented in collaboration with
the radiation oncologists to improve the quality of care, as
radiation therapy may accentuate symptoms and cause
distress to patients and families. This workshop will discuss
the implementation process of the systematic follow up,
what is expected from the nurse and how the oncology
information system supports the integration of care to the
benefit of the patients. Through examples and case reports,
the presenters will discuss the possible impact of this
initiative on the patients and families quality of life and on
the utilization of health care resources.
Inspiring Change in Interprofessional Care:
Defining Scope of Practice for Specialized
Oncology Nurses and Radiation Therapists
in Radiation Oncology; Focusing on Role
Clarity, Enhanced Communication, and
Improved Collaboration
Arlene Court, RN, BScN, CON (C)1, Lisa Di Prospero,
MRT(T) BSc MSc2,3, Tracey Das Gupta, RN BScN MN
CON(C)4, Sheila Robson, MRT(T) BSc ACT12, Philiz
Goh, RN BScN, CON(C)1, Alison McAndrew, BA R AP1.
2Department of Radiation Therapy, Odette Cancer
Centre, Toronto, ON, Canada, 3Department of Radiation
Oncology, University of Toronto, Toronto, ON, Canada,
4Department of Nursing, Sunnybrook Health Sciences
Centre, Toronto, ON, Canada.
Interprofessional care is the provision of comprehensive
health services to patients by multiple health caregivers
who work collaboratively to deliver quality care within
and across settings. However, differing philosophical
and theoretical backgrounds, lack of understanding of
professional roles and responsibilities, and role blurring
can lead to interprofessional tension, protection of scope
of practice, underutilization of professional expertise,
and decreased satisfaction. Our aim was to explore the
perceptions of nurses and radiation therapists related to
interprofessional collaboration for patients on radiation
treatment including the identification of enablers and
potential barriers. Two profession-specific focus groups
were held: Radiation Therapists (N=8) and Radiation
Oncology Nurses (N=4). Emerging themes were identified
by the investigative team and then a consensus was
reached through a series of team meetings.
The results from the focus groups will be shared
including emerging themes related to assumptions about
roles in regards to knowledge, education, and practice.
Enhanced communication fostered by getting to know
each other’s role and expertise as well as building on
our professional relationship will lead to transformed
interprofessional patient care.
Oncology Patient Classification System
Janette S. Klaver, BScN CON(C), Yvonne Zettel, RN
CON(C). Grand River Hospital, Kitchener, ON, Canada.
The care of the admitted oncology patient often
requires complex and advanced nursing skills. Previous
investigations, by the research team, resulted in an
innovative redesigned mixed method research study
that focused on the development of an oncology patient
classification system. The research team conducted
interviews with inpatient oncology nurses to identify
patient care factors that impact patient acuity and nursing
workload. The coded interviews with identified themes were
further reduced to relevant nursing interventions. Some
of the nursing interventions identified were supported by
preexisting literature. Additional interventions, found both
in the literature or from the interviews, were included in the
factor analysis. A factor analysis was undertaken using data
collected from the nursing team over a two week period.
Items were selected based on the results of the factor
analysis along with any clinically supported interventions,
where low levels of occurrence may have falsely supported
the null hypothesis. The tool was further tested to determine
its predictability of patient acuity for the following shift.
Once development was complete the patient classification
system was tested using inter-rater reliability testing. The
classification system can be utilized by front line nursing
staff to ensure equal distribution of the workload on
Oncology units. Recording of patient classification levels by
the nursing staff enables the management team to monitor
the patient acuity on the unit and adjust staffing if required.
When the Best They Can Do Is Live with It:
Exploring the Experience of Families Living
with Chronic Cancer
Linda Watson, RN, MN, PhD(C), CON(C)1, Shelley
Raffin Bouchal, RN, PhD2. 1Alberta Health Services
Cancer Care, Calgary, AB, Canada, 2Faculty of Nursing,
BACKGROUND: Over the past 15 years, numerous novel
targeted therapies have emerged which are changing
how we understand and treat advanced cancer. These
therapies target nuances within the cancer’s cellular
enviroment limiting growth and spread. Clinical research
has demonstrated improvements in overall survival, but to
maintain control patients must stay on these treatments
indefinitely. This has created a new chronic cancer trajectory,
where patients can live for extended periods of time with
incurable but treatable cancer. The ability to live longer with
cancer, without being ‘cured,’ is changing how individuals
and their families experience their cancer journey.
PURPOSE: In an effort to understand the needs of this
emerging population, a qualitative study informed by
Gadamerian philosophical hermeneutics was designed.
METHODOLOGY: Unstructured interviews were conducted,
recorded, transcribed verbatim and analyzed with the goal
of understanding the experience of families as one of their
members received ongoing treatments that offer control but
no cure.
RESULTS: Results highlight the complex impact chronic
cancer has on the everyday life of families as they attempt
to live as well as possible while managing multiple impacts
of ongoing treatments. The ever present fear of treatment
failure, eventual disease progression and death further
complicates this family experience. As more patients find
themselves on treatments for control, it becomes imperative
that supports be developed to ensure families can cope
when cancer becomes part of their everyday world.
Living with a Primary Malignant Brain Tumor:
Recurrent Themes from a Psychosocial
Oncology Practice
Brenda Sabo, PhD Nursing. Dalhousie University,
Halifax, NS, Canada.
A diagnosis of cancer can be an unexpected and devastating
event for both patient and family members frequently
resulting in elevated levels of psychosocial distress.
Furthermore, the primary malignant brain tumor (PMBT)
disease trajectory includes progressive functional decline.
Not only are these tumours life-threatening but they have
the potential to rob the patient of their mind and spirit long
before their death. Research has shown that at least 33%
of patients diagnosed with a PMBT exhibit high levels of
anxiety, depression and poor quality of life outcomes. The
99
Participants were aware of interprofessional collaboration
(in theory), however indicated there was room for
improvement given challenges such as personalities,
historical experiences, lack of communication, and
relationship among team members.
rate of psychosocial distress for intimate partners has been
shown to be as high, if not higher than that of cancer patients
in general. At the same time, the rate of unmet supportive
care needs for both is high. The purpose of this presentation
is twofold: 1) to present an overview of recurring themes
heard from a psychosocial oncology clinical practice which
range from living with uncertainty, to communication,
expectations and existential issues; and, 2) to provide nurses
who may provide care for patients and families following a
diagnosis of a PMBT with strategies on how to facilitate the
creation of meaning and purpose through recognizing and
acknowledging what has been lost; focusing on the present;
and the identification of new opportunities.
Professional Grief: Let’s be Proactive!
Anet Julius, BScN, RN, MN, CON(C). Princess
Margaret Cancer Center, Toronto, ON, Canada.
It was estimated that there would be 186,400 new
diagnoses and 75,700 cancer related deaths in Canada in
2012 (Canadian Cancer Society, 2012). Oncology nurses
play a crucial role in caring for patients and families who
experience tremendous changes due to their cancer
diagnosis, and consequently they bear witness every day to
suffering and death.
A literature review revealed that frequent exposure to
suffering and death has significant impact on the wellbeing
of oncology nurses, putting them at risk of experiencing
intense professional grief. While oncology nurses
continually focus on supporting the patient and family they
may neglect their personal wellbeing. There is currently no
standardized approach in place in our institution to prepare
nurses to recognize, understand and manage professional
grief. Focusing on the radiation and palliative care units
at our institution, leadership implemented a proactive
approach to raise awareness of the negative consequences
of frequent exposure to suffering and death, and the need
for self-awareness and self-care.
This presentation will introduce an innovative approach to
address professional grief through educational sessions
that provided a venue for information, sharing, teambuilding
and the creation of a supportive environment.
The positive results reported by participants, have led to
the recognition that this program should be expanded to all
nurses throughout the institution, and has the potential to
provide information and support to the multidisciplinary team.
100
Compassion Fatigue: Increasing Awareness
and Encouraging Self-Care Strategies Among
Oncology Nurses
Laura Mitchell, RN, BA, MN, CON(C), CNS. Princess
Margaret Hospital, Toronto, ON, Canada.
Increasing numbers of critically ill cancer patients
contributes to oncology nurses feeling drained by their care
giving responsibilities (Potter et al., 2010). Compassion
fatigue (CF) is defined as the profound emotional and
physical exhaustion that nurses and other caregivers can
develop in their roles as helpers (Fetter, 2012; Mathieu,
2012). Since oncology nurses are susceptible to CF, it is
crucial to increase their awareness of CF and how they can
recognize and manage it (Perry et al., 2011).
Education sessions on CF were conducted in a large
cancer center by a nurse with knowledge on this topic.
The audience included 17 specialized oncology nurses
who work on medical/radiation oncology inpatient units.
The content included discussion on the recognition and
management of CF. The Professional Quality of Life Scale
(ProQOL), a screening tool for CF, was also introduced
(Stamm, 2009). Participants were provided with pocket
cards that included examples of self-care strategies.
After the education sessions, participants felt better
informed about CF. Most participants found that the
ProQOL was easy to use; however some felt that the tool
was lengthy and repetitive. All participants believed that the
self-care interventions are applicable and achievable.
Follow-up meetings have been organized with the
participants. The discussion will focus on participants’
feedback regarding self-care interventions to manage CF.
Analysis from the meetings and future directions for this
project will be discussed in this presentation.
The Experience of Well-being in the Midst of
Advanced Cancer
Kathleen Yue, BSN, MN. BC Cancer Agency, VIctoria,
BC, Canada.
Objective: People with advanced cancer may have
significant challenges to their physical, emotional, spiritual,
and social well-being. However, some individuals are able
to experience an overall sense of well-being in spite of
these challenges. This study sought to understand the
experience of well-being from the perspective of people
with advanced cancer.
Results: The participants took an active role in their wellbeing experience and described four main themes: view
of self, the fluctuating nature of well-being, choices made
to enhance well-being (including choosing supportive
relationships, putting ones own needs first, treatments,
focusing on the positive, and honoring the negative), and
living in ambiguity.
Conclusion: These findings have implications for nursing
practice, nursing education, and health care organizations.
An Innovative Solution to Improving the Delivery
of Chemotherapy to Rural Cancer Centres
Janice L. Chobanuk, RN, BScN, MN, CON(C)
HPCN(C), Wayne Enders, RN, Pam Barnaby, RN, BScN,
Pamela Sutton, Pharm Tech (C), Allison Cann, HIM Tech
II, Dave Whiteside, RN, BN, MBA(C), Shelley Cloutier, RN,
BScN, Sarah Champ, RN, BScN, MN(C), CON(C). AHS
Cancer Care, Community Oncology, AB, Canada.
Oncology nurses working in large urban cancer centres
are instrumental in the coordination of chemotherapy
services to rural cancer centres. However with increased
workloads and the array of complex treatment protocols,
a number of coordination and communication issues
can occur impacting the timely delivery of chemotherapy
to patients in rural sites. This presentation will focus on
the inspiring work of an interdisciplinary team led by an
oncology nurse to streamline and improve processes to
overcome these challenges. The underpinning goal of this
innovation is to ensure patients living in rural areas would
receive their treatments on time in spite of the day to day
demands experienced by staff in the tertiary centre. The
common barriers preventing the timely delivery of chemo to
rural settings identified include: unclear referral processes,
increased number of stat calls, missing and /or unclear
orders, and lack of consistency in notifying the rural sites
about patient referrals. Stakeholders were brought together
to identify an innovative transformational project, called
Outreach Chemo. Key outcomes from this transformational
project included standardized referral guidelines for rural
sites, improved communications between the urban and
rural cancer centre staff, reduced stat calls, a follow up data
tracking process, and overall staff satisfaction. The aim of
this presentation is to provide an overview of the outreach
project, the evaluation results and lessons learned.
Oral Chemotherapy & Biotherapy: Effective
Care and Support for Patients
Haley Back, BSN, BKIN, Tyrone Maguire, BSN.
Clinicians and patients alike overwhelmingly prefer oral
chemotherapy to traditional intravenous chemotherapy.
However, the side effect profiles of oral chemotherapy
agents are often just as severe as IV chemotherapy
medications that are given under close supervision.
This leaves a significant ‘care gap’ for those taking oral
chemotherapy as the development of evidence-based
care standards has not kept pace with the increasing use
of these medications. The purpose of this study was to
explore current practice that supports patients taking oral
chemotherapy at the BC Cancer Agency and to make
specific recommendations for future practice based on
current literature. An electronic literature review utilizing the
databases PubMed, CINAHL, and the Cochrane Library
resulted in the selection of 31 relevant, peer-reviewed journal
articles. Models of care identified in the literature for patients
receiving oral chemotherapy & biotherapy included: Nurse/
Pharmacy led clinics, Automated Voice System Response,
and Home Care Nursing. A qualitative cross sectional
survey was administered to the nursing and pharmacy
leaders at the six Regional BC Cancer Agency Centers
to gain understanding of current practice. Inconsistent
practice was identified across the centers in both nursing
and pharmacy. Recommendations based on the literature
include: Development of consistent protocols for nursing/
pharmacy across the BC Cancer Agency, increased support
for patients throughout their first cycle of oral chemotherapy,
and provision of patient/family centered education.
Proactive or Reactive? Transforming the
practice of safer delivery of toxic chemicals.
Anne Schmidt, RN, CON(C), Donna Van Allen, RN,
BHScN, CON(C). Grand River Regional Cancer Centre,
Kitchener, ON, Canada.
Ambulatory medical oncology patients are receiving
numerous drugs within complex protocols. A greater
number of venous accesses are required for this patient
group which exposes the patient to an increased risk of
extravasation. An increase in the number of incidents of
extravasation was seen in 2011 and the quality of care
group in the oncology program at Grand River Regional
Cancer Centre reviewed each case.
101
Design: Guided by interpretive descriptive methodology,
eight participants were interviewed and the data were
analyzed using the constant comparative approach.
A multidisciplinary, interdepartmental task force was struck
to develop program wide guidelines for utilizing central
venous access devices (CVAD) in the oncology population.
This inspired group reviewed research, current literature
and practices. The goal was to create an innovative tool
and process for assessing the need of a CVAD prior to
the initiation of treatment. The tools that were developed
aligned with the RNAO best practice guidelines. This
transformational practice was trialed utilizing small cycles
of change that align with the PDSA cycles in quality
improvement methodology. The tool and decision tree that
were ultimately developed are easy to use, and are critical
in the decision making process.
The data collected during the development and
implementation phases included the measurement of mid
cycle insertion of CVADs, the number of extravasations
and patient satisfaction around the change in this practice.
As Grand River Hospital is a Best Practice Spotlight
Organization this CVAD assessment tool is an asset to the
entire organization and the patients we serve.
From Patient to Participant: Enhancing the
Validity and Ethics of Cancer Research
through Participatory Research
Margaret I. Fitch, RN, PhD1, Connie G. Chiu, MD2,
Terry L. Mitchell, PhD, C.Psych.3. 1Odette Cancer Centre,
Sunnybrook Health Sciences Centre, Toronto, ON, Canada,
2John Wayne Cancer Institute, Santa Monica, CA, USA,
3Wilfrid Laurier University, Waterloo, ON, Canada.
Background: Participatory health research can involve a
wide spectrum of participation from the population under
study. The involvement of cancer patients in conducting
research represents a means of developing the cancer care
system to become more responsive to the needs of people
living with cancer.
Purpose: As part of a large mixed methods study on the
psychosocial impact of dragon boating on individuals with
breast cancer, we engaged breast cancer survivors on all
stages of the study from question formulation to conference
presentation and study publication.
Methods: We utilized specific and intentional strategies
to engage people living with breast cancer throughout the
study. In particular, we utilized a workshop/focus group
approach with 13 women to select the psychometric
102
instruments to measure the salient variables identified
through in-depth interviews with 6 dragon boaters.
Results: It was evident that attention had to be paid to the
value-based elements of participatory research (i.e., power
sharing, voice and respect, reciprocity, mutual benefit).
Both risks and benefits emerge with increased participation
by cancer patients/survivors in designing and conducting
psychosocial research.
Conclusion: Participatory elements have the potential to
increase the validity of survey instruments, enhance the
ethics of working with a cancer population, and optimize
the survey response rate.
Redesigning the Delivery of Nursing Care to
Cancer Patients
Margaret I. Fitch, RN, PhD, Sherrol Palmer-Wickham,
RN, BScN, CON(C). Odette Cancer Centre, Sunnybrook
Health Sciences Centre, Toronto, ON, Canada.
Nursing care at our cancer centre has been rated highly. As
patient numbers increase, treatments become more complex
and costly, and fiscal constraints enlarge, we have to redesign
how we deliver care and improve patient experience.
During the past two years, we have implemented a number
of initiatives, based on lean and quality improvement
principles and a desire for transformative change, in an
effort to continue providing quality nursing care. Each
initiative has been evaluated and served to inform on-going
change approaches.
We have moved from a collaborative partnership model to
a team-based nursing approach where staff members are
able to work with specific patient populations throughout
the cancer journey. Focused efforts have been made
regarding symptom screening and management, patient
education, needs of new patients, needs of individuals on
treatment and survivors.
Documentation, clerical support, visual flow management,
and streamlining of clinic processes have also been
implemented. Focus group and survey approaches have
been utilized throughout the process to gather feedback
and assess progress.
The changes have been challenging for all concerned
and have raised questions about continuity of care and
barriers to practicing the specialized oncology nurse role
in our current oncology settings. Improvements have been
observed in documentation, clarity of role responsibilities,
and access to education. Sharing the workload and
supporting/mentoring other team members have improved.
Poster Group 1:
Addressing Patient Needs across
the Cancer Trajectory
Monday, October 21, 2013
P-04
An Exploration of the Actions of Oncology
Nurses When Further Nursing Interventions
Seem Futile: At Diagnosis, During Treatment,
and in Palliative Situations
Beth Perry, PhD1, Katherine Janzen, MN2. 1Athabasca
University, Edmonton, AB, Canada, 2Mount Royal
University, Calgary, AB, Canada.
10:15 am - 10:45 am | Pavillion Foyer
P-01
P-05
Nursing Management of Neurological Deficits
in Cancer Patients
Bone Modifying Agent Therapy and a
Subcutaneous Injection Teaching Clinic
Tamara Crozier, MS3,2. 1Vancouver Coastal Health,
Vancouver, BC, Canada, 2University of British Columbia,
Vancouver, BC, Canada, 3Fraser Health Authority,
Patricia Bieronski, RN, BScN, CON(C), Colleen
Graham RN, B.N.Sc, CON(C), Nadia Califaretti M.D.,
FRCP(C), Anna Granic BScPharm, Theresa Underwood,
Drug Access Facilitator, Donna Van Allen RN, BHScN,
CON(C). Grand River Regional Cancer Centre, Kitchener,
ON, Canada.
P-06
P-02
Lymphedema Management of a Very Elderly
Inpatient: A Case Study
Adoucir le passage du curatif au palliatif pour
les patients atteints de cancer pulmonaire
Andrea Tilley, BScPT. Horizon Health Network,
Rothesay, NB, Canada.
Chantal Leblanc, B Sc, Manon Coulombe, M Sc. Hôpital
Maisonneuve-Rosemont, Montréal, QC, Canada.
P-03
P-07
Factors Influencing the Pursuit of Fertility
Preservation Treatment in Newly Diagnosed
Cancer Patients: Impact of Fertile Futures’
Power of Hope Program.
A Collaborative Approach to Managing
Steroid Induced Hyperglycemia
Michael G. Woo, M.Sc., Ph.D., Jessica Séguin. Fertile
Future, Ottawa, ON, Canada.
Sabrina Bennett, RN, BScN1, Renee Grant, RN1, Gail
MacNeill, BScN, RN MEd, CDE2, Phillip Segal, MD FRCPC3,1,
Christine Opsteen, RN, MN, NP2, Simonne Simon, RN, BScN,
MN, CON(C)1, Maureen Daniels, RN, BScN1, Chris Marajas,
Hons.B.Sc.4, Vivian Choy, R.Ph., BSc.Phm1, Bruce Perkins, MD,
MPH1,3, Caroline Chung, MD, MSc, FRCPC, CIP1,3. 1University
Health Network, Toronto, ON, Canada, 2Mount Sinai Hospital,
Toronto, ON, Canada, 3University of Toronto, Toronto, ON,
Canada, 4Eli Lilly Canada, Toronto, ON, Canada.
103
Poster
Presentations/
Séance d’affichage
P-08
P-12
Head and Neck Cancer: Nutritional
Management with Radiation Therapy Patients
Evaluation of the Psychometric Properties of
the French WCCNRR-F Stomatitis Instrument
to Determine the Degree of Severity of
Stomatitis
Jenn Knoll, RN BScN, CON(C). London Health
Sciences Centre, London, ON, Canada.
Poster Group 2:
Tools for Practice
Nicole Allard, PhD1, Rédouanne Bettahar, md2.
1Université Du Québec À Rimouski, Lévis, QC, Canada,
2CSSS Rimouski-Neigette, Rimouski, QC, Canada.
P-13
P-09
Integrated Documentation: A Good Marriage
or Impending Divorce
3:30 pm - 4:00 pm | Pavillion Foyer
Collaborative Development of Advance Care
Planning Materials for Cancer Patients and
Professionals
Tracey Kerr, BScN, Laurie Young, RN. Durham
Angela C. Bedard, MSc1, Megan Stowe, RN, BN, MSN1,
Gillian Fyles, MD2, Louise Hanvey, RN, BN, MHA3.1BC
Cancer Agency, Vancouver, BC, Canada, 2BC Cancer Agency,
Kelowna, BC, Canada, 3Canadian Hospice and Palliative
Care Association, Ottawa, ON, Canada.
Poster Group 3:
Education: Patient and HCP
P-10
“The Chemotherapy Tubing Map”:
Challenges for Standardization of How to Set
Up Chemotherapy Tubing by Using Principles
poster presentations/séance d’afficahge
Tomoko Uemoto, RN, CON(C).Stronach Regional
Cancer Centre, Newmarket, ON, Canada.
P-11
Transitioning to Electronic Documentation:
The Innovative Use of Ipads in Improving
Patient Care and Nursing Satisfaction
Sarah N. Proulx, RN, BScN, CON (C), CHPCN (C).
Sault Area Hospital, Algoma District Cancer Program,
Sault Ste Marie, ON, Canada.
104
Tuesday, October 22, 2013
P-14
Providing Standardized Chemotherapy and
Biotherapy Education Across Ontario - Is
eLearning the New Frontier to Support High
Quality Care?
Komal Patel, RN, BScN, CON(C), CHPCN(C)1,
Laura Rashleigh, RN, BScN, MScN, CON(C)1, Donalda
MacDonald, RN, CON(C)1, Jiahui Wong, PhD1, Tracy
Soong, BSc(C)1, Leah Miller, BSc1, Liat Brudnoy, BA, MA1,
Mathew Gancarz, Hon. BSc1, Thomas Grahman, BA1,
Allan Holtzman, BSc1, Mark Ossowski, MDP. Diploma1,
Tobi Lam, BSc, MSc, BMC1, Esther Green, RN, BScN,
MSc(T)2. 1de Souza Institute, Toronto, ON, Canada,
P-15
P-20
Surveying the Patient Education Landscape
at BCCA
Annual Surgical Oncology Education Day:
The Event Continues to Grow
Joy Bunsko, BScN, CON(C), Amanda Bolderson,
MRT(T), FCAMRT, MSc, Pamela Dent, MLIS, Angela
Bedard, MS, Lynne Ferrier, BscP, Anne Hughes, RN, MSN,
Paris Ann Ingledew, MD, FRCPC, MHPE. Fraser Valley
Cancer Agency, Surrey, BC, Canada.
Debbie Miller, RN, BScN, MN, CETN(C); Smitha
Casper-DeSouza, RN, MScN, CHE; Elaine Avila, RN,
BScN; Anita Long, RN, MSN/ED, CON(C); Barbara AnneMaier, RN, BScN, CON(C) and Cynthia Robinson, BSW,
MSW, RSW.
P-16
P-21
Lymphoma Canada Supports mdBriefcase
in Online Accredited Continuing Medical
Education for Healthcare Professionals
Improving Nurses’ Attitudes Pertaining To
Assessment of Sexuality-Related Concerns in
Patients with Cancer Diagnosis
Sue Robson, RN. Lymphoma Canada, Mississauga, ON,
Canada
Ioulia Konovalova, MN. Stronach Regional Cancer
Centre, Newmarket, ON, Canada.
P-17
Poster Group 4:
Roles/Models of Care
Jodi Hyman, RN, BScN, CON(C). Cancer Care
Manitoba, Winnipeg, MB, Canada.
P-22
P-18
The Oncology Practice Consultant: An
Innovative Approach to Supporting Oncology
Health Care Professionals Across NS
Before and After Breast Surgery Education
Sessions
Shelley Cloutier, RN, BScN, Daena C. Lamoureux, MSc
RD, Janice Chobanuk, R,N BScN. Alberta Health Services,
Michele Rogez, RN, BScN, CON(C)1, Kara Henman,
RN, MN, CON(C)2. 1Cancer Care Nova Scotia, Sydney, NS,
Canada, 2Cancer Care Nova Scotia, Halifax, NS, Canada.
P-23
Transforming a Community Oncology Clinic
to Improve Quality of Care
P-19
Education and Support: Transforming a
Patient Education Program to Promote
Empowerment
Janet White, RN, CON(C), Leslie A. Forrester, BA
(Hons), MA, MSc, Corinna Curtis, RN, BSN. Powell River
General Hospital, Powell River, BC, Canada.
Kathleen M. Weir, RN, CON(C), Chelsea Seguin,
BHSc, Algoma District Cancer Program. Sault Area
Hospital, Sault Ste Marie, ON, Canada.
105
Use of CANO Standards and Competencies
to Enhance the Nursing Curriculum for the
Community Cancer Programs Network
P-24
Shelley Cloutier, BScN, RN, Janice Chobanuk, BScN,
RN, Daena C. Lamoureux, MSc, RD. Alberta Health
Services, Edmonton, AB, Canada.
Several oncological conditions can result in neurological
impairment including spinal cord compression, cerebral
and central nervous system tumors, chemical or radiation
toxicity, or pathologic bone fractures. Oftentimes the
oncology nurse is not adequately prepared or confident
enough to care for patients with neurological deficits
including fatigue, pronounced weakness or paralysis,
confusion, impairment or loss of speech, decreased
consciousness, gait alterations, tremors, paresthesia, or
neurological pain. This presentation aims to provide nursing
care recommendations from the neurological perspective
while maintaining careful consideration of underlying
cancer comorbidities. Our clinical presentation unites
expertise in oncology nursing with neurology nursing to
provide the latest best practice recommendations. In this
facilitated workshop we will survey neurological deficits
most common in the oncology patient community, including
those that are encountered in home care, day care, and
acute care settings. Using case studies and collaborative
activities, participants will review pathophysiological
concerns, diagnostics, and treatments within the context of
nursing interventions aimed at improving patient outcomes.
P-26
P-02
Patient Satisfaction Survey Results on a
Hematology-Oncology In-Patient Unit
Lymphedema Management of a Very Elderly
Inpatient: A Case Study
Karine Lepage, RN, B.Sc.N., M.Sc., Vanessa Lewis, RN.
Jewish General Hospital, Montréal, QC, Canada. Abstract
Listings for Poster Presentations/Liste des abrégés pour
presentations par affiches
Andrea Tilley, BScPT. Horizon Health Network,
Rothesay, NB, Canada.
A “Quick Click” to a “Quick Guide” - An
Innovation to Enhance the Nurse’s Role in
Clinical Trials
Inara H. Karrei, RN, BScN, MEd, CON(C), Donna
Leafloor, RN, MHSM, Lise Thaw, RN, Meri-Jo Thompson,
MSc., MBA, Janelle Desjardins RN, BScN. The Ottawa
Hospital Cancer Center, Ottawa, ON, Canada.
P-25
A Virtual Breast Health Program Transforms
the Patient Experience
Poster Group 1:
Addressing Patient Needs across
the Cancer Trajectory
P-01
Nursing Management of Neurological Deficits
in Cancer Patients
Tamara Crozier, MS3,2. 1Vancouver Coastal Health,
Vancouver, BC, Canada, 2University of British Columbia,
Vancouver, BC, Canada, 3Fraser Health Authority,
106
Introduction: Multiple case series report the benefits
of Complete Decongestive Therapy (CDT) for patients
suffering with Lymphedema of the limbs. RJ is unique
as she was a 90year old inpatient who had had
brachialplexopathy for many years as a result of cobalt
treatments in the 1970’s. 4 years prior to treatment she
developed Lymphedema as well.
Methods: On admission to Geriatric Medicine, stage 3
Lymphedema of RJ’s right arm was noted. The right arm was
flaccid with gross deformity and skin lesions present. The
right arm measured 124% greater volume than the left. RJ
was emotionally distraught when discussing her right arm.
Complete Decongestive Therapy(CDT) was administered
by a physiotherapist using Manual Lymph Drainage
massage(MLD),a cohesive 2 layer compression bandage
system, passive exercise and skincare. The patient was
treated 3 times a week but compression was maintained
between sessions.
Figure 2 shows before and after treatment images.
Lymphedema reduced from 729mLs on admission, to
273mls after 2.5 weeks. Custom compression was then
ordered. After 8 weeks the LE had reduced to 224mLs.
Discussion: RJ was elated with the appearance of her arm.
Nursing appreciated that the cohesive bandages stayed
perfectly in place between physiotherapy sessions so that
they did not need to be reapplied.
P-03
Factors Influencing the Pursuit of ertility
Preservation Treatment in Newly Diagnosed
Cancer Patients: Impact of Fertile Futures’
Power of Hope Program.
Michael G. Woo, M.Sc., Ph.D., Jessica Séguin Fertile
Future, Ottawa, ON, Canada.
Rationale and Objective: Loss of fertility as a result of
cancer treatment is a major concern for cancer patients of
reproductive age. The choice to pursue fertility preservation
(FP) treatment can be difficult during this stressful time,
having to weigh immediate concerns against future
desires for a family. Fertile Future (FF) have provided FP
information and support services to cancer patients and
oncology professionals since 2010. Through the Power of
Hope (PoH) Program, FF provides qualifying applicants
reduced clinic fees, compassionate pharmaceuticals and
bursaries. PoH recipients represent a unique demographic
that are: 1) in financial need; 2) are of a reproductive age;
3) have completed fertility preservation treatment; as such,
we investigated the factors that influenced their decision
to pursue fertility preservation treatment after a cancer
diagnosis. Methods: Self-report survey of PoH recipients
regarding demographics and factors affecting their decision
to pursue FP treatment. Descriptive statistics were used.
Results: Treatment cost was the greatest barrier for women
vs. men, and FF’s PoH Program had the greatest influence
on women in the pursuit of treatment. Conclusions: Pursuit
of FP treatment is promoted by timely education and
referral to fertility specialists, and is facilitated by information
resources and financial support services, as offered by FF.
P-04
An Exploration of the Actions of Oncology
Nurses When Further Nursing Interventions
Seem Futile: At Diagnosis, During Treatment,
and in Palliative Situations
Beth Perry, PhD1, Katherine Janzen, MN2. 1Athabasca
University, Edmonton, AB, Canada, 2Mount Royal
University, Calgary, AB, Canada.
“There is nothing more I can do.” While less common,
this phrase may still occur in the minds of oncology
nurses and other caregivers. The literature is consistent
that patients should never be told that there is nothing
more that can be offered, the literature is lacking in
nursing interventions to assist patients whose situations
seem hopeless and in which further nursing interventions
seem futile. Oncology patients in these circumstances
may be at any phase of the care trajectory (diagnosis,
treatment or in palliation). In this study potential
participants (clinical oncology RNs) were recruited
though advertisements in the Canadian Oncology
Nursing Journal that directed them to a research website
developed for this study. This website was the instrument
for data collection. Additional participants were recruited
by snowball sampling and also directed to the study
website. Nineteen nurses consented to participate and
shared demographic data and a written description(s)
of a time during their practice when they took nursing
action in a situation where others indicated that no
more could be done. Data were analyzed in a two-tiered
process using hand-coding for themes and QRS NVivo10
software. Further, demographic data were tabulated and
analyzed using descriptive statistics. Preliminary analysis
includes the themes of personalization of care, attending
to minutia, and establishing connections. This study has
implications for quality of patient care, nurse well-being
and nurse retention.
Transitioning to Electronic Documentation: The Innovative
Use of Ipads in Improving Patient Care and Nursing
Satisfaction
107
Results: Figure 1 Illustrates excess volume reduction over
a period of 8 weeks.
P-05
P-06
Bone Modifying Agent Therapy and a
Subcutaneous Injection Teaching Clinic
Adoucir le Passage du Curatif au Palliatif
pour les Patients Atteints de Cancer
Pulmonaire
Patricia Bieronski, RN, BScN, CON(C), Colleen
Graham RN, B.N.Sc, CON(C), Nadia Califaretti M.D.,
FRCP(C), Anna Granic BScPharm, Theresa Underwood,
Drug Access Facilitator, Donna Van Allen RN, BHScN,
CON(C). Grand River Regional Cancer Centre, Kitchener,
ON, Canada.
In 2012 an Ontario regional cancer centre implemented
a new initiative addressing bone modifying agent (BMA)
therapy to serve the needs of individuals with advanced
cancer to promote optimal health and functional well
being. This provided a unique opportunity to establish
a nurse led clinic involving health assessment and care
planning with utilization of BMA therapy. A specialized
oncology nurse has been an instrumental leader in
developing a subcutaneous injection education clinic, a
Denosumab® medical directive, new patient education
materials, and help facilitate change in practice. The
inception of the bone health clinic fosters intraprofessional
collaboration. For example, the Coordinator and Drug
Access Facilitator of the Cancer Centre Pharmacy and a
medical oncologist reviewed the charts of all patients on
BMA therapy to determine if a different agent would be
appropriate. Eligible patients changed from Pamidronate®
to Zometa® or Denosumab®. Ultimately a subcutaneous
injection education clinic enhanced patient quality of life
by reducing visits and inspiring patient independence.
Fewer visits to the Systemic Therapy Suite enabled more
treatment opportunities. Through the implementation of
this initiative several patient education materials were
developed to support best practice and a pivotal change
occurred in the delivery of care for a specialized oncology
population. Practice changes included: a nurse led
subcutaneous injection education clinic, nursing/physician
awareness of dental prophylaxis for patients starting bone
modifying agent therapy, and a more comprehensive
assessment pre administration.
108
Chantal Leblanc, B Sc, Manon Coulombe, M Sc. Hôpital
Maisonneuve-Rosemont, Montréal, QC, Canada.
Le passage du curatif au palliatif est une étape
cruciale dans le cheminement de la maladie. Chez les
professionnels, il y a souvent un malaise à aborder le
fait que la fin de vie devient une éventualité. Pourtant,
reconnaître cette éventualité et l’aborder avec le patient et
sa famille est essentielle pour assurer cette transition.
Dans un contexte de cancer pulmonaire, la transition
se fait souvent rapidement vers les soins palliatifs
comparativement à d’autres sites tumoraux.
Un des rôles centraux dans cette transition est
celui de l’infirmière pivot en oncologie. A l’Hôpital
Maisonneuve-Rosement, le rôle d’infirmière pivot en
oncologie pulmonaire et celui d’infirmière pivot en soins
palliatifs co-existent. Ceci permet de mettre en valeur la
complémentarité d’expertise car une expertise particulière
est requise pour les traitements et une autre est requise
pour les soins de fin de vie.
Un suivi conjoint durant quelques temps survient
fréquemment. Il n’est pas considéré un dédoublement
mais plutôt le développement de soins intégrés où les
traitements et les soins palliatifs ne sont plus mutuellement
exclusifs. Pour réussir ce travail d’équipe, toutefois, la
communication est essentielle.
Dans le but de guider et soutenir les patients et les
membres de leur famille dans cette transition, des
interventions concrètes seront présentées pour outiller
les professionnels.
P-07
P-08
A Collaborative Approach to Managing
Steroid Induced Hyperglycemia
Head and Neck Cancer: Nutritional
Management with Radiation Therapy Patients
Sabrina Bennett, RN, BScN1, Renee Grant, RN1,
Gail MacNeill, BScN, RN MEd, CDE2, Phillip Segal, MD
FRCPC3,1, Christine Opsteen, RN, MN, NP2, Simonne
Simon, RN, BScN, MN, CON(C)1, Maureen Daniels, RN,
BScN1, Chris Marajas, Hons.B.Sc.4, Vivian Choy, R.Ph.,
BSc.Phm1, Bruce Perkins, MD, MPH1,3, Caroline Chung,
MD, MSc, FRCPC, CIP1,3. 1University Health Network,
Toronto, ON, Canada, 2Mount Sinai Hospital, Toronto, ON,
Canada, 3University of Toronto, Toronto, ON, Canada, 4Eli
Lilly Canada, Toronto, ON, Canada.
Jenn Knoll, RN BScN, CON(C). London Health
Sciences Centre, London, ON, Canada.
The protocol was developed with a multidisciplinary team
that spanned three hospital sites. As it is recognized
that the ability to minimize hyperglycemia is dependent
upon consistent monitoring of blood sugars and clear
communication of the overall plan with the patient and
treating team so that timely interventions could be
introduced, a standard treatment algorithm was developed.
This poster presentation will highlight the role of nursing
in the implementation of this protocol This includes patient
education including the introduction of glucose meters for
glucose monitoring and the introduction of insulin as well as
liaising with interdisciplinary team (physicians, pharmacists
and social workers) to coordinate care.
Overall, this project demonstrates the strength of
collaborative interdisciplinary and multidisciplinary patientcentred efforts to improve patient care. The program has
been implemented and evaluation of the program is ongoing.
Poster Group 2:
Tools for Practice
P-09
Collaborative Development of Advance Care
Planning Materials for Cancer Patients and
Professionals
Angela C. Bedard, MSc1, Megan Stowe, RN, BN, MSN1,
Gillian Fyles, MD2, Louise Hanvey, RN, BN, MHA3. 1BC
Cancer Agency, Vancouver, BC, Canada, 2BC Cancer
Agency, Kelowna, BC, Canada, 3Canadian Hospice and
Palliative Care Association, Ottawa, ON, Canada.
Advance care planning is important for all individuals,
but is particularly critical for those with a serious illness.
In response to a recognized gap in national resources
for advance care planning specifically designed for
cancer patients and their families, as well as for cancer
professionals, a partnership was formed between the BC
Cancer Agency (BCCA) and the Canadian Hospice and
Palliative Care Association (CHPCA) to develop materials
for this population. An environmental scan was performed
by the CHPCA to look at existing materials for advance
care planning that were available for both the public and
professionals. A content analysis was performed on the
resources that were located. Based on the content themes,
draft fact sheets for the public and professionals were
developed. Content expert review was performed on the
109
Patients with brain tumors are often on high doses of
corticosteroids to manage brain edema, particularly
during their radiation treatment. Patients on high dose
corticosteroids are at risk for hospital admissions due to
acute complications of severe hyperglycemia, sometimes
interrupting their cancer treatments. This raised the need
for a preventative strategy and lead to the development of
our Steroid-Induced Hyperglycemia Protocol. The goal of
this protocol was to prevent unnecessary emergency room
visits and hospital admissions for acute hyperglycemic
complications secondary to glucocorticoid therapy.
Maintaining adequate nutrition is one of the largest
challenges for patients receiving radiation therapy for
head and neck cancers. Specially trained Oncology
nurses provide support, assessment, health education and
intervention to patients through this difficult journey. A focus
on four of the major impacts to nutrition in this vulnerable
patient population; mucositis, xerostomia, odynophagia
and dysgeusia will highlight what symptoms to expect and
when, what’s new in prevention and management, as well
as patient risk factors. The objective is to offer a view of not
only the role Oncology nurses play in supporting patients,
but the impact to patients when nutrition isn’t maintained.
materials. A focus group was done with potential users of
the materials developed for the public. Attendees included
cancer survivors and family members, who were identified
from the BC Patient Voices Network. Consultation with
potential users of the materials developed for professionals
took place via email with physicians from the BC Cancer
Agency. Feedback from both groups was incorporated to
improve the materials. The fact sheets were adapted into
small, attractive booklets. The booklets are available in
both French and English at www.advancecareplanning.
ca, and will be a helpful resource for those wanting a better
understanding of advance care planning and cancer.
P-10
“The Chemotherapy Tubing Map”:
Challenges for Standardization of How to Set
Up Chemotherapy Tubing by Using Principles
Tomoko Uemoto, RN, CON(C). Stronach Regional
Cancer Centre, Newmarket, ON, Canada.
The Chemotherapy Tubing Maps, IV- tubing set up for
chemotherapy administration, could be as complicated as
a subway map in a big city due to the increased complexity
and diversity of recent combination chemotherapy/
biotherapy protocols. Chemotherapy nurses may have
to draw a “map” before setting up the IV tubing for each
complicated protocol, and the map could be drawn in
different ways. We have challenged to standardize the
chemotherapy tubing maps to educate both new staff
and experts for patient/ staff safety and to maximize the
effectiveness of chemotherapy. “Principles” were made as
guidelines from the consideration of special requirements,
drug compatibility, and safety although these are already
well known by experts. Then, the new tubing maps have
been implemented strictly from the principles as a pilot
project with exciting results; all chemotherapy nurses have
been trained to set up the tubing in the same way.
P-11
Transitioning to Electronic Documentation:
The Innovative Use of Ipads in Improving
Patient Care and Nursing Satisfaction
Sarah N. Proulx, RN, BScN, CON(C), CHPCN (C).
Sault Area Hospital, Algoma District Cancer Program,
Sault Ste Marie, ON, Canada.
The best care possible for every patient is the driving force
that lays the groundwork for collaboration and innovation at
our outpatient cancer clinic.
Our clinic was introduced to Mosaiq, an electronic
medical record, which allows multidisciplinary teams to
communicate, document and plan treatments.
The goal was to improve chart accessibility for the team,
and have a place where physicians and nurses could
document treatment plans, chemo administration and
patient assessments.
Having a single point of access for all elements of
the patients’ treatment plan improves the flow of
communication to all team members. The accessibility of
this information improves the continuity of care, increases
the patients’ confidence in their care provider and makes
their journey as seamless as possible.
A computer at each treatment station allows for improved
patient wait times and accurate, real-time charting. We
found that ipads could not only support Mosaiq, but had
many other functions useful for our patients. Cancer Care
Ontario apps were added for nurses to access and review
with patients. Patient education videos were also added for
improved patient teaching sessions.
The poster presentation highlights how electronic
documentation has improved our patients’ experience, and
how ipads improve our nurses’ ability to access information
and document promptly. The ipads have opened the doors
to endless possibilities.
This poster presentation will introduce this challenging
journey and explain how the combination of the principles
and the mapping would improve the quality and safety in
chemotherapy practice. This new innovation has a great
potential for standardization of the chemotherapy tubing
maps among chemotherapy units in Ontario as well as
across country.
110
Evaluation of the Psychometric Properties of
the French WCCNRR-F Stomatitis Instrument
to Determine the Degree of Severity of
Stomatitis
Nicole Allard, PhD1, Rédouanne Bettahar, md2.
1Université Du Québec À Rimouski, Lévis, QC, Canada,
2CSSS Rimouski-Neigette, Rimouski, QC, Canada.
Stomatitis, an inflammation and ulceration of the mouth,
is a common and devastating complication of cancer
therapy. Incidence levels can range from 10% to 90%.
Therapy factors include the chemotherapy regimen,
treatment schedule, drug dose, and the use of radiation
therapy. Stomatitis can cause treatment delays and dose
reduction, severe pain, weight loss, difficulty talking,
infections, emotional distress, and altered morbidity and
mortality (Sonis et al., 2004). Management of stomatitis
requires thorough assessment. The Western Consortium
for Cancer Nursing Research (WCCNR) developed a short
tool, the 3 items WCCNR Stomatitis Staging System, to
incorporate into a routine nursing assessment. The lack of a
French version of this tool prevented the testing of nursing
interventions for stomatitis Canada-wide. Hence, a French
version of the WCCNR tool was created by bilingual nurses
living in Quebec, using the back translation procedure.
In a previous study, the 3-item instrument was found to
be reliable and valid both in French and English. The
purpose of the current study was to address the validity and
reliability of the adapted 6 items French version (items of
humidity, pain and ability to eat were added) in a population
of French patients with head and neck cancer at 10 and
25 weeks of their radiotherapy treatments. Results will be
presented and discussed.
P-13
Integrated Documentation: A Good Marriage
or Impending Divorce
Tracey Kerr, BScN, Laurie Young, RN. Durham Regional
Cancer Centre, Oshawa, ON, Canada.
The integration of computerized physician order entry
(CPOE) with an electronic health record (EHR) has both
positive and negative aspects, as would any marriage. We
initiated this task six months ago. Our poster presentation
takes a retrospective look to analyze the benefits and
challenges of integrating CPOE into an existing EHR
environment.
CPOE was implemented in August 2012. It required a
tremendous amount of work by pharmacy, IT, nursing and
medicine. It has been extremely taxing and rewarding. Our
centre has utilized electronic charting since 2005, added an
enterprise oncology module in 2007. This transformation
of technology enabled nurses to electronically document
across the full spectrum of the specialty, from oncology/
palliative assessment, to chemotherapy protocol and
other medication sign-off in an electronic medication
administration record (EMAR) to full documentation of
interaction and follow-up. Our systemic nursing team
encompasses a broad spectrum of computer expertise.
This includes nurses still struggling with electronic
documentation to the computer savvy. CPOE integration
has intensified the stress in our clinic. We will look at the
challenges and the benefits of CPOE amalgamation, as well
as a qualitative review of nursing reactions to this marriage.
Through this exploration we hope to formulate an innovative
teaching strategy for new nurses in oncology to streamline
and inspire their learning needs for CPOE and the EHR.
Poster Group 3:
Education: Patient and HCP
P-14
Providing Standardized Chemotherapy and
Biotherapy Education Across Ontario - Is
eLearning the New Frontier to Support High
Quality Care?
Komal Patel, RN, BScN, CON(C), CHPCN(C)1,
Laura Rashleigh, RN, BScN, MScN, CON(C)1, Donalda
MacDonald, RN, CON(C)1, Jiahui Wong, PhD1, Tracy
Soong, BSc(C)1, Leah Miller, BSc1, Liat Brudnoy, BA, MA1,
Mathew Gancarz, Hon. BSc1, Thomas Grahman, BA1,
Allan Holtzman, BSc1, Mark Ossowski, MDP. Diploma1,
Tobi Lam, BSc, MSc, BMC1, Esther Green, RN, BScN,
MSc(T)2. 1de Souza Institute, Toronto, ON, Canada,
Since 2009, a Provincial Standardized Chemotherapy and
Biotherapy Course was offered in Ontario to support nurses
in building their knowledge and skills in Chemotherapy
and Biotherapy administration and care. The program
reflects the provincial, national and international standards
for chemotherapy delivery. Currently, the course consists
of 15 hours of learning via videoconference, delivered
simultaneously across the province, with a 7.5 hour in-person
workshop day that includes a skill’s lab with standardized
patients, in designated hospital sites across Ontario.
111
P-12
The course has just been transitioned to an online format
with the same content and modified in-person skills lab
in 2013. The eLearning course aimed to augment the
participants’ learning potential by integrating multimedia
design and interactive features that maximize application of
concepts and facilitate deep learning, while accommodating
various adult learning styles. The eLearning further
standardizes content delivery while eliminating variances
between educators and between offerings.
If the findings warrant, the report will include concrete
recommendations toward the development of a formal
cancer patient education program at BCCA. Our patients
inspire us each day, and we anticipate this innovative
approach towards standardizing patient education in our
centres will lead to a transformation in the way we deliver
patient-focused cancer information and education.
To evaluate the effectiveness of the eLearning course in
comparison with the videoconference teaching method,
the following domains were assessed: knowledge quiz
scores, learners’ perceived confidence, and course exit
exam success rate. User satisfaction regarding content,
quality and access of this course will also be analyzed and
stratified by user demographics and practice locations.
Evaluation results will be discussed with insights gained
on the integration of information technology in the delivery
of high quality educational programs to address oncology
nurses learning needs.
P-16
P-15
Surveying the Patient Education Landscape
at BCCA
Joy Bunsko, BScN, CON(C), Amanda Bolderson,
MRT(T), FCAMRT, MSc, Pamela Dent, MLIS, Angela
Bedard, MS, Lynne Ferrier, BscP, Anne Hughes, RN, MSN,
Paris Ann Ingledew, MD, FRCPC, MHPE. Fraser Valley
Cancer Agency, Surrey, BC, Canada.
Patient education interventions are an essential component
of support for people undergoing cancer treatment to
decrease anxiety and stress, increase treatment compliance
and self-efficacy. Oncology nurses are ideally positioned
to meet the education and informational needs of patients
undergoing treatment for cancer. Despite the known benefits,
there is considerable variability in patient education services
in Canadian cancer centres. Many lack an identifiable patient
education program, institutional commitment, program
leadership, and financial resources. An interprofessional
group at the BC Cancer Agency is taking a multiphased
approach to surveying the landscape of patient education
at the BC Cancer Agency. After identification of key
stakeholders within the agency, including Regional Patient
Education Groups, an environmental scan will be performed
along with a comparison of internal processes with the
framework set by the Canadian Partnership Against Cancer
for patient education. There will also be focus groups
followed by a provincial survey regarding staff attitudes and
perceptions related to patient education. A final report will be
prepared, which will summarize areas requiring improvement
in patient education at BCCA..
112
Lymphoma Canada Supports mdBriefcase
in Online Accredited Continuing Medical
Education for Healthcare Professionals
Sue Robson, RN. Lymphoma Canada, Mississauga, ON,
Canada
For several years, we have heard the same story over and
over. “It took me more than 6 months to receive an accurate
diagnosis of lymphoma. I saw three different doctors,
insisting that something was wrong.” Still there was no
further investigation and the patient was sent home.
We felt there had to be a way to change this. At the centre
of the problem was education of Primary Care Physicians
on recognizing the signs and symptoms of lymphoma.
We had the opportunity to collaborate with mdBriefcase,
a leading on-line continuing medical education (CME)
provider that offered the free course for physicians.
The result was Lymphoma Canada’s “Early Detection
of Lymphoma in Primary Care” program, which was
developed in cooperation with a planning committee
made up of lymphoma experts from across Canada. The
course was available from June 2012 to June 2013, and
by September, it had become the #1 utilized program
by physicians. As of May 16, 2013, 1453 physicians had
completed the course.
Doctors were surveyed pre- and post-completion of the
course. One of the questions asked was, “If you had
a patient present with lymphadenopathy would you
investigate?”; 36% answered yes in the pre-course survey.
After the course, that number had increased to 78% that
said they would investigate further.
The feedback from physicians was very positive and many
said they would change their practice as a result of the
course. Lymphoma Canada felt it was our responsibility to
try and influence the time-to-diagnosis and, potentially, the
prognosis for patients.
Use of CANO Standards and Competencies
to Enhance the Nursing Curriculum for the
Community Cancer Programs Network
Jodi Hyman, RN, BScN, CONc. Cancer Care Manitoba,
The Community Cancer Programs Network (CCPN) is a
provincial program of Cancer Care Manitoba (CCMB) that
allows patients to receive cancer care closer to home. The
CCPN supports 16 Community Cancer Programs (CCPs).
CCPs offer comprehensive cancer care in an out-patient
unit set in a rural acute care hospital. CCPs are staffed by
oncology trained family physicians in oncology, nurses,
pharmacists, and allied health professionals. This oncology
training is organized by the CCPN office and takes place at
CCMB in Winnipeg.
The program has provided services virtually to over 9000
patients and 1200 physicians in a six year period. On
average a nurse navigator within this breast program
spends 90 minutes providing pre and post operative
education to each patient over the telephone and an
additional 15-20 minutes answering questions. In an effort
to manage the escalating number of referrals, standardize
the teaching and improve overall efficiencies, the oneon-one education sessions were transformed into group
education classes. The evaluation of this project included
satisfaction surveys, a focus group and a cost analysis.
Preliminary results of the evaluation have shown patient
and nurse satisfaction and significant cost savings. The aim
of this presentation is to provide an overview of the group
education processes, the final results of the evaluation and
lessons learned.
P-19
The enhanced CCP nursing curriculum was created to
reflect the CANO Standards and Competencies presented
in Halifax in 2011. The initiative for the CCPN curriculum
enhancement was based on the fact that : (1) Cancer
specific nursing education is required to transform the
general nurse caring for cancer patients into a specialized
cancer nurse as oncology nurses remain at the forefront
of the cancer patient journey. (2) Systemic therapy can
be highly toxic and present risks for patients, health care
providers and care givers. As such, the care of patients
receiving systemic therapy requires specific knowledge,
skill and judgment within an environment that supports
quality practice. CANO/ACIO (2010) Position statement for
Cancer Chemotherapy Nursing Practice
Education and Support: Transforming a
Patient Education Program to Promote
Empowerment
This poster presentation will outline the enhanced CCPN
nursing curriculum phases and components as well
as methods for continued competencies and future
considerations for ongoing improvement.
Our clinic has built a strong foundation for an improved and
innovative education program that provides patients with
evidence-based information to ensure they are able to play
an integral role in their cancer treatment.
P-18
Before and After Breast Surgery Education
Sessions
Shelley Cloutier, RN, BScN, Daena C. Lamoureux,
MSc, RD, Janice Chobanuk, RN, BScN. Alberta Health
An innovative virtual Breast Care Program was established
in 2007, to provide clinical navigation and support for
patients with breast health issues from point of suspicion
through the complex diagnostic and surgical breast cancer
pathways to the first treatment at a cancer centre.
Kathleen M. Weir, RN CON (C), Chelsea Seguin,
BHSc, Algoma District Cancer Program. Sault Area
Hospital, Sault Ste Marie, ON, Canada.
Our organization is committed to providing the best care
possible to patients at all points along the cancer care
journey. Research has shown that education following a
cancer diagnosis empowers patients to understand and
manage their disease, reduce anxiety, and improve the
overall patient experience.
The newly designed education program includes: patient
education classes instructed by a nurse navigator, social
worker, and dietitian; numerous tools and information sheets
to aid patients in managing treatment side effects; and a
comprehensive Patient Information Binder, which is used as
both a guide to living with cancer and cancer treatment, as
well as an organizational tool to manage appointments, track
symptoms and store educational materials.
With the introduction of the nurse navigator, patients are
provided with support at the time of diagnosis and at other
crucial transition points throughout their cancer journey. By
using evidence-based methods in designing a holistic, patient
centered curriculum, ADCP has transformed patient education
with the ultimate goal of empowering patients and their families
to form partnerships with their care providers and to ensure
support and education is tailored to their individual needs.
113
P-17
P-20
P-21
Annual Surgical Oncology Education Day:
The Event Continues to Grow
Improving Nurses’ Attitudes Pertaining To
Assessment of Sexuality-Related Concerns in
Patients with Cancer Diagnosis
Debbie Miller, RN, BScN, MN, CETN(C); Smitha
Casper-DeSouza, RN, MScN, CHE; Elaine Avila, RN, BScN;
Anita Long, RN, MSN/ED, CON(C); Barbara Anne-Maier, RN,
BScN, CON(C) and Cynthia Robinson, BSW, MSW, RSW.
In 2005 a Patient Care Manager, Clinical Educator and
two Advanced Practice Nurses working with staff on a 36
bed surgical unit, in a tertiary academic centre in Toronto,
Ontario, brainstormed the concept of developing an
educational event with a focus on knowledge translation
in surgical oncology. The rational for this decision was
to highlight surgical oncology as one of the specialized
treatment modalities for patients with cancer and to share
knowledge and evidence based care that would enhance
the quality of care provided by interprofessional team
members. This was also an important concept as many
staff nurses viewed themselves as general surgery nurses
not specialized oncology nurses.
Over the past eight years this full day event has grown from
under 40 participants to 128 participants. It is promoted as an
interprofessional education day for staff working with surgical
oncology patients and has expanded to include staff from
other hospitals, rehabilitation centres and the community.
Presenters range from nurses, physicians, social workers,
occupational therapists, physiotherapists and chaplains.
Various vendors and support group organizations are also
present which participants find extremely valuable.
This presentation will discuss the evolution of this innovative
event, highlighting the various topics covered to date. Annual
participant feedback will also be shared which assists in the
design of each program. This educational program can be a
model for other centres to consider in future.
114
Ioulia Konovalova, MN. Stronach Regional Cancer
Centre, Newmarket, ON, Canada.
Sexuality is an integral part of every person’s identity that
greatly influences the quality of life (WHO, 2002). Up to
90% of cancer survivors report sexuality-related problems.
Despite the widespread acceptance of the importance of
assessing sexuality and provision of counseling by oncology
practitioners, many patients report their information needs
in this area remaining unmet. Nurses’ attitudes have been
quoted as an important barrier for addressing sexuality
concerns in clinical practice. The purpose of this project
was to evaluate the effect of an educational workshop on
oncology nurses’ attitudes pertaining to assessment of
and counseling regarding sexual issues. It also aimed to
ascertain whether improved nurses’ attitudes correlate with
improved patient satisfaction with their care. A literature
search of CINAHL, PubMed, MEDLINE databases and
publications of professional organizations such as ONS
and NCCI was conducted to review recommendations for
improving oncology practice in the domain of sexuality. The
results of this review served as basis for the educational
workshop for nursing staff. Pre and Post questionnaires
using Sexual Health Care Scale-Attitude (Kim et al 2011) will
be used to evaluate the impact of the workshop on nurses’
attitudes. Cancer Centre patient satisfaction scores before
and after intervention will be also compared. This project can
help to better understand how nurses’ attitudes can impact
on clinical practice and patient satisfaction.
P-23
Transforming a Community Oncology Clinic
to Improve Quality of Care
P-22
Janet White, RN, CON(C), Leslie A. Forrester, BA
(Hons), MA, MSc, Corinna Curtis, RN, BSN.Powell River
General Hospital, Powell River, BC, Canada.
The Oncology Practice Consultant: An
Innovative Approach to Supporting Oncology
Health Care Professionals Across NS
Michele Rogez, RN, BScN, CON(C)1, Kara Henman,
RN, MN, CON(C)2. 1Cancer Care Nova Scotia, Sydney, NS,
Canada, 2Cancer Care Nova Scotia, Halifax, NS, Canada.
In 2008, in response to the need for education and support
for oncology health professionals practicing outside of
the two tertiary cancer centers, Cancer Care Nova Scotia
(CCNS) created two innovative positions titled “Oncology
Practice Consultants” (OPC’s). The role of the OPC
was created to support health professional education
interventions required to meet the outcomes defined
in oncology provincial standards, guidelines, policies
and procedures. The OPC’s demonstrate leadership in
oncology clinical education and work collaboratively with
existing oncology education resources across the province.
The OPC’s are part of a virtual team with one OPC located
at each of the provincial cancer centers. Some of the
services provided include: ‘just in time consultation”, policy
development, curriculum development, facilitating the
Administration of Cancer Chemotherapy Online Program,
and developing and delivering educational programs to
meet the needs of health care professionals caring for
cancer patients across Nova Scotia.
In 2011, CCNS assessed the impact of the role of the
OPC. There was broad consensus that the OPC role was
valued, as it supported the districts in making changes
in practice to achieve safe, quality care, thus enabling
patients to receive care closer to home. Services noted as
particularly beneficial included support for chemotherapy
related issues/learning needs, maintaining a connection to
the Cancer Centres, establishing confidence in the system,
standardizing practice, increased access to oncology
education, and supporting best practice.
Background: When the Powell River General Hospital
chemotherapy clinic opened in 1997 routines were
established that met the needs of the patients and
staff. Over the years the increase in patients receiving
chemotherapy has resulted in less than best practice,
specifically relating to wait times for chemotherapy and
privacy while discussing current therapy with the physician.
Objectives: The project had two primary objectives: (1)
to implement a new clinic schedule aimed at decreasing
patient wait times to receive their chemotherapy and (2) to
provide patients with privacy when discussing therapy with
the physician.
Methods: A new clinic schedule involving patient preregistration at the laboratory followed by physician
assessment and a scheduled appointment for
chemotherapy was implemented in December 2012. A
quality improvement team was assembled to oversee the
project and monitor its progress.
Results: Baseline data showed that patients waited on
average 133 minutes from arrival at the clinic to start of
chemotherapy. Post-intervention average wait time was
decreased to 29.7 minutes representing a 77.7% reduction.
Patients are now seen in private to discuss their current
therapy. Key informant interviews with Pharmacy and
Laboratory managers have identified several unforeseen
positive outcomes including Pharmacy now meeting two
best practice standards set out by BC Cancer Agency and
reducing turn-around time for laboratory results with preregistration of oncology patients.
P-24
A “Quick Click” to a “Quick Guide” - An
Innovation to Enhance the Nurse’s Role in
Clinical Trials
Inara H. Karrei, RN, BScN, MEd, CON(C), Donna
Leafloor, RN, MHSM, Lise Thaw, RN, Meri-Jo Thompson,
MSc., MBA, Janelle Desjardins RN, BScN. The Ottawa
Hospital Cancer Center, Ottawa, ON, Canada.
The results of clinical trials provide the scientific foundations
for many of the treatment interventions available to
cancer patients today. In some cases, a new anti-cancer
115
Poster Group 4:
Roles/Models of Care
agent may be studied, either alone, or in combination
with other agents. In facilities that engage in clinical
trials, it is not unusual for a nurse working in the
chemotherapy administration suite to be called upon
to administer such agents. This nurse is expected to
be knowledgeable about many aspects of the study
protocol. These include an awareness of study goals,
agent infusion time, side effects and documentation
requirements. Failure to comply with any of the
requirements may place the patient at risk and leads
to study deviations and violations. These in turn,
negatively affect data quality.
Ensuring that every nurse in the chemotherapy
administration suite is aware of all clinical trials is a
daunting task. This poster outlines the steps taken by
a working group to address this dilemma. The result
was the development of the electronic “Quick Guide”.
This summary sheet outlines the essential information
required by the nurse prior to administering the study
agent. By opening the guide, the nurse’s electronic
signature is recorded, indicating that the guide was
reviewed. Enhanced nurse confidence, patient care and
compliance with study requirements have resulted.
P-25
A Virtual Breast Health Program Transforms
the Patient Experience
Shelley Cloutier, BScN, RN, Janice Chobanuk,RN,
BScN, Daena C. Lamoureux, MSc, RD. Alberta Health
The health care system has been described by patients
as complicated, difficult to navigate, fragmented,
and with limited coordination between the various
systems and health care providers. An innovative
virtual clinical breast health program was established in
2007 as an access and wait times project. The primary
objective was to assist patients with a suspicion of or
a confirmed diagnosis of breast cancer through the
complex diagnostic and care pathways. The program
utilizes nurse navigators in pivotal roles to coordinate,
support, inform and educate patients diagnosed with
a breast cancer. The nurse navigator possesses expert
knowledge in both breast health and Oncology, which
enables comprehensive clinical assessments, and
triaging of patients to the right service at the right time.
The nurse navigators collaborate with patients and
their families and have developed strong collaborative
partnerships with diagnostic imaging, surgeons,
pathologists, primary care, breast expert physicians
and the cancer centres. The success of the project
phase led to the implementation and development of an
operational virtual program. To date the program has
116
received referrals from over 1800 physicians to navigate
over 9000 patients. This program provides consistent
seamless, high quality, multi-disciplinary, person centered
care. This poster presentation will highlight the program’s
success and growth; joint efforts to reduce wait times and
improve the patient’s experience. A case study will illustrate
the program’s effectiveness.
P-26
Patient Satisfaction Survey Results on a
Hematology-Oncology In-Patient Unit
Karine Lepage, RN, BScN, MSc., Vanessa Lewis,
RN.Jewish General Hospital, Montréal, QC, Canada.
Introduction:
In a context of continuous quality improvement, patient
satisfaction is a valuable method of assessing quality
of care. Data obtained through patient satisfaction
questionnaires allow managers and clinicians to focus
improvements on interventions that truly matter to
patients and families. The insights gained via a patient
satisfaction survey on a 34-bed hematology-oncology and
internal medicine unit in a university-affiliated hospital are
described.
Methods:
Validated questions were selected by our multidisciplinary
team and Quality Program staff. The survey, offered in
French and English, consisted of 28 satisfaction and 2
socio-demographic questions. Topics included cleanliness
of facilities, information transmitted to patients and families,
staff’s interpersonal skills, and specific questions about
physicians, nurses and the multidisciplinary team. Seventy
surveys were distributed prior to discharge in pre-paid
envelopes from January-July, 2012. Once completed, they
were forwarded directly to the Quality Program to ensure
confidentiality. Twenty-five surveys were returned.
Results:
Participants consisted of 60% males and 40% females aged
25-84 years. The overall satisfaction rate was 80%. Areas
with highest satisfaction were the quality of care provided
by the medical team and being treated as a person by
nursing staff. Areas identified for improvement were noise
levels and explanations provided by nurses before doing
procedures.
Conclusion:
A high percentage of patients were very satisfied with their
overall care and stay on the unit.
Conference
Exhibitor Listings/
Liste des exposants
AbbVie est une société d’envergure mondiale centrée sur
la recherche biopharmaceutique créée en 2013 à la suite
de la scission de la société Abbott. AbbVie combine les
activités de haut niveau d’une entreprise de biotechnologie
de pointe à l’expertise et à la capacité d’une entreprise
pharmaceutique chef de file établie de longue date pour
développer et commercialiser des traitements évolués qui
répondent à certaines des maladies les plus complexes et
3M
les plus graves au monde.
3M is a diversified technology company serving customers
Amgen
of our businesses has earned leading global market positions.
3M captures the spark of new ideas and transforms
them into thousands of ingenious products. Our culture
of creative collaboration inspires a never-ending stream
of powerful technologies that make life better. 3M is the
innovation company that never stops inventing. With $30
billion in sales, 3M employs 88,000 people worldwide and
has operations in more than 70 countries.
3M Critical & Chronic Care offers product solutions for the
securement of IV catheters as well as for the prevention of
skin breakdown and treatment for both chronic and acute
wounds. 3M values its partnerships with the health care
community, and as a result, offers resources that enable
organizations to increase efficiency of patient care, enhance
clinicians knowledge, skill and expertise, ultimately
improving patient outcomes.
Abbott Nutrition
Abbott Nutrition is a division of Abbott. We are a worldwide
leader in nutrition science, research, and development. The
Ensure family of products provides balanced nutrition for
adults with a source of nutrition that can help them focus on
specific nutritional goals.
Amgen, a biotechnology pioneer, discovers, develops, and
delivers innovative human therapeutics. Our medicines
help millions of patients in the fight against cancer, kidney
disease, rheumatoid arthritis, bone disease, and other
serious illnesses. With a deep and broad pipeline of
potential new medicines, we continue to advance science
to serve patients
Amgen, pionnière en biotechnologie, découvre, élabore
et distribue des traitements novateurs. Nos médicaments
ont aidé des millions de patients à combattre le cancer,
les maladies rénales, la polyarthrite rhumatoïde et d’autres
maladies graves. Nantis d’une solide pépinière de produits,
nous faisons avancer la science pour toujours mieux servir
les patients
Astellas
Astellas Pharma Canada, Inc., headquartered in Markham,
ON, is a Canadian affiliate of Tokyo-based Astellas Pharma
Inc.
Astellas is a pharmaceutical company dedicated to
improving the health of people around the world through
the provision of innovative and reliable pharmaceutical
products.
The organization is committed to becoming a global
AbbVie
category leader in focused areas by combining outstanding
AbbVie is a global, research-based biopharmaceutical
company formed in 2013 following separation from Abbott.
AbbVie combines the focus of a leading-edge biotech
with the expertise and capabilities of a long-established
R&D and marketing capabilities.
In Canada, Astellas has an intense commercial focus on
five therapeutic areas – Urology, Immunology, Infectious
Disease, Dermatology and Oncology.
pharmaceutical leader to develop and market advanced
For more information about Astellas Pharma Canada, Inc.,
therapies that address some of the world’s most complex
please visit the corporate website: www.astellas.ca
and serious diseases.
117
and communities with innovative products and services. Each
Bayer
HurriCaine Topical Anesthetic was the first of its kind, and
Bayer is an inventor company with a long tradition
HurriCaine is a brand you can trust and a product that
of research. By applying science to the major global
patients will thank you for. Stop by our booth to learn more
challenges, we deliver innovations that address unmet
about HurriCaine Topical Anesthetics for the temporary
customer and market needs.
relief of oral pain associated with oral complications due to
Our focus on innovation is the key to maintaining or gaining
a leading position in every market in which we operate. It is
also the foundation for improving the lives of many millions
of people:
By working sustainably and accepting our role as a socially
and ethically responsible corporate citizen – and by
committing to our Bayer values – we create benefits for the
remains the highest quality choice in the marketplace.
treatment along with other great Beutlich Products.
Bio-Oil
Bio-Oil is the best-selling scar product in Canada and is
recommended by doctors and pharmacists around the
world. Bio-Oil helps to reduce the appearance of all types of
scars, including those from surgery. In addition to helping
communities in which we live.
oncology patients with scarring, Bio-Oil can also help with
Science For A Better Life: this is the promise we all give to
unique formula of vitamins and natural plant oils is non-
our stakeholders.
greasy, rapidly absorbed and suitable for all skin types.
the irritation and general healing of radiation burns. Its
Bio-Oil is available without a prescription at retailers across
BD
Canada. For more information, visit www.bio-oil.com
BD is a leading global medical technology company
Boehringer Ingelheim
that develops, manufactures and sells medical devices,
instrument systems and reagents. The Company is
Boehringer Ingelheim is a research-driven pharmaceutical
dedicated to improving people’s health throughout the
group of companies committed to the development of
world. BD is focused on improving drug delivery, enhancing
innovative, cost-effective medicines and finding medical
the quality and speed of diagnosing infectious diseases
breakthroughs for therapies which fulfill unmet medical needs.
and cancers, and advancing research, discovery and
production of new drugs and vaccines. BD’s capabilities
are instrumental in combating many of the world’s most
pressing diseases. Founded in 1897 and headquartered
in Franklin Lakes, New Jersey, BD employs approximately
29,000 associates in more than 50 countries throughout
the world. The Company serves healthcare institutions,
life science researchers, clinical laboratories, the
pharmaceutical industry and the general public. For more
Boehringer Ingelheim (Canada) operations have been
based in Burlington since 1978 with more than 650
employees across Canada.
Our drug discovery focuses on six major therapeutic areas:
Respiratory diseases, Cardiometabolic diseases, Oncology,
Neurological diseases, Immunology and inflammation, and
Infectious diseases.
information, please visit www.bd.com.
Calmoseptine
Beutlich Pharmaceuticals
Calmoseptine Ointment is an effective, multi-purpose
Beutlich® Pharmaceuticals is a company that focuses on
the development and commercialization of innovative OTC
solutions for pain management and patient care. Beutlich
has been offering medical and dental professionals unique
solutions for pain management and preventative care
since 1954. We are best known for our family of HurriCaine
Topical Anesthetics containing 20% Benzocaine. Since
Beutlich introduced HurriCaine Topical Anesthetic over
40 years ago, doctors around the world have built better
moisture barrier that protects and helps heal skin irritations.
People benefiting from Calmoseptine Ointment are those
needing protection, or with impaired skin integrity related
to urinary and fecal incontinence, feeding tube site
leakage, fecal or vaginal fistula drainage, moisture, such
as perspiration, diaper dermatitis and minor scrapes &
burns. It also temporarily relieves discomfort and itching.
Calmoseptine Ointment is available without a prescription.
Free samples at our booth!
practices by easing their patients’ pain.
118
The Canadian Cancer Society
Cancer and Careers
For 75 years, the Canadian Cancer Society has been
Cancer and Careers empowers and educates people with
providing information and support services to help
cancer to thrive in their workplace by providing expert
Canadians living with cancer.
advice, interactive tools and educational events. Through a
We offer information on 200+ types of cancer, cancerrelated services and resources. Our highly-trained staff
use credible sources to communicate information without
giving advice or making recommendations. Since 1996,
we’ve answered over 1 million inquiries and last year over 4
million Canadians visited our website, cancer.ca.
Our peer support service connects patients and caregivers
with fully screened and trained volunteers who’ve had, or
cared for someone, with cancer. Our volunteers listen, offer
encouragement and share ideas for coping – all from their
unique perspective as “someone who’s been there”.
Our online community, CancerConnection.ca /
ParlonsCancer.ca is a place where those facing cancer can
share their experiences and build supportive relationships.
Last year more than 35,000 people visited.
comprehensive website, free publications, career coaching,
and a series of support groups and educational seminars
for employees with cancer and their healthcare providers
and coworkers, Cancer and Careers strives to eliminate
fear and uncertainty for working people with cancer.
Cancerandcareers.org informs more than 250,000 visitors
per year, providing essential tools and information for
employees with cancer.
Cardinal Health Canada (CHC)
At Cardinal Health Canada our mission is to be the premier
provider of products, services and solutions for safer and
more efficient healthcare in Canada.
Through Clinical Technologies and Services (CTS), Cardinal
Health Canada is a leader in technologies and services that
help hospitals manage all medications from the moment they
For further information please call 1-888-939-3333, visit us
arrive until they are administered to the patient; store and track
at cancer.ca, or drop by our booth.
specialty supplies; and identify and prevent hospital-acquired
infections. Through our Alaris® Products and Pyxis® Products,
The Canadian Nurses
Association (CNA)
The Canadian Nurses Association (CNA) is the national
professional voice of registered nurses in Canada.
A federation of 11 provincial and territorial nursing
associations and colleges representing 148,992 registered
nurses, CNA advances the practice and profession of
nursing to improve health outcomes and strengthen
Cardinal Health Canada is helping bring new levels of safety
and efficiency to Canadian hospitals and healthcare providers.
Through Medical Products and Technologies (MPT), Cardinal
Health Canada develops and manufactures a wide range of
surgical, respiratory therapy, and diagnostic products used
in all healthcare facilities. Cardinal Health Canada markets
over 15,000 of these self manufactured products in Canada.
At Cardinal Health Canada, we surround our products with
clinical and educational expertise providing solutions for our
Canada’s publicly funded not-for-profit health system.
customers. All MPT products are distributed in Canada
CNA is responsible for the overall management of the only
CHC is one of the largest and most comprehensive supplier
national areas of nursing practice competency certification
program. There are currently 20 areas of nursing practice
and more than 17,600 CNA-certified nurses in Canada. For
more information about the CNA Certification Program, visit
the CNA website at http://getcertified.cna-aiic.ca.
in Canadian Healthcare; Cardinal Health Canada distributes
products from over 400 manufacturers to hospitals, surgery
centers, laboratories, long term care facilities and physician
offices throughout Canada. We provide integrated supply
chain and logistics solutions that help customers control costs,
improve efficiencies and increase effectiveness.
119
CANO/ACIO
Cold Comfort Canada
The Canadian Association of Nurses in Oncology (CANO/
No longer do cancer patients receiving chemotherapy have
ACIO) is the national organization that supports Canadian
to suffer the trauma of hair loss.
nurses to promote and develop excellence in oncology
nursing pratice, education, research and leadership. CANO/
ACIO’s mission is to lead nursing excellence in cancer
control for Canadians, with avision of being an international
nursing leader in cancer control. We are a member-run
association that takes direction from its members in
formulating activities and initiatives.
We are the exclusive importer and distributor of Paxman
Scalp Coolers in Canada. Paxman is the World Standard in
Scalp Cooling for the Prevention of Chemotherapy-related
hair loss. Paxman Scalp Cooling Systems have been used
by hundreds of thousands of patients in the UK, where it is
offered as the standard of care to the majority of patients
undergoing chemotherapy. Scalp cooling is widely used
Fondée en 1984, l’Association canadienne des infirmières
in the UK and Europe and has been proven to be safe
en oncologie (ACIO/CANO) est un organisme d’envergure
and effective. Paxman Scalp Coolers are now available
nationale qui appuie les efforts des infirmières du pays en
in Canada for use in patients wishing to preserve their hair
matière de promotion et développement de l’excellence
and self-esteem during chemotherapy.
dans les soins infirmiers en oncologie et ce, aussi bien sur
le plan de la pratique que sur celui de la formation, de la
recherche et du leadership. La mission de l’ACIO consiste
à développer l’excellence infirmière dans le domaine de
*Systems available for sale or lease to patients and
institutions.
la lutte contre le cancer pour le bénéfice de la population
de Souza Institute
canadienne; sa vision est de devenir un leader international
de Souza Institute is an oncology continuing education
dans le domaine des soins infirmiers en cancérologie. Nous
constituons une association dirigée pas ses membres qui
suit les orientations de ces derniers lors de l’élaboration des
activités et des initiatives.
centre. Created in 2008, de Souza Institute provides the
latest best practices in oncology to Canadian nurses that
care for cancer patients and their families.
Through innovative online learning, de Souza Institute
Celgene
offers study groups for the Canadian Nurses Association
Committed to Improving the Lives of Patients Worldwide
well as a number of valuable courses including Provincial
Celgene is a global biopharmaceutical company committed
Standardized Chemotherapy and Biotherapy, Foundations
to improving the lives of patients worldwide.
in Oncology Nursing, Patient Navigation, Psychosocial Care,
Celgene Inc., a wholly-owned subsidiary of Celgene Corp.,
certification in oncology and hospice palliative care, as
Managing Grief and Loss, Advance Care Planning and more.
established its presence in Canada in 2006 and is located
Nurses taking de Souza Institute courses will receive credits
in Mississauga, Ontario.
towards a full de Souza Nurse Designation.
At Celgene, we seek to deliver truly innovative and lifechanging drugs for our patients. Our mission as a company
is to build a major global biopharmaceutical corporation
while focusing on the discovery, the development, and the
To learn more about de Souza Institute, visit
www.desouzainstitute.com
commercialization of products for the treatment of cancer
Eisai Limited
and other severe, immune, inflammatory conditions.
Eisai Limited was established in Canada on April 1, 2010.
There are more than 300 clinical trials at major medical
Our corporate mission involves giving first thought to
centers using compounds from Celgene. Investigational
patients and their families and to increasing the benefits
compounds are being studied for patients with incurable
health care provides, a concept called human health care
hematological and solid tumor cancers, including multiple
(hhc). Eisai strives to find and develop new compounds
myeloma, myelodysplastic syndromes, chronic lymphocyte
that help to improve the lives of people. Global research
leukemia (CLL), non-Hodgkin’s lymphoma (NHL),
focuses on the therapeutic areas: Neuroscience, Oncology
myelofibrosis
& Vascular/Immunological Reactions.
120
Approved products in Canada: Aloxi® (palonosetron HCl),
which prevents chemotherapy-induced nausea & vomiting,
GlaxoSmithKline
Halaven® (eribulin mesylate), a chemotherapy used for
GlaxoSmithKline (GSK) is a leading research-based
Metastatic Breast Cancer, Gliadel® Wafers, implantable
pharmaceutical company with a challenging and inspiring
chemotherapy for Glioblastoma, and Banzel®, which treats
mission: to improve the quality of human life by enabling
seizures associated.
people to do more, feel better, and live longer. This mission
gives GSK the purpose to develop innovative medicines,
Fertile Future
vaccines and healthcare solutions that help millions of
Fertile Future is a national charitable organization that
employers in Canada and is a top 20 investor in Canadian
provides fertility preservation information and financial
research and development, contributing $118 million in 2011
assistance to qualifying cancer patients and promotes
alone. With a proud tradition of charitable and community
cause awareness among oncology professionals.
support, GSK is designated a Caring Company by Imagine
people. GSK is consistently recognized as one of the 50 best
Every year more than 10,000 Canadians between the
ages of 20 and 44 are diagnosed with cancer – and over
Canada. Discover more at www.gsk.ca.
80% will survive. Fertile Future strives to provide vital
ICU Medical Inc
information to these patients about the availability of fertility
ICU Medical helps keep pharmacists, nurses and
preservation services, as well as to oncology professionals,
patients safe from exposure to hazardous drugs with
enabling them to make timely patient referrals. Our
the ChemoClaveTM system, the world’s only needlefree
objective is to provide information and assistance to young
closed system and closed system transfer device (CSTD)
cancer patients to help them achieve the fullest life possible
for the safe handling of hazardous drugs. ChemoClave is
after cancer; a life complete with children.
needlefree, easy-to-use, generates less waste, and costs
less to implement than any other CSTD. www.icumed.com/
Fresenius Kabi Canada
We are dedicated to supporting health care professionals
oncology/index.asp.
by providing pharmaceuticals and medical devices. Our
International Society of Nurses in
Cancer Care
products are vital in the acute, surgical and therapeutic
International Society of Nurses in Cancer Care (ISNCC) is
treatment of patients and are used in the hospital and in
an international membership organization dedicated to the
outpatient care.
following charitable, educational and scientific purposes:
Fisher Health Care Inc.
1. Improving the health and well-being of people at risk
Fisher Health Care Inc. imports and distributes Fresenius
and partnerships, the Society influences and participates
Medical Treatment chairs, which are manufactured in
in setting directions for cancer nursing, health policy and
Australia. They work very well for oncology and dialysis
cancer control initiatives that are intended to improve the
departments and emergency rooms. They are relatively
health and well-being of people around the world.;
in the best therapy of chronically and critically ill patients
new to the Canadian market but in Australia they have
about a ninety percent market share. The chair is
appreciated by nurses and patients. The T688 has a lift
up feature so nurses no longer have to bend over during
procedures; removable upholstery for easy cleaning; nurse
and patient hand controls for flexibility and comfort; one
touch Trendelenburg position; and swing away arms for
easy transfers.
for or living with cancer. Through its strategic coalitions
2. Promoting the nurse’s role in improving cancer care.
The Society leads a global community of cancer nurses
to share, discuss and debate strategies and innovations
that advance clinical practice, education, research and
management.; and
3. Developing nursing leadership in cancer care delivery.
The Society supports the development of current and
emerging cancer nursing leaders globally.
121
Janssen Inc.
Our purpose: Make a difference
Leukemia and Lymphoma Society of
Canada
The Leukemia & Lymphoma Society of Canada® (LLSC) is a
As a member of the Janssen Pharmaceutical Companies
voluntary health agency dedicated to blood cancer. The LLSC
of Johnson & Johnson, Janssen Inc. is dedicated to
mission: Cure leukemia, lymphoma, Hodgkin’s disease and
addressing and solving the most important unmet medical
myeloma, and improve the quality of life of patients and their
needs of our time. Driven by our commitment to the
families. LLSC funds lifesaving blood cancer research across
passionate pursuit of science for the benefit of patients,
Canada and provides free information and support services.
we work together to bring innovative ideas, products and
services to patients across Canada and around the world.
Founded in 1955, LLSC has offices across Canada. To learn
more, visit www.llscanada.org or contact 1-877-668-8326.
Nous mettons la science au service des patients
À titre de membre du groupe des enterprises
pharmaceutiques Janssen de Johnson & Johnson, Janssen
Inc. s’emploie à répondre aux besoins non satisfaits les plus
importants de notre temps. Poussés par notre passion de
mettre la science au service des patients, nous collaborons
à de nouvelles solutions, produits et services pour le bien
des patients dans le monde entier.
Look Good Feel Better and
FacingCancer.ca
The Canadian Cosmetic, Toiletry and Fragrance Association
Foundation is dedicated to helping lives affected by cancer
through the Look Good Feel Better® and FacingCancer.ca
programs.
Look Good Feel Better offers free two-hour workshops
Kidney Cancer Canada
in 120 hospital and cancer care facilities, helping women
Kidney Cancer Canada is a charitable patient-led support
appearance. Women learn cosmetic tips and techniques,
organization established to improve the quality of life for
hair alternatives and cosmetic hygiene to help them look
patients and their families living with kidney cancer. Kidney
and feel more like themselves again. The workshop also
Cancer Canada advocates for access to new treatments,
provides a safe place where they can share stories and
provides support and information to patients, funds much-
insights with other women on the same journey. To learn
needed research, and works to increase awareness of
more, visit lookgoodfeelbetter.ca.
address the ways cancer and its treatment can affect their
kidney cancer as a significant health issue.
Our Vision: To improve the lives of Canadians affected by
kidney cancer.
FacingCancer.ca, is a warm and welcoming online
community where women with cancer, and those who
Our Mission: To improve the lives of Canadians affected by
support them, can give and get support for ‘everything
kidney cancer by advocating for access to new treatments,
else’ they’re going through with cancer. The online
promoting research, and providing support, information
network provides information, resources and tools to
and education.
help manage the many social and emotional effects of
The Kidney Cancer Canada Nurses Network (KCCNN)
cancer. To learn more, visit FacingCancer.ca
provides a national resource for nurses, nursing students
and other healthcare professionals working in the field of
renal cell carcinoma.
KCCNN Vision: To connect, educate, support and facilitate
collaboration between nurses practicing in the field of
kidney cancer across Canada, in an effort to improve
patient outcomes.
122
Lundbeck
Montreal-based Lundbeck Canada, proud sponsor of
Novartis Pharmaceuticals
Canada Inc
CANO 2012, is a subsidiary of H. Lundbeck A/S, a leading
Novartis Pharmaceuticals Canada Inc. is one of the world’s
international research-based pharmaceutical company.
leading healthcare companies committed to improving patient
For more than a decade, Lundbeck has been a respected
health. We discover and develop medicines that make a real
leader in developing and bringing central nervous system
difference. There can be no delay. Patients are waiting.
disorder treatments to Canadians in a way that reflects our
Danish origins of respecting every individual and taking
care of one another. It is with this mindset that Lundbeck
is bringing new oncology treatments to Canada, wishing
to give hope, strength and humanity to Canadian cancer
Oncology Nursing Society
The Oncology Nursing Society (ONS) is a professional
organization of more than 35,000 registered nurses and
patients. Visit us at lundbeck.ca
other healthcare providers dedicated to excellence in
Lymphoma Canada
oncology nursing. The overall mission of ONS is to promote
Lymphoma affects many people, from patients,
ONS is also a full-service publisher, with book titles in
family and caregivers, to medical professionals
symptom management, chemotherapy administration, and
and researchers. Lymphoma Canada connects and
survivorship, and will provide a bookstore for CANO/ACIO
empowers this community through education, support
members in the exhibit hall.
patient care, education, research, and administration in
excellence in oncology nursing and quality cancer care.
and research. Together we are promoting early
detection, finding new and better treatments, helping
patients access those treatments, learning lymphoma’s
many causes and finding a cure. For more information
about this registered charity, please visit lymphoma.ca
or call 1-866-659-5556.
On the Tip of the Toes Foundation
Since 1996, On the Tip of the Toes Foundation has
organized therapeutic adventure expeditions for
teenagers living with cancer. In 2013, the Foundation
has decided to open its expeditions to young adults
up to 29 years old. More than a trip into the wild, these
Merck
expeditions are a chance for them to share and be
Today’s Merck is a global healthcare leader working to help
the world be well. Through our medicines, vaccines, biologic
therapies, and consumer and animal products, we work with
customers and operate in more than 140 countries to deliver
innovative health solutions. For more information about our
operations in Canada, visit www.merck.ca.
La société Merck d’aujourd’hui est un chef de file
mondial dans le domaine des soins de santé qui vise à
aider le monde à vivre mieux. Grâce à nos médicaments,
vaccins, traitements biologiques, produits de santé
grand public et de santé animale, nous collaborons
avec nos clients et œuvrons à procurer des solutions de
santé novatrices dans plus de 140 pays. Pour de plus
amples renseignements à propos de nos activités au
Canada, visitez le site www.merck.ca.
understood, make new friends and face new challenges
together. By going beyond their limits and succeeding,
we aim to rebuild self-esteem and hope in life.
Depuis 1996, la Fondation Sur la pointe des pieds a
organisé des expéditions d’aventure thérapeutique pour
les adolescents atteints de cancer. C’est en 2013 que la
Fondation a choisi d’élargir sa mission afin d’accueillir
dans ses expéditions, les jeunes adultes allant jusqu’à
29 ans. Bien plus que des sorties de plein air, ces
aventures offrent une occasion de côtoyer des jeunes
qui partagent les mêmes réalités, d’échanger et de se
comprendre sans avoir besoin d’expliquer les choses.
C’est aussi une opportunité de tisser des liens d’amitié
en relevant ensemble des défis, comme bien des jeunes
souhaitent le faire à cette période de la vie.
123
Paladin Labs Inc.
Our commitment is reflected in everything Pfizer
Paladin Labs, headquartered in Montreal, Quebec, is a
community partnerships, to our belief that it takes more
specialty pharmaceutical company focused on acquiring
than medications to be truly healthy. To learn more
or in-licensing innovative pharmaceutical products for the
about Pfizer’s More than Medication philosophy and
Canadian and world markets. Key products include Tridural
programs, visit www.morethanmedication.ca. To learn
(extended-release tramadol for moderate persistent pain),
more about Pfizer Canada, visit www.pfizer.ca.
does, from our disease awareness initiatives to our
Abstral (fentanyl citrate sublingual tablets for breakthrough
cancer pain) and Metadol (tablet or solution of methadone
for severe pain).
Paladin est une compagnie pharmaceutique canadienne
dont ses produits principaux sont Tridural (tramadol à
libération prolongée pour la douleur modérée), Abstral
(comprimes sublinguaux de citrate fentanyl pour les
percées de douleur cancéreuse) et Metadol (comprimé
ou d’une solution de méthadone pour le traitement de la
douleur intense).
Pendopharm
Proven medicines. Dedicated people.
A division of Pharmascience Inc.
A Strong Focus on Specialty Medicines
PENDOPHARM is a rapidly growing and independent
business that focuses on commercializing a portfolio of
specialty prescription products and an established line of
OTC/BTC products.
Strategically committed to growth, PENDOPHARM is actively
engaged in licensing, developing and marketing late-stage
Rethink Breast Cancer
Rethink Breast Cancer is Canada’s leading breast
cancer organization focused on raising awareness
about younger women and breast cancer. Established
in 2001, our mission is to continuously pioneer
cutting-edge breast cancer education, support and
research that speak fearlessly to the unique needs
of young women. With our recent focus on advocacy
and our National Needs Assessment, we are pleased
to introduce our newest program: Rethink’s Young
Women’s Network (RYWN). RYWN is a group comprised
of women from across the country committed to raising
awareness about young women and breast cancer to
the greater community, supporting advocacy work and
assisting us in delivering our mission.
Roche Canada
From our approach to clinical trials for new drug
therapies, to industry partnerships and community
involvement, Roche Canada is a leader in providing
pharmaceutical and diagnostic solutions that make a
profound difference in people’s lives. Our innovative
prescription products as well as consumer brands.
approach improves the effectiveness and efficiency of
Pfizer Canada Inc.
management of acute and long-term disease.
Pfizer Canada Inc. is the Canadian operation of Pfizer
Inc., one of the world’s leading biopharmaceutical
companies. Our diversified health care portfolio
includes some of the world’s best known and most
prescribed medicines and vaccines. Every day, Pfizer
Canada employees work to bring therapies to patients that
significantly improve their lives. The company is a major
contributor to health research in Canada. We apply science
and our global resources to improve the health and well-
the healthcare system in the diagnosis, treatment and
Roche Canada employs approximately 1,000 people
across the country, with its pharmaceuticals head
office located in Mississauga , Ontario and diagnostics
division based in Laval , Quebec . We serve a broad
base of healthcare facilities and practitioners across
the country, working in partnership with them to ensure
that the diagnostics and therapies we deliver meet the
medial needs of today and of the future. For more
information, visit www.rochecanada.com
being of Canadians at every stage of life.
124
Sanofi
Sanofi, a global and diversified healthcare leader,
Shoppers Drug Mart Specialty
Health Network
discovers, develops and distributes therapeutic
Shoppers Drug Mart Specialty Health Network
solutions focused on patients’ needs. Sanofi has core
(SDMSHN) is a Canadian Specialty Healthcare
strengths in the field of healthcare with seven growth
company that delivers superior service to our customers
platforms: diabetes solutions, human vaccines,
optimizing healthcare outcomes. Our integrated
innovative drugs, consumer healthcare, emerging
National network of infusion/injection clinics, Specialty
markets, animal health and the new Genzyme.
Pharmacies and Healthcare Professionals place patients
Sanofi companies in Canada include sanofi-aventis
Canada Inc. (pharmaceuticals), Sanofi Pasteur
at the centre of care, delivering the support they need to
start and stay on therapy.
(vaccines), Sanofi Consumer Health (health and
Operating from our main facility in Mississauga and
beauty), Genzyme (rare diseases) and Merial (animal
complying with all Health Canada regulations SDMSHN
health). Together they employ more than 1,700
provides:
people, mainly in the greater Montreal and Toronto
areas. In 2011 Sanofi companies invested $151.7
- National Infusion/Injection Clinics
million in R&D in Canada, creating jobs, business
- Integrated Specialty Pharmacy
and opportunity throughout the country.
- Patient Assistance Solutions
- Customized National wholesaling and distribution
Sanofi est un leader mondial et diversifié de la santé
strategies
qui recherche, développe et commercialise des
- eSHN - Sales Solutions
solutions thérapeutiques centrées sur les besoins des
For more information on how SDMSHN can support your
patients. Sanofi possède des atouts fondamentaux
specialty product(s) please visit www.sdmshn.ca or
dans le domaine de la santé avec sept plateformes
contact us at: shninfo@sdmshn.ca
de croissance : la prise en charge du diabète, les
vaccins humains, les produits innovants, la santé
grand public, les marchés émergents, la santé
Takeda Canada Inc.
animale et le nouveau Genzyme.
Better Health, Brighter Future
Les sociétés Sanofi au Canada comprennent Sanofi-
For more than 230 years, we have been serving
aventis Canada Inc. (produits pharmaceutiques),
Sanofi Pasteur (vaccins), Sanofi Santé grand public
(santé et beauté), Genzyme (maladies rares) et
Merial (santé animale). Ensemble, elles emploient
plus de 1 700 personnes, principalement dans les
régions métropolitaines de Montréal et de Toronto.
En 2011, les sociétés Sanofi ont investi 151,7 millions
society with innovative medicines and helping
patients reclaim valuable moments of life from illness.
Now, with new healthcare solutions from preventative
to care and cure, we are determined to help even
more people enjoy their lives to the fullest. www.
takedacanada.com
de dollars dans la recherche et le développement
au Canada, créant ainsi des emplois, de l’activité
économique et des perspectives dans tout le pays.
125
Cough & cold relief for everyone.
Kim has
asthma
Did you know that many Canadians can’t take
common cough and cold products because they
contain drugs that can seriously interact or interfere
Anna takes
antidepressants
with prescription medications ? Helixia® remedies
*
contain only naturally sourced medicinal ingredients
and are clinically proven to relieve cold symptoms, with
NO known interactions with other medications.
Trusted in Europe for over 20 years,
Helixia is the medicine everyone can count on.**
Marcia takes
thyroid
medication
For more details, ask your pharmacist or visit
www.helixia.com
Lionel has
high blood
pressure
® Registered trademark of Pharmascience Inc.
* Including: diabetes, high blood pressure, heart, liver, kidney or thyroid disease, asthma or respiratory conditions, and many others.
** May not be suitable for everyone. Always read the label and follow the directions of use. †Contains sorbitol as a sugar substitute.
SUCROSE-FREE †
•
GLUTEN-FREE
•
DYE-FREE
•
ALCOHOL-FREE
PS 237 Annonce Helixia 3.indd 1
2013-09-11 4:24 PM
LET’S THINK
IF ONE OF US CAN COME UP WITH AN IDEA TO HELP OUR PATIENTS,
WHAT COULD ALL OF US COME UP WITH?
Supporting patients together.
www.sdmshn.ca
MEDICAL BREAKTHROUGHS MAY COME OUT OF THE LAB.
BUT THEY BEGIN IN THE HEART.
For more than 150 years, a very special passion has driven the
people at Merck. Our goal is to develop medicines, vaccines,
consumer care and animal health innovations that will improve
the lives of millions. Still, we know there is much more to be
done. And we’re doing it, with a long-standing commitment
to research and development. We’re just as committed to
expanding access to healthcare and working with others who
share our passion to create a healthier world. Together, we’ll
meet that challenge. With all our heart.
Copyright ©2013 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
All rights reserved.
Eisai_half_page_program_ad_FINAL.indd 1
2013-09-27 3:11 PM
Think What’s Possible!
Novartis Oncology is dedicated to answering unmet medical needs.
Our priority is to discover, develop and make broadly available novel
therapies that may improve and extend the lives of patients.
© Novartis Pharmaceuticals
Canada Inc., 2013
CANCER TAKES.
BAYER GIVES.
Our hope is that through research,
we will be able to help those with cancer enjoy their lives to the fullest.
www.bayer.ca
© 2013, Bayer Inc. Toronto, Canada M9W 1G6
® Bayer and Bayer Cross are registered trademarks of Bayer AG, used under license by Bayer Inc.
"!" " #" !
$#!
!
!
!"""
%!
Canadian Association of Nurses in Oncology
Association canadienne des infirmières en oncologie
CANO/ACIO Annual Conference 2013
Conférence annuelle ACIO/CANO 2013
www.cano-acio.ca

conference Program - CANO-ACIO

Transcription

Similar documents

Foreword - touchONCOLOGY

3134 West Highway 34 Post Office Box 4903 Grand Island, NE 68802

Welcome message from our new president, Piya Shult

Mary Ellen Smith Glasgow, PhD, RN, ACNS-BC

`Why I came here? It`s the Pounds...` `Dark, gloomy cold, brrr...... this

RNs are too! - Tact Medical Staffing

Gamma Alpha Chapter News

Treatment Planning: Flexible Options

Travel Nursing 101: Get the Facts